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This thesis describes investigations of small intestinal motility in horses with
and without equine grass sickness using an in vitro technique. Equine grass sickness is
a disease of horses of unknown aetiology, characterised by dysfunction of the
autonomic nervous system, primarily affecting the alimentary tract. Examination of
autonomic ganglia taken from horses affected with grass sickness shows evidence of
neuronal degeneration and ultimately depletion of cell numbers.
The in vitro technique implemented used strips of intestinal smooth muscle cut
parallel to the longitudinal muscle layer from the duodenum and ileum. Tissue was
taken from control horses and those affected with the three clinical forms of grass
sickness (acute [AGS], subacute [SAGS] and chronic grass sickness [CGS]). Motility
patterns were measured isometrically using strain gauge transducers and recorded
onto a Washington ink writing oscillograph. Contraction rate and amplitude,
alterations in tone (baseline) and the latency before a response to pharmacological
agents were recorded.
The characteristics of the background contractions were established. In the
control group the duodenal preparations had a significantly higher contractile rate
than ileal preparations (P<0.05). There was no significant difference in contractile
amplitude between the two regions. The contractile rate was reduced in grass sickness
cases, although not always significantly. The effect of storage for 24 hours at 4"C was
investigated to determine whether stored control tissue would subsequently behave
like fresh grass sickness tissue: it was concluded that this was not the case.
Physostigmine was used to establish the viability of enteric cholinergic
neurones and to test their capacity to release endogenous acetylcholine. All muscle
strips from both control horses and those affected with grass sickness showed
significant increases in the rate of contractions following physostigmine addition
(P<0.05 or less). The latency before a response to physostigmine in the AGS and
SAGS groups was significantly larger than for the control groups in both regions of
the gut (PcO.OOl for duodenal tissue, P<0.05 for ileal tissue). The effect of storage on
responses to physostigmine confirmed that neuronal cell death takes place during this
iii
storage period. Grass sickness tissue could no longer produce a significant increase in
contractile rate following physostigmine. Dose response curves to bethanecol were
constructed for control, AGS and CGS tissue. For the AGS group there was a
leftward shift of the dose response curve and a reduced ED50 value, which suggested
that the tissue has become supersensitive (denervation hypersensitivity). However,
there were no significant differences between the tissue sensitivity of the CGS and the
control groups.
Cisapride is a prokinetic drug which has been used with some clinical success
in the treatment of selected chronic grass sickness cases. Experiments using cisapride
indicated there was an increase in the contractile rate in control and CGS duodenal
muscle strips (P<0.06) and in control, AGS and CGS groups in ileal regions (P<0.06).
Cisapride also caused an increase in the amplitude of contractions in ileal muscle strips
taken from control horses (P<0.06).
In agreement with other workers, it was found that in vitro equine small
intestine contracts oa addition of noradrenaline or adrenaline. This contractile
response was found to be due to excitatory a2 receptors on the smooth muscle
membrane. Grass sickness affected tissue responded similarly to control tissue in the
duodenal region, however, in certain AGS and SAGS cases no contractile response to
noradrenaline could be achieved until tissue was pretreated with the (3 antagonist
propranolol. As cold storage had no significant effect on the contractile response to
noradrenaline it would suggest the response was independent of nervous elements.
A subjective histological scoring method was applied on sections of small
intestine adjacent to those used in pharmacological experiments, to investigate
neuronal cell number, size and the proportion of abnormal cells in the myenteric and
submucous plexuses. There was a significantly lower score for neuronal cell number
for the AGS and CGS groups compared with control values (P<0.05). The evidence
suggested that in CGS cases the largest enteric neurones were preferentially affected
by grass sickness (P<0.05). In the ileal AGS group, the proportion of abnormal cells
was significantly greater than both the control and CGS ileal groups (P<0.05). In the
duodenum there was no significant difference between the proportion of abnormal
cells between the AGS and CGS groups, although they were both awarded
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1.1 Equine grass sickness
1.1.1 History
Equine grass sickness, formerly known as 'grass disease', was first reported at
a military training camp at Barry, Forfarshire, UK, in 1907, although odd cases may
have been seen prior to this (Pool, 1928; Pool and Greig, 1928). The disease
subsequently progressed through other regions of Scotland and by the 1940's had
been recorded in Angus, Perthshire, Kincardinshire, Aberdeenshire, Fife, Inverness-
shire, Lothians, Lanarkshire, Renfrewshire, Ayrshire, Wigtown, Kircudbright and the
Tweed Valley. In 1939 the Agricultural Research Council carried out a survey which
reported that several hundred cases had also occurred in different parts of England in
the previous years (Greig, 1942). To date there have been no confirmed cases of grass
sickness in Ireland. Grass sickness has however, been recognised in Sweden,
Denmark, Germany, Belgium, France and Switzerland (Gilmour, 1989). There has
also been an isolated case in the Falkland Islands (Wood and Gilmour, 1991).
Similarities with the disease 'mal seco' in Argentina and Chile have lead to the
suggestion that this is the same disease (Uzal, Robles and Olaechea, 1992; Uzal and
Robles, 1993). Today the prevalence of grass sickness remains highest in Scotland,
but the incidence varies widely from district to district.
In the early 1980's clinical conditions with virtually identical pathological
changes to grass sickness were recognised in cats (Key and Gaskell, 1982) and dogs
(Rochlitz and Bennett, 1983). Despite almost epidemic outbreaks of the feline disease
at this time, the condition has now become uncommon. Similarities between these
diseases (collectively classified as dysautonomias) were extensively discussed at the
Waltham Symposium in 1984 (Edney, Gaskell and Sharp, 1987).
More recently, similar neuropathy to that seen in grass sickness has also been
recognised in wild hares (Whitwell, 1991; Griffiths and Whitwell, 1993). In man there
are no diseases recognised with identical pathological changes to those seen in grass
sickness. Primary autonomic failure and autonomic failure combined with Parkinson's
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disease, or associated with other neurological abnormalities, such as multiple system
atrophy, have been reported (Price, 1988). Hirschsprung's disease is a congenital
disease in children associated with an area of abnormal intrinsic innervation of the
large intestine (Trounce and Nightingale, 1960; Heaton, Garrett and Howard. 1988).
1.1.2 Epidemiology
Although principally a disease of horses and ponies, grass sickness has
occasionally been recorded in donkeys and once in a zebra (Ashton, Jones and
Gilmour, 1977; Gilmour, 1989). All breeds of horse appear to be equally susceptible
and whether animals are homebred does not appear to protect them from the disease
(Doxey, Gilmour and Milne. 1991a). Grass sickness appears to be rare during the first
year of life, and has only once been recorded in a suckling foal, which was 4 months
old (Milne, E.M., personal communication). There is evidence that the causal agent of
grass sickness does not cross the placenta. In pregnant mares which were euthanased
due to the disease, none of the foetuses examined exhibited the characteristic
histological changes seen in grass sickness (Whitwell. 1992). However, Gilmour
(1973b) reported that a full-term foal born by caesarean section to a mare with acute
grass sickness, had some of the lesions associated with grass sickness on histological
examination, following its death 24 hours after its birth.
Following surveys undertaken in 1971 and 1972, Gilmour and Jolly (1974)
concluded that grass sickness is more frequently encountered in animals between 2
and 7 years of age. No significant differences have been recorded in association with
the sex of the animals (Greig, 1942; Gilmour and Jolly, 1974: Doxey et al., 1991a),
with the exception of a preliminary study by Wood, Doxey and Milne (1994) which
suggests that mares are at less risk than male horses.
Grass sickness occurs most frequently in horses at pasture. Cases of grass
sickness in stabled horses given a diet free from green grass are rare. Gilmour and
Jolly (1974) reported that only 2% of grass sickness cases were stabled full time, in
their survey of 90 cases. Wood et al. (1994) however, reported that no horse with
grass sickness was stabled full time in their survey. Greig (1942) recorded that grass
sickness had frequently been observed in horses shortly after they had been moved
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from one pasture to another. Later, Gilmour and Jolly (1974) confirmed this, stating
that horses which had been on the premises for less than two months experienced
grass sickness more frequently than those kept there for longer periods (PcO.Ol).
Obel (1955) reported that at a Swedish remount station, animals acquired since the
previous spring were those commonly affected by grass sickness. Grass sickness is
also more likely to occur on premises previously affected than on those which have
never experienced the disease (Doxey et al., 1991a).
Grass sickness has a seasonal incidence, although cases are seen throughout
the year. Pool (1928) reported that 60% of cases occurred in June and that the
majority of these cases were of the acute type. As the season advanced, the disease
was reported to become more chronic in its manifestations. It should be noted that at
that time horses were turned out 'full-time' around 28th May. Doxey et al. (1991a)
reported that the greatest number of cases occurred in May (27.5%) and very few
cases occurred in August, January or February. August is often a very wet month in
Scotland (Doxey, Gilmour and Milne 1991b). However, cases are currently seen
throughout the year (Milne, E.M.. personal communication). Pool (1928) remarked
that cases became most numerous 10-14 days after most horses were put out at night.
However, Gilmour and Jolly (1974) found only a low proportion of affected animals
had been turned-out within four weeks before the start of the illness.
As early as the 1920's it was known that fine, dry, warm weather with frosty
nights appeared to be a predisposing factor for the disease, while it stopped after rain.
This has been confirmed by more recent epidemiological studies. Doxey et al. (1991b)
found an association between grass sickness and mean temperatures of 7-11°C in the
ten days preceding outbreaks of the disease on premises in Scotland. Ground frosts
are also often reported prior to the occurrence of the disease. Doxey et al. (1991b)
reported that in the 14 days preceding the first case of grass sickness during March,
April or May there was a mean number of seven frosty mornings.
Grass sickness is associated with varied topographical conditions and has been
encountered at all elevations from sea level up to 1200 feet (Greig, 1942). No
significant differences in the association of grass sickness and the nature of the pasture
has been found (Gilmour and Jolly, 1974; Doxey et al., 1991a). It occurs on new
3
grass leys, hill and moorland, rough grass and permanent pasture. Doxey et al.
(1991a) found that horses in good condition were more likely to get grass sickness
than would have been expected from their reference population (P<0.005).
Doxey et al. (1991a) also reported that (in the grass sickness population) there
was a high percentage of horses subjected to a stress such as foaling, castration or
breaking, although no statistical analysis was carried out on these data. With regard to
supplementary feeding, Gilmour and Jolly (1974) found that a higher proportion of
horses suffering from grass sickness received no supplementary feeding or only had
concentrates, compared with the group receiving hay with concentrates. However,
this was not confirmed by subsequent surveys (Doxey et al., 1991a; Wood et al.,
1994).
The mortality rate of grass sickness is high, approaching 90%. Most cases are
euthanased on humane grounds (Pogson, Doxey, Gilmour, Milne and Chisholm,
1992). There is no evidence that an attack of the disease confers immunity. The
disease does not appear to be contagious with only certain horses being affected on a
particular premises (Gilmour and Jolly, 1974).
1.1.3 Clinical signs
There are a number of publications which describe the clinical signs of grass
sickness in detail (Greig, 1942; Pinsent, 1989; Doxey, Milne, Gilmour and Pogson,
1991; Milne, 1991; Milne, Woodman and Doxey, 1994). The clinical signs vary with
the type of case and the stage of the disease. Grass sickness occurs in three
overlapping clinical forms; acute (AGS), subacute (SAGS) and chronic (CGS).
Horses with AGS show signs of depression. Nasogastric reflux is often present in
these cases, although spontaneous reflux is less common than reflux induced by
nasogastric intubation. Acute cases usually have dysphagia indicated by difficulty in
swallowing food and water, excessive salivation, and intestinal stasis with an absence
of gut sounds. Salivation is often periodically very profuse but there is some doubt
whether there is an absolute increase in salivary secretion, or whether it results from
accumulation of saliva in the mouth due to dysphagia. Horses usually appear to want
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to drink but are unable to do so in AGS. Signs of dehydration develop rapidly. Acute
cases die or require euthanasia within 48 hours of the onset of the clinical signs.
In SAGS and CGS the clinical signs are less intense but weight loss is a
marked feature. Muscle tremors and intermittent sweating are often present in these
cases and there is a tendency for tachycardia. The horse often chews slowly, food
drops out of the mouth and oesophageal choking may also occur. Horses frequently
adopt a huddled posture. All cases have a reduced appetite. Breathing is usually
normal in rate, but may sometimes be accompanied by a snoring sound from the nasal
cavity. Milne etal. (1994) reported that rhinitis was common in chronic cases and was
more severe in nonsurvivors.
In AGS and SAGS there may be secondary impaction of the large colon and a
few pellets of dry sticky faeces may be passed in the early stages of the disease. A
retention of urine has also been recorded. In geldings the penis is usually pendulous
(Pool, 1928). In SAGS cases, which live more than a few days after the onset of
clinical signs, there is an exceedingly rapid loss of condition, with the abdomen being
tucked up to an exaggerated degree. Most horses with SAGS die or require
euthanasia within two to seven days of the onset of the disease. A few cases progress
to the chronic form, classified as lasting eight days or more. Subclinical cases of grass
sickness are suspected to occur (Whitwell, K.E. discussion at the Waltham
Symposium, 1984).
There is no definite ante mortem test for grass sickness diagnosis at present
other than histopathological examination of ileal biopsies obtained at laparotomy
(Scholes, Vaillant, Peacock, Edwards and Kelly, 1993b). Confirmation otherwise
relies on post mortem examination of autonomic ganglia which show characteristic
lesions (see Chapter 1.1.5). The clinical signs of AGS and SAGS can be very similar
to certain types of equine colic. Analysis of peritoneal fluid demonstrates that grass
sickness cases have a higher specific gravity and protein content than cases of medical
colic, although the appearance of the peritoneal fluid is similar. Cases of surgical colic
associated with gut ischaemia tend to have bloodstained peritoneal fluid, and a higher
alkaline phosphatase activity than grass sickness cases (Milne, Doxey and Gilmour,
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1990). However, there is considerable overlap between the peritoneal fluid profile
obtained from grass sickness and colic cases.
1.1.4 Pathological Features
Gross post mortem findings tend to confirm the clinical observations.
However, the gross pathological findings are largely non-specific and cannot be
considered to be of a primary nature (Pollin and Griffiths, 1992). Linear erosions in
the lower oesophagus are often present (Pinsent, 1989). Acute cases show dilation of
the stomach and small intestine with greenish foul-smelling fluid (Milne, 1991). The
small intestine may also be found to be empty. Usually there are no gross lesions
found in the small intestine (Gilmour, 1987). The large colon and proximal small
colon show impaction of ingesta, which often has a characteristic black coating of
changed blood where it is in contact with the mucosa. However, gross mucosal
lesions, including haemorrhage, are not usually seen (Gilmour, 1987). Mucous coating
of faecal balls in the small colon in AGS and SAGS cases is sometimes seen (Milne,
1991). In SAGS and CGS cases there are few gross abnormalities, although the
gastrointestinal tract is generally empty and in chronic cases the carcase varies from
thin to emaciated (Milne, 1991). In chronic cases the spleen is often enlarged (Greig,
1942).
1.1.5 Histological Findings
Obel (1955) was first to describe the characteristic changes in the
paravertebral and prevertebral ganglia of grass sickness cases. She described
chromatolytic ganglia, pyknotic nuclei and vaculation of cytoplasm. Other
degenerative changes have since been recorded, such as loss of Nissl substance, foamy
cytoplasm, and eosinophilic bodies (Mahaffey, 1959; Gilmour, 1975a; Hodson,
Wright, Edwards. Mescall, Suswillo, Evans and Jeffries, 1984). Obel reported similar
changes in the submucous plexus, but only slight changes in the myenteric plexus in
acute cases of grass sickness. However, the specificity of these changes to grass
sickness alone has been questioned (Brownlee,1959; 1965; Schuffler, 1990; Valentine,
De Lahunta, George, Summers, Cummings, Divers and Mohammed, 1994).
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Barlow (1969) observed that the severity of the lesions in grass sickness cases
appeared to be directly proportional to the duration of the clinical illness i.e. CGS
cases showed extensive chromatolysis. Gilmour (1973a) examined the autonomic
ganglia, as well as certain brain stem nuclei and the intermedio-lateral nucleus of the
spinal cord from 35 cases of grass sickness. He found that ganglionic lesions were
related to the clinical severity of the disease rather than the duration of the illness. He
suggested that chromatolysis of autonomic neurones may occur coincidentally with,
or in advance of alimentary dysfunction, rather than as a consequence of it. Doxey,
Pogson, Milne, Gilmour and Chisholm (1992) found no connection between the
severity of the clinical signs of AGS and SAGS and the amount of neuronal damage in
the superior cervical, stellate and coeliaco-mesenteric ganglia. A higher proportion of
normal neurones were found in chronic cases than acute cases (60% normal neurones
were observed in CGS compared with 26% for AGS, 25% for SAGS and 100%
normal neurones in the control group). Only neuronal damage in the submucous
plexus of the jejunum correlated with clinical severity in their study. Scholes, Vaillant,
Peacock. Edwards and Kelly (1993a) reported that enteric neuropathy was
widespread in acute cases but was localised to the distal small intestine in chronic
cases.
Electron microscopical studies of ultrastructural changes that occur in grass
sickness have been undertaken. Gilmour (1975a) first described the appearance of
neuronal nuclei in grass sickness affected ganglia which were crenated, sited
eccentrically in the perikaryon and had increased electron density of the nucleoplasm.
Eosinophilic bodies were also observed which resembled dystrophic axons (Gilmour,
1975b). Pollin and Griffiths (1992) suggest that the lesions seen in grass sickness
primarily involve the glycoprotein biosynthetic pathway of neurones and state that
numerous toxins are known to have an effect on the organelles associated with
protein synthesis in neurones.
The neuropathy of the enteric nervous system is discussed further in Chapter
7. The possible mechanism(s) for the neuronal damage which occurs in grass sickness
is discussed in Chapter 1.3.
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1.1.6 Possible aetiology
Despite intensive investigation, the cause of grass sickness is still a mystery.
Greig (1928) first noted the similarity of the clinical signs of grass sickness with those
of sympathicotonia. The one exception was the pupil which is rarely dilated in grass
sickness. However, Greig (1928) and others found no appreciable effect upon the
pupil following intravenous injection of adrenaline in the horse, which could explain
this exception.
In 1942, Greig reviewed the early hypotheses of aetiology which included
plant poisoning, a dietary deficiency, anaphylaxis, digestive disturbances (from
poisonous products of intestinal origin), a toxic chemical substance developed in the
pasture and living infective agents (invasive bacteria, protozoae parasites, fungal
toxins, a toxin-producing bacterium and a filtrable virus). Tocher (1924) put forward
a theory that grass sickness was caused by Bacillus botulinus, now known as
Clostridium botulinium. There are some similarities between the clinical signs of grass
sickness and botulism, however, botulism is usually associated with paralysis of the
tongue and jaw which are not seen in grass sickness.
An association between Clostridium perfringens Type A enterotoxin and
'grass sickness' seen in Columbia was suggested (Ochoa and de Velandia, 1978).
Gilmour, Brown and Johnson (1981) repeated the seroneutralisation tests carried out
by Ochoa and de Velandia but their results suggested that there was no association
between Clostridium perfringens Type A enterotoxin and grass sickness in Scotland.
They therefore proposed that grass sickness in Europe and the equine disease in
Columbia have a different aetiology.
The epidemiology, and particularly the association with grazing, or a change in
pasture, suggests that grass sickness is caused by a toxin ingested with the herbage.
Doxey, Robb, Milne and Gilmour (1990) discussed the possibility that grass sickness
was due to a fungal toxin: grass sickness occurs in spring and early summer when
fungal activity in pasture is high. They also suggested that the histological damage
present in grass sickness was similar to that associated with a toxic process. However,
the fungi isolated exclusively from horses with grass sickness in their study were
uidikely to be toxin producers. It is possible that common fungi present in all horses
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require specific conditions for toxin elaboration, or that there is a specific sensitivity
of individual animals to specific fungal toxins.
Gilmour (1973b) and Gilmour and Mould (1977) experimentally reproduced
the neurological lesions of grass sickness by injecting normal ponies with serum and
plasma from acute cases, confirming that a neurotoxin is present. However,
subsequent work has failed to identify this neurotoxin (Johnson, Dawson and
Mould, 1983; Johnson, 1985; Pemberton, Hodgson, Gilmour and Doxey, 1990).
Griffiths, Smith, Doxey, Whitwell and Love (1994) injected serum from cases of grass
sickness into the parotid salivary gland of experimental ponies and after a week,
pathological changes similar to those found in the natural disease were found in the
cranial cervical ganglion. This suggests there was a specific effect on the post
ganglionic neurone supplying the tissue which was injected and that there was
retrograde axonal transport to the cell body.
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1.2 Gastrointestinal motility regulation
1.2.1 Introduction
To understand the pathophysiology of equine grass sickness a detailed
knowledge of gastrointestinal motility in the horse is required. Despite the fact that
disturbances of the gastrointestinal tract account for a large proportion of clinical
disorders in the horse, there has been limited research into the regulatory mechanisms
involved in the control of gastrointestinal motility (Davies and Gerring, 1983; Adams,
Lamar and Masty, 1984; Sellars, Lowe and Rendano, 1984; Gerring and Hunt, 1986;
Lester, Bolton and Thurgate, 1992). In addition to these studies, the following
account summarizes the structural and functional features of the gastrointestinal tract
using equine references wherever possible.
1.2.2 Structure of the gastrointestinal tract
The structure of the gastrointestinal tract varies throughout its length, but
there are common features in its overall organization. The general layered structure of
the wall of the gastrointestinal tract is shown in Figure 1.1.
The serosa is the outermost layer and consists mainly of connective tissue
covered with a layer of squamous mesothelial cells. The muscularis externa consists of
two layers of smooth muscle, an outer longitudinal layer and an inner circular layer.
Between these muscle layers lies the myenteric plexus (Auerbach's plexus). The
submucosa consists of loose connective tissue with collagen and elastin fibres. Within
the submucosa there is a network of small ganglia and connecting strands which form
the submucous plexus. In the horse this plexus can be divided further into the internal
submucous plexus (ISP), which lies closest to the mucosa, and the external
submucous plexus (ESP), which is closer to the circular smooth muscle (Pearson and
Woodman, 1992; Pearson, 1994). The mucosa is made up of an epithelium, the lamina
propria and the muscularis mucosae (Guilford, 1990; Herdt, 1992).
In the enteric nervous system of the pig, which has a similar structure to the
horse, it is suggested that there are different physiological functions for the ISP and
ESP, the former being involved with mucosal events and the latter with circular
muscle control (Gunn, 1968).
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Figure 1.1. Diagramatic representation of the structure of the wall of the
gastrointestinal tract, A) in whole mount, B) in transverse section,
(modified from Furness & Costa, 1980, Neuroscience 5, 1-20).
11
1.2.2.1 Overview of gastrointestinal control mechanisms
The gastrointestinal tract is regulated at two levels. One level of control is by
the extrinsic autonomic nervous system and endocrine systems, the second is by
intrinsic nerves (the enteric nervous system) and endocrine components located within
the gut. This intrinsic level of control allows the gut to regulate its function
autonomously based on local conditions, such as distension of the gut wall and
chemical stimuli. Control of the gut by the central nervous system is mainly secondary
to the enteric mechanisms, although there are regional differences along the length of
the gastrointestinal tract (Thompson, 1991). The small intestine is heavily dependent
on the enteric nervous system whereas the stomach relies on extrinsic nerves such as
the vagus for some of its reflexes (Grundy, 1985: Kutchai, 1993).
The extrinsic autonomic nervous system of the gastrointestinal tract can be
divided into the parasympathetic nervous system, which generally increases
gastrointestinal motility and the sympathetic nervous system, which opposes motility.
Preganglionic parasympathetic nerves are always excitatory but they can synapse with
excitatory or inhibitory enteric neurones. Preganglionic sympathetic nerves synapse in
the paravertebral or prevertebral ganglia. Postganglionic sympathetic fibres either
directly inhibit the smooth muscle or have an inhibitory effect on excitatory or
inhibitory enteric neurones (Guyton, 1991; Kutchai. 1993).
The pharmacological receptors involved in parasympathetic and sympathetic
gastrointestinal motility control can be divided into cholinoceptors and adrenoceptors
respectively. Cholinoceptors are further divided into nicotinic and muscarinic
receptors and adrenoceptors can be divided into alpha and beta adrenoceptors
(Furness and Costa, 1987). Nonadrenergic noncholinergic (NANC) inhibitory nerves
also innervate the gastrointestinal tract. These nerves contribute to propulsion of
material, the reflex opening of sphincters, the receptive relaxation of the stomach, and
descending inhibition during peristalsis (Kutchai, 1993). Several substances are
believed to be transmitters in NANC nerves such as adenosine triphosphate (ATP)
(Ruckebusch, Paneuf and Dunlop, 1991) and nitric oxide (Maczka, Thor, Lorens and
Konturek, 1993: Wiklund, Leone, Gustafsson and Moncada, 1993). The NANC
mechanisms are not discussed further within this thesis.
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Certain hormones have important physiological roles in the control of
gastrointestinal motility (for review see Walsh, 1987). Hormones are signalling
molecules that are transmitted around the body via the blood stream. Many hormones
may also act as neurotransmitters. Gastrointestinal hormones are all peptides, thus the
term neuropeptide may be used to describe hormones such as gastrin and
cholecystokinin (CCK).
1.2.3 Properties of intestinal smooth muscle
Intestinal smooth muscle possesses a mechanism for the self generation of
rhythmic changes in excitability. These recurrent depolarizations of the muscle are
referred to as slow waves, basic electrical rhythm, electrical control activity, or
pacesetter potentials (Grundy, 1985). Intestinal motility depends on the
superimposition of the action of nerves and hormones on this underlying rhythm.
While it is clear that slow waves are generated by muscle (or at least not by
nerves), the ionic basis for the oscillations in membrane potential is not known. There
is controversy as to whether the slow waves are due to oscillations in ionic
permeability (increased sodium permeability being involved in the depolarizing phase;
increased potassium permeability in repolarization) or to oscillation in a metabolically
driven sodium pump (Daniel and Sarna, 1978; Benham and Bolton, 1983; Furness and
Costa, 1987). Grundy (1985) presents good evidence for slow waves being due to the
oscillatory activity of the electrogenic sodium/potassium pump. However, the ionic
mechanism may not necessarily be the same in gastrointestinal smooth muscle of the
horse.
When the membrane potential reaches a particular threshold, voltage
dependent channels in the membrane are opened, spikes (or action potentials) are
generated and the muscle contracts. In alimentary smooth muscle, spiking activity
depends on the inward movement of calcium ions and, therefore, unlike action
potentials in nerves and skeletal muscle, they are resistant to treatment with
tetrodotoxin (Wood, 1972). Slow waves have a major role in setting the frequency of
muscle contraction. The activity of nerves determine the amplitude of contraction
associated with each slow wave (Furness and Costa. 1987).
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The intrinsic frequency of slow waves (cycles/min) and velocity of propagation
along the intestine (cm/min) varies with species and region of the gastrointestinal
tract. Slow wave activity and spike bursts (contractile activity) have been recorded
from the stomach, small intestine, caecum and colonic pelvic flexure of horses using
electromyography. Davies and Gerring (1983) reported that the frequency of slow
waves varies inversely with the distance from the duodenum in the horse. The
frequency of slow waves measured ranged from 11.9-15.5 per minute in their study.
Rates of slow waves of 5/min for the stomach, 15/min for the duodenum, 10/min for
the ileum and 12-13/min for the pelvic flexure have also been reported in the horse
(Ruckebusch, 1973: Adams etai, 1984; Lester et al., 1992).
Smooth muscle cells are arranged in bundles and are electrically coupled to
each other. The occurrence of slow waves in one area therefore influences those in the
next. In the equine gastrointestinal tract, there are thought to be at least three
pacemaker regions. One is located in the gastric antrum and responsible for the
progression of the migrating motor complex (phase III, see next paragraph) along the
small intestine. This pacemaker also coordinates activity between the antral region of
the stomach and duodenum to permit gastric emptying (Gerring, 1991). The second
pacemaker is near the pelvic flexure and it is responsible for the bidirectional
contraction waves needed both to retain digesta within the right ventral colon for
microbial fermentation and to transport the digesta distally once this process is
completed (Sellars. Lowe, Drost, Rendano, Georgi and Roberts, 1982; Sellars and
Lowe, 1986; Ross. Donawick, Sellars and Lowe, 1986). The third pacemaker has
been described near the apex of the caecal body, which is thought to be associated
with the origin of a progressive series of coordinated spike bursts, which conduct
through the caecocolic orifice and continue into the right ventral colon (Ross,
Rutkowski, and Cullen, 1989). lessen and Thuneberg (1991) suggested that the origin
of the pacemakers in the guinea pig is the interstitial cells, a thin layer of which are
present at the border between the circular and longitudinal smooth muscle layers.
Phaneuf and Ruckebusch (1983) reported that in the horse stomach and small
intestine, slow waves originate from the longitudinal smooth muscle layer.
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The migrating motor complex (MMC) is the pattern of myoelectrical activity
which propagates aborally along the intestine and occurs at regular intervals
(Wingate, 1981). The spiking activity relates to contraction of the muscle. The MMC
can be divided into 3 phases; phase I is slow waves with non-spiking activity (NSA),
phase II is irregular spiking activity superimposed on the slow waves (ISA) and phase
III is regular spiking activity (RSA) (Gerring, 1991). ISA is associated with peristaltic
activity whereas RSA corresponds to rhythmic segmentation (Phaneuf and
Ruckebusch, 1983). Adams et al. (1984) recorded periods of NSA, ISA and RSA in
the horse, the mean interval from one RSA period to the next was 65.5 minutes. In
the fasted horse, the MMC occurs about 20 times a day (Davies and Gerring, 1983).
The velocity of MMC propagation is usually greater in the more proximal regions of
the gut. A mean value of 7.3cm/min was recorded in the distal jejunum in the horse
(Davies and Gerring, 1983). They estimated that the mean velocity throughout the
whole small intestine was 32cm/min, which implies that at other regions the velocity
of propagation is much higher. The mechanisms which initiate, drive and terminate the
MMC are not fully understood. Ruckebusch (1981) suggested that the origin of the
MMC was the antral region of the stomach, although in some species, such as sheep,
the complex originates in the duodenum. It is suggested that the MMC is triggered by
the release of a hormone or hormones. Duodenal alkalisation. which occurs after
eating, has been found to stimulate the release of the hormone motilin. Injecting
motilin induces premature MMC-like activity in the dog (Lee. Chey, Tai and Yajima,
1978; Walsh, 1987). Thus hormonal release may be related to, but not necessarily be
the causal factor of MMC initiation. The initiation of the MMC may be due to some
'neural clock' in the enteric nervous system which gradually alters the activity of
neurones (Furness and Costa, 1987). The propagation of the MMC depends on the
enteric nervous sytem. as complete extrinsic denervation does not interrupt the MMC
progression (Bueno, Pradduade and Ruckebusch, 1979; Oliveira, Meneghelli, Godoy,
Dantas and Padovan, 1989). In certain species (e.g. dog, cat, and human), but not in
the horse, interruption of the MMC occurs after feeding. This is probably due to a
number of factors, such as chemical stimulation of the mucosa by nutrients (Furness
and Costa, 1987).
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The MMC is not a feature of the large intestine. Analysis of electromyographs
from this region in the horse is based on the duration of the bursts of spiking activity.
Short spike bursts (SSB) last less than 5 seconds and are usually localised or
unpropagated, associated with mixing the digesta. Long spike bursts (LSB) last 10-20
seconds and are spread aborally and/or orally from a pacemaker in the pelvic flexure.
LSB are associated with powerful contractions and the propulsion of digesta (Phaneuf
and Ruckebusch, 1983). The relative percentages of SSB and LSB activity determine
the retention time and alterations from normal may result in constipation or diarrhoea
(Adams, 1987).
1.2.4 The enteric nervous system
The enteric nervous system can be defined as the system of neurones and their
supporting cells which is found within the walls of the gastrointestinal tract, including
the neurones within the pancreas and gall bladder (Furness and Costa, 1987).
Numerous descriptions of the morphology and arrangements of the enteric ganglia
and plexuses are available, although most studies have been carried out in laboratory
species (Dogiel, 1899; Gabella, 1976; Furness and Costa, 1987; Wood, 1987;
Furness, Bornstein and Trussed, 1988). Extrapolation of observations from the guinea
pig to larger animals may not be justifiable. For example the submucous plexus of the
horse (Pearson, 1994), humans (Hoyle and Burnstock, 1989) and pigs (Gunn, 1968;
Scheurmann, Stach, Timmermans and Adriaensen, 1989) can be divided further into
two plexuses, unlike the rat and guinea pig (Furness and Costa, 1987).
Functional studies have shown that there are several physiologically distinct
neuronal cell types in the enteric nervous system. These include both excitatory and
inhibitory motor neurones to the muscle, vasomotor neurones, secretomotor
neurones, interneurones and sensory neurones (Hirst, Holman and Spence, 1974;
Erde, Sherman and Gershon, 1985; Katayama, Lees and Pearson, 1986). The main
physiological functions of the enteric nervous system are the control of
gastrointestinal motility and blood flow, together with intestinal fluid and electrolyte
secretion. Most neurones influencing motility are situated in the myenteric plexus
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(Furness and Costa. 1987; Wood, 1987). The submucous plexus is involved in the
control of secretion and absorption.
In the last 20 years, it has been found that a number of different substances,
some of which may be neurotransmitters, are released in the gastrointestinal tract.
These include acetylcholine, noradrenaline, substance P, vasoactive intestinal
polypeptide (VIP), dopamine, ATP, enkephalin, somatostatin, dynorphins, 5-
hydroxytryptamine, neuropeptide Y, neurotension, galanin, calcitonin gene-related
peptide, angiotension, peptide HI, endorphins, gastrin releasing peptide, substance K,
CCK and gamma-aminobutyric acid (Furness and Costa, 1987; Wood, 1987). The
physiological roles of many of these substances with regards to control of
gastrointestinal motility have been difficult to elucidate because they belong to groups
of molecules with wide-ranging hormonal functions, in addition to any actions as
neurotransmitters (Dockray, 1987).
Acetylcholine is the dominant excitatory neurotransmitter (Grundy, 1985).
Substance P is released by nerve stimulation and is probably also an excitatory
transmitter (Leander, Hakanson, Rosell, Folkers, Sundler and Tomquist, 1981). It
also probably contributes a non-cholinergic excitatory component in the peristaltic
reflex. There is evidence that VIP is an inhibitory transmitter to intestinal muscle, a
vasodilator and a stimulant of mucosal water and electrolyte secretion (Furness and
Costa, 1987). Dopamine is thought to be a neurotransmitter for interneurones and is
the probable mechanism by which the sympathetic system effects some inhibitory
control (Gerring, 1991). ATP is postulated as a transmitter from enteric inhibitory
neurones but there is no adequate pharmacological antagonist to confirm this
hypothesis (Grundy, 1985). In the horse, very little work has been carried out on
possible functions of neuropeptides. Prostaglandins, such as prostaglandin El, can
increase motility in the gastrointestinal tract in ponies (Hunt and Gerring, 1985).
Immunohistochemical methods have allowed more detailed studies of the
enteric neuronal circuitry. The distributions of nerve cell bodies and fibres showing
immunoreactivity for putative neurotransmitters (mostly peptides) have been studied
in detail for certain species, mainly the guinea pig (Costa and Furness, 1983; Ekblad,
Ekman, Hakanson and Sundler, 1984). It is now generally accepted that each enteric
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neurone contains more than one neuropeptide i.e. that colocalisation occurs (Furness
and Costa, 1987). There have been some recent immunohistochemical studies carried
out in the horse (Sabate, Stephenson, Bishop, Probert, Cole, Hodson, Yeats, Bloom
and Polak, 1983; Merighi, Kar, Gibson, Ghidella, Gobetto, Peirone, Polak, 1990;
Burns and Cummings, 1991 and 1993; Pearson and Woodman, 1992; Pearson, 1994).
Pearson (1994) found immunoreactivities for galanin, VIP, and neuropeptide
Y in each of the enteric plexuses of the horse. Substance P was found in the enteric
nerve fibres of the horse, but reactivity was weak in the cell bodies of the submucous
neurones and less common in the cell bodies of the myenteric plexus. To date, there
are no published studies on colocalization in the horse, although neuropeptide Y and
galanin have been found to be colocalised in equine enteric neurones (Pearson, G.T.,
unpublished observations).
1.2,4.1 Reflexes in the enteric nervous system
Bayliss and Starling (1899) proposed the Law of the Intestine of ascending
excitation and descending inhibition in response to a distension of the gut by a bolus,
now commonly known as peristalsis or the peristaltic reflex. Langley and Magnus
(1905) established that this reflex was due to intrinsic reflex circuits from in vitro
experiments using rabbit gut. Even though this reflex was identified almost 100 years
ago, there are still a number of questions that remain unanswered about its neural
circuitry, including the nature of the chemical transmitters, type and location of
sensory structures involved, and the type of stimuli that initiate the physiological
response. After distension of the gut, the increase in amplitude of contractions oral to
the distension is due to an increase in the number and frequency of spikes
superimposed on every slow wave. Usually there is also a slight increase in slow wave
frequency in the excited area. Furness and Costa (1987) suggest that the appearance
of this new pacemaker area, associated with distension, was induced by acetylcholine
being released from enteric cholinergic nerves, which are the final neurones of this
reflex pathway. If the distension is more marked, the spikes may occur between, as
well as on top of, the slow waves, resulting in a stationary ring of tonic contraction.
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On the aboral side of the distension the existing contraction of the circular
muscle ceases almost instantly. The corresponding spikes disappear although the slow
waves can still be recorded. Two mechanisms contribute to descending inhibition; the
actions of inhibitory motor neurones that cause inhibitory junctional potentials in the
muscle (Hirst and McKirdy, 1974) and the inhibition of the excitatory cholinergic
motor neurones. The latter has been shown to be by a presynaptic mechanism and is a
consequence of a reduction in neurotransmitter release (Grundy, 1985).
Conclusions from the work to date are as follows: that interruption of the
myenteric plexus abolishes the peristaltic reflex; the ascending excitation seen in the
peristaltic reflex is blocked by muscarinic antagonists such as atropine or hyosine;
there is also a non-cholinergic component of the reflex which is blocked by nicotinic
antagonists such as tubocuarine, by substance P receptor desensitization or by
substance P receptor antagonists; descending inhibition is mediated by a NANC
transmitter, possibly VIP (Wood, 1987).
1.2.4.2 Reflexes involving the extrinsic nervous system
In the horse, if there is an obstruction in the gut the circular muscle proximal
to the obstruction contracts. Should this persist, repeated vascular compression and
increased metabolic demands may damage the intestinal mucosa and musculature. The
intestino-intestinal inhibitory reflex acts to prevent this damage and results in the
inhibition of the whole gastrointestinal tract (MacHarg, Adams, Lamar and Becht,
1986). This reflex involves the extrinsic nervous system.
1.2.5 Mechanisms of action of drugs enhancing gastrointestinal motility
Drugs are chemical substances which interact with biological systems and
change them in some way. They are rarely selective and therefore have side actions as
well as their main pharmacological action. There are a number of different
mechanisms by which drugs work, with many acting by more than one mechanism
(Adams, 1987). A number of drugs have an effect on the gastrointestinal tract.
Anticholinesterase drugs (physostigmine, neostigmine) combine reversibly
with endogenous cholinesterase thereby promoting accumulation of endogenous
t?
acetylcholine in tissues to produce both muscarinic and nicotinic effects. Neostigmine
is used clinically in the horse but may cause pain associated with intestinal spasm
(Adams etal., 1984).
Other drugs act directly on the smooth muscle e.g. bethanecol, a muscarinic
cholinergic receptor agonist, which is unaffected by cholinesterases (Kilbinger and
Weihrauch, 1982). Bethanecol causes nonspecific cholinergic-like stimulation of the
gastrointestinal smooth muscle, but it lacks the ability to coordinate intestinal motor
activity. Its clinical use is therefore limited.
Cholinergic drugs are rarely administered to horses because of their unwanted
side effects (Adams, 1987). Anticholinergic drugs e.g. atropine and glycopyrrolate are
administered to horses for their cardiovascular effects. These drugs decrease motility
and their effects may last beyond the duration of an anaesthetic (Roberts and
Argenzio, 1986).
There is a group of prokinetic drugs e.g. metoclopramide. domperidone and
cisapride, which have the ability to increase coordinated motor activity resulting in a
net aboral movement of digesta. Metoclopramide increases tone in the lower
oesphageal sphincter, increases the force and frequency of gastric antral contractions,
relaxes the pyloric sphincter, promotes peristalsis in the duodenum and jejunum,
resulting in accelerated gastric emptying and upper intestinal transit (Pinder, Brogden,
Sauyer, Speight and Avery, 1976; Burrows, 1983). Metoclopramide improved transit
time and restored coordination of gastric and small intestinal activity in an
experimental model of post operative ileus (POI) in ponies (Gerring and Hunt, 1986).
The mechanism of action is poorly understood, even though it is clearly a
dopaminergic antagonist. The gastrointestinal effects of the drug can be blocked by
the local or systemic administration of dopaminergic agonists. Albibi and McCallum
(1983) suggest its action is due to either its effects on cholinergic nerve terminals
and/or its antidopaminergic properties.
Domperidone possesses both prokinetic and antiemetic properties. It is also a
dopaminergic antagonist whose effects closely resemble those of metoclopramide
(Laduron and Leysen, 1979). Gerring and King (1989) reported domperidone is
effective in restoring electrical and mechanical activity, coordination between gastric
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and small intestinal activity cycles and the stomach to anus transit time in POI models
in experimental ponies. Cisapride is discussed in further detail in Chapter 5.3.
Adrenergic agonists e.g. noradrenaline, dopamine and isoproterenol are not
currently used clinically to modify intestinal motility, but are commonly used in
general anaesthesia. They inhibit gut motility by direct inhibition of the smooth muscle
or by decreasing the release of acetylcholine from enteric neurones (Adams, 1987).
Adrenergic antagonists such as yohimbine (an alpha antagonist) produce a slight
increase in propulsive motion in the intestines of ponies with experimental ileus
(Gerring and Hunt, 1986).
1.2.6 Conclusion
The control of gastrointestinal motility can be divided into myogenic, neural
and humoral components. This thesis is concerned with the enteric nervous system.
To date only very limited investigation into the morphology, histology, physiology
and transmitter neurochemistry of the enteric nervous system of the horse have been
performed. There is considerable evidence of pathological changes in the enteric
nervous system that are associated with disorders of the gastrointestinal tract (Smith,
1972). In the horse, enteric neuropathy has been reported in cases of grass sickness
(Doxey et al., 1992; Scholes et al., 1993; Doxey, D.L., Milne, E.M., Woodman,
M P, Gilmour, J.S. and Chisholm, H.K. submitted for publication). An improved
knowledge of enteric neuropathy in the horse and the possible mechanisms for




The enteric nervous system may be affected by a wide variety of pathological
processes which include congenital, degenerative, inflammatory, metabolic and
parasitic disease. The aetiology of grass sickness is unknown but there is evidence to
suggest that a neurotoxin may be implicated (Gilmour, 1973b; Gilmour and Mould,
1977). The route by which the putative neurotoxin reaches susceptible neurones is
unknown.
Although a great deal is known about the histological, ultrastructural and
chemical effects of chronic denervation on skeletal muscle, little is known about
denervation in alimentary smooth muscle. However, the end result of damage to
intrinsic nerves is loss of coordinated peristalsis, smooth muscle hypertrophy and
dilation of the lumen (Smith, 1972; Heaton, et al., 1988).
This section includes discussion of mechanisms of neuronal cell death, the
phenomenon of neuronal cell depletion with age and some congenital enteric diseases.
1.3.2 Mechanisms of cell death
The mechanism of neuronal cell death which occurs in cases of grass sickness
is unknown. In cell degeneration there may be a loss of cellular material (atrophic) or
an accumulation of cellular constituents (dystrophic), both of which result in cellular
necrosis (Agid and Blin. 1987). Necrotic cells have leaky membranes through which
intracellular constituents escape and normally excluded extracellular molecules, such
as calcium, enter (Schanne. Kane, Young and Farber, 1979; Nayler, 1981). The mode
of action of calcium in cell death is uncertain. It is known to inhibit the membrane
sodium/potassium ATPase and thus calcium in abnormally high concentrations could
abruptly amplify the intracellular sodium gain and potassium loss. However, it appears
more likely that the primary site of action of the incoming calcium is on membrane
lipids, activating phospholipase and thus initiating the dissolution of membranes
(Wyllie, Duvall and Blow. 1984). It is possible that the uncontrolled swelling of the
injured cell, resulting from fluid influx secondary to the failure of membrane pumps,
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itself promotes irreversible changes through physical disruption of the membranes
(Ganole, Worsted, Iannotti and Kaltenbach, 1977).
Lysosomes appear to play little part in the initiation of necrosis, although their
contents become dispersed in the later phases and probably contribute to the terminal
intracellular disruption (Wyllie et al., 1984). It is thought that lysosomal hydrolases,
leaking from necrotic cells, may also cause secondary effects on adjacent tissue cells,
including the initiation of inflammatory and reparative responses, however the
evidence for this is not conclusive (Wyllie et al., 1984). Instead, products of
membrane phospholipids such as platelet activating factor may be responsible
(Camussi, Pawlowski, Tetta. Forrinello, Alberton, Brentjens and Andres, 1983).
Some workers (Gilmour. 1975b and 1976; Hodson and Wright, 1987) have
proposed that in cases of grass sickness the axonal lesions are primary and that the
changes to the neuronal cell body represent a retrograde axonal reaction, such as that
seen after axonotomv. However, Pollin and Griffiths (1992) suggested that the
primary effect is on the neuronal cell body and that axonal changes are secondary.
Most recently Griffiths, et al. (1994) suggested that the putative neurotoxin gains
access to the axon terminal and is then transported retrogradely along the axon to the
neuronal cell body where it exerts its toxic effect.
There are numerous examples of agents such as viruses, lectins and
neurotoxins being transported retrogradely along axons to neuronal cell bodies
(Grafstein and Forman, 1980; Harper, Gonatas, Mizutani and Gonatas, 1980; Wiley,
Blessing and Reis, 1982; Wiley, Donohue-Rolfe and Keusch, 1985).
Grafstein and Forman (1980) reviewed intracellular transport in neurones and
reported that the rates of retrograde axonal transport vary from about 75 to 500mm
per day. If similar rates of transport occurred in the horse, neurones with short
processes such as those found in the enteric nervous system would be damaged within
one or two days of exposure to the toxin in the gut lumen.
Other routes for the 'neurotoxin' spread in grass sickness cases such as cell to
cell transfer between Schwann cells or passage along the connective tissue sheaths of
the nerve are less probable (Griffiths et al., 1994).
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1.3.3 Effects of ageing on the enteric nervous system
In view of the relationship between age and incidence of grass sickness it is
interesting that ageing has an effect on the nervous system. A growing number of
studies have been concerned with changes in autonomic nerves in development and
ageing (Collins, Exton-Smith, Jones and Oliver, 1980; Baker and Santer, 1988; Willis
and Douglas, 1988; Burnstock, 1990). Many of these studies concern the innervation
of blood vessels. Gabella (1989) found that the number of myenteric neurones in the
small intestine of ageing guinea pigs is about half that found in young adult guinea
pigs. Santer and Baker (1988) agreed with this in their experiments using rats. Gabella
also reported that degenerating neurones were occasionally seen in apparently healthy
enteric ganglia, especially in older animals. A study is needed to determine whether
neuronal ceil reduction occurs with advancing age in the horse. G.F. Schusser and
N.A. White (1994 unpublished data) found that foals had a greater number of
myenteric plexuses and neurones than adult horses in specific segments of the large
and transverse colon. The lower number of neurones seen in adults may be due to the
neurones present at birth being stretched apart during the growth in length and
circumference of the gastrointestinal tract (Schusser and White, 1994).
Morphological and histochemical evidence suggests that the influence of the
sympathetic innervation on intestinal function declines with age. Baker, Watson and
Santer (1990) suggested that with age there is either a decrease in the beta-
adrenoceptor number in relation to the muscarinic receptor density or a decrease in
the coupling of beta-adrenylate cyclase.
Many reports describe changes in peptide populations with age. Burnstock
(1990) reported a decrease in the expression of putative vasoconstrictor
cerebrovascular neurotransmitters (noradrenaline and 5-hydroxytryptamine) in ageing
rats, but an increase in putative vasodilator neurotransmitters (VIP and calcitonin
gene-related peptide). These findings are interesting in relation to the increased
incidence of cerebrovascular disorders in elderly humans. There is also increasing
evidence that the expression of autonomic transmitters can alter in diseases such as
Hirschsprung's disease (Hamanda, Bishop, Federici, Rivosecchi, Talbot and Polak,
1987). There is, as yet, no evidence for an age-related effect of peptide population in
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the horse (Burns and Cummings, 1991). There have been a number of studies which
report reductions in neuropeptide populations in the enteric nervous system in cases
of grass sickness (Sabate, Stephenson, Bishop, Probert, Cole, Hodson, Edwards,
Yeats, Bloom and Polak, 1983; Bishop, Hodson, Major, Probert, Yeats, Edwards,
Wright, Bloom and Polak, 1984; Vaillant, 1991).
1.3.4 Intestinal congenital aganglionosis in the horse
A congential absence of enteric neurones may also occur. Aganglionosis is the
absence of enteric ganglia, the effect of which is to produce a region of atony in the
gut. Very few accounts of intestinal aganglionosis in the horse have been reported
which do not involve the Overo breed (Anderson, King and Rotwell, 1987; Murray,
Parker and White, 1988). The mating of two Overo horses (a type of spotting pattern )
occasionally results in the production of a white foal which appears clinically normal
at birth. However, the foal fails to pass meconium, quickly develops colic and dies
between 23 and 132 hours later (Hultgren, 1982). The syndrome is commonly called
'lethal white foal' in the spotted horse industry. Overo horses are numerous in the
United States but are uncommon in Europe and other parts of the world.
Microscopically, the myenteric and submucous neuronal plexuses are found to be
absent throughout the large intestine and in extensive portions of the small intestine.
These findings are consistent with the primary diagnosis of ileocolonic aganglionosis.
The only other significant finding is the lack of melanin in the skin (Vonderfecht,
Trommershausen Bowling and Cohen, 1983). The mode of inheritance of this
congential disease is undetermined. Male as well as female foals are affected.
1.3.4.1 Intestinal aganglionosis in other species
Syndromes of congenital intestinal aganglionosis have been reported in other
species. A colonic aganglionosis has been described in a strain of piebald mice
(Webster, 1974; Brann, 1977). In this strain of mice congenital megacolon results
from the expression of a simple recessive gene. Hirschsprung's disease in man is a
congenital defect characterised by a region of aganglionic large intestine (Trounce and
Nightingale, 1960; Sane and Girdany, 1973; Schuffler, 1990).
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CHAPTER 2
THE SCOPE OF THE THESIS
The aims of this work were to increase our knowledge about the nature and
extent of damage that occurs to the enteric nervous system in cases of grass sickness
and improve our understanding of the relationship between gut motility and muscle
and neuronal excitability in the control and grass sickness affected horse. In order to
achieve this, the following procedures were developed:-
1) Apparatus was designed to investigate the mechanical activity of horse
small intestine, using strips of intestinal smooth muscle cut parallel to the longitudinal
muscle layer, organ baths and isometric strain gauge transducers.
2) A method for transporting horse gut to the laboratory in a viable state was
devised, involving an iced, oxygenated, modified Krebs solution.
3) The characteristics of background motility in the control horse was
established and the differences for the three clinical forms of grass sickness (acute,
subacute and chronic) recorded.
4) The responses of control horse small intestine to selected cholinergic and
adrenergic pharmacological agents were established.
5) The reports in the literature that in vitro horse small intestine contracts in
response to the addition of catecholamines was investigated and the mechanism of
action determined using adrenergic antagonists.
6) Responses of small intestine taken from horses affected by grass sickness to
pharmacological agents were compared with control values and with the clinical
severity of the disease.
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7) All the results were analysed for statistical significance using the computer
statistical package Minitab.
8) The extent of histological damage to the enteric nervous system was





3.1 Collection of tissue
All tissue was collected from the Royal (Dick) School of Veterinary Studies,
Veterinary Field Station, Bush Estate, Edinburgh. Horses and ponies (100-600kg) of
either sex were killed by intravenous (jugular) injection of 50-250ml of a 200mg/ml
solution of sodium phentobarbitone (Euthatal(R), Rhone Merieux, Harlow, UK)
depending on body weight and hydration status. Following euthanasia, they were
immediately exsanguinated from the jugular veins.
Control horses were defined as those euthanased for diseases unrelated to
grass sickness such as orthopaedic cases (details of control horses are given in the
appendices). The clinical cases of grass sickness were assessed to be acute, subacute
or chronic depending on the severity of the clinical signs and the duration of the illness
(see Chapter 1.1.3). Horses with AGS showed signs of severe depression, dysphagia
and intestinal stasis and were euthanased within 48 hours of the onset of clinical signs.
Horses with CGS had less severe clinical signs and survived for eight days or more
before euthanasia. Horses with SAGS showed intermediary clinical signs and survived
for two to seven days before euthanasia. Diagnosis of grass sickness was confirmed
post mortem by histological examination of autonomic ganglia (by the staff of the
Department of Veterinary Pathology) which identified characteristic lesions (Gilmour,
1973; Howell, Baker and Ritchie, 1974, Chapter 1.1.5).
Samples of small intestine (ten cm lengths) were removed within 15 minutes of
death from two sites; the caudal flexure of the duodenum and the terminal ileum
proximal to the ileocaecal fold. Figure 3.1 is a diagrammatic representation of the
sample sites. The two areas were chosen to determine if grass sickness affected two
widely spaced regions of the small intestine to different degrees. Tissue was
immediately placed in chilled, oxygenated modified krebs solution which was in a
container surrounded by ice. The tissue was continually aerated with 95% oxygen and
5% carbon dioxide using filled balloons attached to three-way taps and cannulas
which passed into the modified Krebs solution. The tissue was then transported to the
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Right dorsal colon Left ventral colon
Figure 3.1. The equine gastrointestinal tract showing the sampling sites,
1) the caudal flexure of the duodenum, 2) the terminal ileum. Adapted
from; Lehrbuch der Anatomie der Haustiere. Nickel, R., Schummer, A. and
Seiferle, E. (1975). Verlag Paul Parey, Berlin and Hamburg, Germany.
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laboratory, which took approximately 15 minutes. Pharmacological investigations
were performed either immediately (within one hour) or after storage for 24 hours at
4°C. Additional samples were fixed in Bouins solution for histological purposes.
3.2 Pharmacological experiments
On arriving in the laboratory the tissue was transferred into fresh modified
Krebs which had been kept on ice and continuously aerated with 95% oxygen 5%
carbon dioxide while the tissue was being collected.
Strips of smooth muscle (3x0.5cm) were cut parallel to the longitudinal
muscle layer. The mucosa was carefully removed using forceps and a scalpel blade
and the strips were suspended in an organ bath (35ml) using a glass rod as shown in
Figure 3.2. For duodenal samples from both control and grass sickness material the
initial tension applied to the strip of smooth muscle was 2g. For ileal strips, the
circular muscle was very thick especially in larger horses and had a tendency to curl
up. The tension used for these strips was therefore sufficient just to straighten the
preparation; in some ileal strips from control horses this was as great as 35g.
The modified Krebs solution contained mM/litre; sodium chloride 119.8,
potassium chloride 3.4, calcium chloride 3.0, magnesium chloride 0.6, sodium
hydrogen carbonate 26.2, sodium hydrogen phosphate 1.3 and glucose 6.7. Chemicals
were standard laboratory chemicals of Analar grade. This provided salts within the
range of normal horse serum and had a pH of 6.8. The modified Krebs solution was
maintained at 37°C and aerated with 95% oxygen and 5% carbon dioxide, with the
use of a needle into the silicon tubing which attached the organ bath within the water
bath. The supply of oxygen was kept constant with the use of a metal tap. Figure 3.2
shows a flow diagram of the apparatus.
Motility was measured isometrically using a Washington Type D strain gauge
transducer (Washington Ltd., Kent, UK) and recorded on a Washington 400 MD2 ink
writing oscillograph pen recorder (Washington Ltd.). For each experiment there were
four sets of apparatus which were set up in the corners of a single perspex water bath



















Figure 3.2. Flow diagram of in vitro pharmacological apparatus.
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Figure 3.3. Apparatus showing perspex temperature controlled water
bath. It contains one organ bath in each corner. Glass coils heat up
fresh modified Krebs solution to 37 °C. Strain gauge transducers
measure motility isometrically which is recorded on pen recorders.
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depending on the amplitude of the background contractions and the amplitude of the
responses being recorded. For each sensitivity the strain gauge transducers were
calibrated using standard metal weights. Measuring the pen amplifier deflections with
a ruler allowed calibration curves to be calculated. Initially calibrations were carried
out monthly but as there were no significant differences subsequent measurements
were made less frequently.
The parameters recorded were the rate of contractions (contraction peaks
were measured over a ten minute period), the peak amplitude (which was the force in
grams of an individual contraction which returned to the baseline), the tone (which
was a sustained change in baseline), and the latency (which was the time before a
measurable response could be seen following addition of a drug).
A one hour equilibration period was allowed for all fresh tissue, and a two
hour period for tissue which had been stored for 24 hours, during which time
background contractions developed in all the preparations.
3.2.1 Drugs used
The cholinergic and adrenergic systems of gastrointestinal motility control
were investigated using the following drugs: physostigmine sulphate (BDH
Chemicals. Poole, UK), bethanecol chloride (Sigma Chemical Co., St. Louis, USA),
atropine sulphate (Sigma), tetrodotoxin (Sigma), noradrenaline hydrochloride
(Aldrich Chemical Co. Ltd., Dorset, UK), adrenaline hydrogen tartrate (BDH), (S)-
propranolol hydrochloride (Sigma), phentolamine hydrochloride (Sigma), prazosin
hydrochloride (Sigma), yohimbine hydrochloride (Sigma) and cisapride (Janssen
Research Foundation. Wantage, Oxon, UK). The tetrodotoxin was obtained in pure
crystalline form and was dissolved in citrate buffer (pH 4.5) before use. Cisapride was
dissolved in 0.1ml acetone before being made up to a ImM solution with fresh
modified Krebs solution. All other compounds were prepared daily in modified Krebs
solution and kept on ice for the duration of the experiment. Drugs were superfused
and washed out by overflow using fresh modified Krebs solution at 37°C. Details of
the end bath concentrations used are given in the relevant Chapters.
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3.2.2 Statistical analysis
For all statistical tests, probability levels less than or equal to 5% were taken
to be significant. Data was analysed using the Minitab computer package, using the
non parametric Mann-Whitney U-test and Kruskal-Wallis test for analysing
differences between the control and grass sickness groups. The Wilcoxon Signed
Rank test was used to measure effects of drugs within a group i.e. for paired data.
3.3 Problems of tissue taken from animals after barbiturate euthanasia
Barbiturates affect neurotransmitter release and ion conductance (Rail, 1990).
However, initially an experiment was carried out to see if pentobarbitone could be
added in vitro to smooth muscle preparations to an estimated lethal dose (0.8mg/g of
tissue pentobaritone sodium, 'Lethobarb', Duphar Veterinary Limited, Southampton,
UK) and then be washed off again without permanently affecting the rate of
background contractions. It was found that pentobarbitone could be washed off after
several minutes. Following the initial equilibration period for the muscle strips,
therefore, all traces of barbitruate should have been removed. Any concern about
residual effects of barbitruate used for euthanasia was therefore dispelled.
3.4 Reasons for 24 hour storage
Tissue was sometimes stored for 24 hours at 4°C in unoxygenated modified
Krebs solution in the fridge. This was because early researchers had reported using
this method as a technique for causing neuronal death within the enteric nervous
system (Vogt, 1943; Kuriyama, Osa and Toida, 1967; Ruckebusch, Grivel and
Fargeas, 1971). The aim was to determine whether the neuronal damage that occurred
due to storage of control tissue was a suitable model for the neuronal damage known
to occur in cases of grass sickness.
3.5 Histological investigations
A light microscopical investigation of the enteric nervous system was carried




BACKGROUND MOTILITY OF SMALL INTESTINAL SMOOTH MUSCLE
STRIPS
4.1 Introduction
Studies of gastrointestinal smooth muscle in vivo are limited by such factors as
ethical and technical difficulties, by anaesthetic drugs that may be needed, by
regulatory effects of extrinsic nerves, by reflexes arising from other parts of the body
and by the effects of hormones. These problems do not occur in vitro but there are
other problems associated with isolation of tissue. There is, for example, no blood
supply, so tissue must be kept viable using a warmed oxygenated physiological
solution. Also drugs administered into an organ bath may not diffuse into tissue in the
normal manner. There may also be changes in tissue sensitivity during the course of an
experiment. With these reservations, in vitro studies using clinical cases euthanased
for reasons unrelated to grass sickness, as well as grass sickness cases, can provide
useful information about the mechanisms of equine gut motility, and how it is altered
by grass sickness (Murray, Cottrell and Woodman, 1994).
The phenomenon that intestinal smooth muscle undergoes myogenic rhythmic
changes in excitability, referred to as slow waves, was discussed above (Chapter
1.2.3). Spikes, or action potentials, are superimposed on these slow waves which lead
to contractions of the smooth muscle and it is these background contractions (also
referred to as background motility) which can be recorded isometrically in vitro.
The aims of this Chapter were to establish the characteristics of the
background contractions from the two regions of the small intestine from both control
and grass sickness affected horses. Effects of selected pharmacological agents on
these background contractions were also investigated.
4.2 Materials and methods
The method of tissue collection, transportation to the laboratory and protocol
for setting up intestinal smooth muscle strips into organ baths was discussed above
(Chapter 3). Following a one hour equilibration period, the pen recorders were
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switched on and the background motility of the equine small intestinal smooth muscle
strips recorded isometrically.
The characteristics of the background contractions were calculated for each of
the four groups i.e. control, AGS, SAGS and CGS and both regions of the small
intestine. Eight horses were used for each group. A minimum of five muscle strips
were used to investigate how these background contractions were altered by selected
pharmacological agents (see Appendix B for details of horses).
The drugs used were tetrodotoxin (TTX) (Sigma), atropine sulphate (Sigma),
(S)-propranolol hydrochloride (Sigma), phentolamine hydrochloride (Sigma), prazosin
hydrochloride (Sigma) and yohimbine hydrochloride (Sigma) (see Chapter 3.2.2 for
details of the preparation of these drugs).
Samples of duodenum and ileum were examined fresh and after storage at 4°C
for 24 hours in unoxygenated modified Krebs. As it took longer for background
contractions to develop with stored tissue, a two hour equilibration period was
allowed before recordings of the background contractions were taken.
To measure the characteristics of the background contractions, a ten minute
recording period was used. The rate of contractions was determined by counting the
number of contractions in this period by hand. The amplitude of each individual
contraction was measured with a ruler and the mean amplitude calculated. The
equivalent isometric force in grams was then calculated using calibration graphs
constructed for each transducer, at each sensitivity, for each pen recorder (see
Chapter 3.2). The amplitude of contractions was then expressed in terms of grams per
gram ofwet tissue weight, to take into account some of the variation in tissue
thickness between samples.
4.2.1 Statistical analysis
The smooth muscle strips which were used to establish the baseline values for
rate and amplitude of background contractions (Tables 4.1 - 4.4) were from different
horses to those used for measuring the effects of pharmacological agents on the
characteristics of the background contractions, which are described in Chapter 4.3.2.
The characteristics of background contractions, following treatment with
36
pharmacological agents, were therefore analysed for statistical significance using the
Mann-Whitney U-test. The same horses were used to study the duodenal and ileal
regions, therefore the Wilcoxon Signed Rank test was used to test for significant
differences in the characteristics of background contractions between the two regions.
For stored tissue the same horses were used to establish the initial rate and
amplitude of the background contractions and the effect of adrenergic antagonists on
these characteristics. Therefore any differences due to these pharmacological agents
were analysed using the Wilcoxon Signed Rank test. Differences between the two
regions of the small intestine were also analysed using the Wilcoxon Signed Rank test.
Differences between fresh and stored tissue for the rate and amplitude of background
contractions were analysed using the Mann-Whitney U-test. The grass sickness data
were also combined into one group and the analysis carried out between the control
and grass sickness groups.
4.3 Results
4.3.1 Characteristics of background contractions
4.3.1.1 Duodenal preparations
Within the one hour equilibration period, background contractions developed
in all preparations from both control horses and those affected by grass sickness. The
tone, i.e. baseline, of all the smooth muscle preparations remained constant following
a preliminary relaxation in response to the initial tension applied to the smooth muscle
strip (Figure 4.1).
The characteristic pattern of regular background contractions for the duodenal
strips of intestinal smooth muscle is shown in Figure 4.2A and 4.2B, for both control
tissue and tissue taken from a horse affected by AGS. Table 4.1 shows the analysis of
control data compared with all the grass sickness data. From the eight horses analysed
for each group, the median rate of contractions for duodenal preparations varied from
3.2 contractions per minute in the AGS and SAGS groups to 6.3 contractions per




switched recorder off for
one hour equilibration period
Figure 4.1. Shows the initial tension applied to a duodenal muscle strip
which was equivalent to 2g. The tissue relaxed to this tension during the
one hour equilibration period. When the pen recorder was switched on,
regular contractions could be recorded. Often the sensitivity of the pen
recorder needed to be reduced to allow detection of responses to






Figure 4.2A. The characteristic pattern of background contractions for
duodenal muscle strips taken from control horses.
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Figure 4.2B. Shows the lower rate of contractions for duodenal muscle










Control 8 6.3 (4.1-8.5)3 7.5 (3.3-16.0)b
Grass 24 3.4 (0.8-8.4)3 3.5 (4.2-25.5)b
sickness
Table 4.1. Background contractile motility of equine duodenal smooth muscle strips
measured isometrically in vitro. Values are medians with the range shown in brackets.
Values with the same superscript are significantly different from each other when








Control 8 6.3 (4.1-8.5)ab 7.5 (3.3-16.0)cd
AGS 8 3.2 (0.8-8.4)a 13.8 (4.2-22.4)c
SAGS 8 3.2 (2.0-8.0)b 17.3 (7.1-22.5)d
CGS 8 4.1 (2.6-7.8) 11.0(6.2-18.2)
Table 4.2 Background contractile motility of equine duodenal smooth muscle strips.
Values are medians with the range shown in brackets. Values with the same
superscript are significantly different from each other when analysed with the Mann-









Control 8 3.2(1.5-5.4) 10.6(5.3-27.5)
Grass 24 1.9(0.8-5.8) 10.6(1.0-27.8)
sickness
Table 4.3 Background contractile motility of equine ileal smooth muscle strips
measured isometrically in vitro. Values are medians with the range shown in brackets.








Control 8 3.2(1.5-5.4)* 10.6 (5.3-27.5)
AGS 8 1.7(0.8-3.9) 14.4 (9.5-16.1)
SAGS 8 1.9(1.5-2.6)* 9.8 (3.1-27.8)
CGS 8 2.9(1.2-5.8) 6.9(1.0-21.0)
Table 4.4 Background contractile motility of equine ileal smooth muscle strips
measured isometrically in vitro. Values are medians with the range shown in brackets.
There were no significant differences between any of the groups. A * symbol
indicates there is a significant difference from the corresponding duodenal value when
the results were analysed using the Wilcoxon Signed Rank test (P<0.05).
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from 7.5 g/g of tissue in the control group, to 17.3 g/g of tissue in the SAGS group
(Table 4.2).
The AGS and SAGS duodenal grass sickness groups had a significantly lower
rate of contractions than the duodenal control group (SAGS P< 0.01, AGS P< 0.05).
There were no significant differences between the contractile rates for any of the grass
sickness groups themselves.
The median amplitude of the background contractions was greater in grass
sickness affected tissue compared with the control tissue, only the amplitude of the
AGS and SAGS groups was significantly higher than the control group (P<0.05)
(Table 4.2).
4.3.1.2 Ileal preparations
With ileal smooth muscle strips the background contractions occurred in
bursts with periods of quiescence between them in both control and grass sickness
affected tissue (Figures 4.2C and 4.2D). Occasionally the background contractions
were more regular (see Figure 4.2A).
Regardless of the pattern of background activity, the rate of contractions of
the control ileal tissue was significantly lower than for control duodenal tissue
(P<0.05) (Tables 4.3 and 4.4). In the ileal control group the median amplitude of
contraction per gram of tissue was larger than for the control duodenal group,
however, this was not significant. The rate of contractions for the ileal SAGS group
was also significantly lower compared with the duodenal SAGS group (P<0.05).
There were no significant differences in contractile amplitude for any of the grass
sickness groups between the two regions.
When the contractile rates and amplitude for the ileum of control and grass
sickness groups were compared between themselves, there were no significant




Figure 4.2C. The characteristic pattern of background contractions for ileal
muscle strips taken from control horses.
1 min
Figure 4.2D. Shows the lower rate of contractions but higher amplitude of
contractions for ileal muscle strips taken from horses suffering from acute
grass sickness.
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4.3.2 Effect of pharmacological agents on background contractions of duodenal
and ileal smooth muscle strips
A standard concentration was used for each drug investigated, this was chosen
from experiments involving other species where no data was available with horse
tissue (Perry, 1968). All concentrations given are final bath concentrations.
4.3.2.1 Tetrodotoxin (TTX)
The effect of TTX (4.5xlO'6M) on background contractile activity was
investigated using tissue taken from five control horses (Table 4.5). There was no
significant effect of TTX on either contractile rate or contractile amplitude when
compared with those in Tables 4.1 and 4.3 (Figures 4.3 A and B). There was also no
significant difference before and after TTX treatment within each group. When the
results were compared between the two regions, using the Wilcoxon Signed Rank
test, for contractile rate P<0.06 which means the difference approached significance.
It may be that with larger experimental numbers this would indeed be the case. There
was no significant difference between the contractile amplitude between the two
regions. TTX was not used on grass sickness affected tissue.
Contractile rate following Contractile amplitude following
n TTX addition [4.5xlO^M] TTX addition [4.5xlO^M]
Duodenum 5 7.9(5.6-9.5) 6.2(1.6-6.8)
Ileum 5 3.0(1.9-4.2)* 4.1 (2.5-12.9)
Table 4.5 Background contractile motility of equine smooth muscle strips taken from
control horses following addition of TTX (4.5xlO"6M). Values are medians with the
range ofvalues shown in brackets. A * indicates there may be a difference of
biological importance between the duodenal and ileal values when the results were




Figure 4.3. Tetrodotoxin addition (4.5x10"6M) had no significant effect on
the rate or amplitude of background contractions for both A) duodenal,




Atropine 8.6x10"6M 1 min
25g
Figure 4.4. Addition of atropine (8.6x10"6M) did not affect the rate or amplitude
of background contractions. This trace was from a duodenal strip from a





contractions [g/g of tissue]
Control 5 4.8 (4.5-6.6) 16.2(4.9-19.6)
Grass 15 2.8 (1.2-8.8) 13.3 (5.3-30.9)
Sickness
Table 4.6 Background contractile motility of equine duodenal smooth muscle strips
following addition of propranolol (lxlO^M). Values are medians with the range of




contractions [g/g of tissue]
Control 5 4.8 (4.5-6.6)a 16.2(4.9-19.6)
AGS 5 2.0(1.2-6.6) 13.3 (9.0-21.1)
SAGS 5 4.8(2.2-8.8) 12.8 (8.0-30.9)
CGS 5 3.9 (2.2-4.l)a 14.3 (5.3-15.5)
Table 4.7. Background contractile motility of equine duodenal smooth muscle strips
following addition ofpropranolol (1x10"4M). In this Table the grass sickness data is
divided into AGS, SAGS and CGS groups. Values are medians with the range of
values shown in brackets. Values with the same superscript are significantly different





contractions [g/g of tissue]
Control 5 2.6 (2.4-3. l)a 16.5 (11.2-22.8)b
Grass 15 1.8 (0.6-3.8)a 9.2(1.8-28.6)b
Sickness
Table 4.8. Background contractile motility of equine ileal smooth muscle strips
following the addition of propranolol (lxlO^M). Values are medians with the range of
values shown in brackets. Values with the same superscript are significantly different




contractions [g/g of tissue]
Control 5 2.6 (2.4-3.l)a* 16.5 (11.2-22.8)
AGS 5 0.9 (0.6-2.8) 9.2 (2.7-13.2)4
SAGS 5 1.4(0.8-2.6)a* 5.7(2.2-28.6)
CGS 5 2.2 (1.3-3.8) 9.7(1.8-15.3)
Table 4.9. Background contractile motility of equine ileal smooth muscle strips
following the addition of propranolol (lxlO^M). Values are medians with the range of
values shown in brackets. Values with the same superscript are significantly different
from each other when analysed with the Mann-Whitney U-test (P<0.05).
A ♦ symbol indicates there was a significant difference between this value and the
initial values before pretreatment with propranolol (i.e. Table 4.4) (P<0.05, this was
analysed using the Mann-Whitney U-test as it involved different horses).
A * symbol indicates there may be a difference ofbiological importance from the
corresponding duodenal value (i.e. Table 4.7) when the results were analysed using
the Wilcoxon Signed Rank test (P<0.06).
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4.3.2.2 Atropine
Atropine (8.6x10^) appeared to have no effect on background motility in
control and grass sickness tissue (Figure 4.4), although only three experiments were
performed and no statisitcal analysis was carried out.
4.3.2.3 Propranolol
Following the addition ofpropranolol (lxl O^M) there was no significant
difference between the rate or amplitude of the background contractions for duodenal
muscle strips between any of the groups, with the exception of the contractile rate for
the CGS group which was significantly lower than the contractile rate for the control
group (P<0.05) (Table 4.7). For ileal muscle strips there was no significant difference
in the rate or amplitude of the background contractions following the addition of
propranolol (lxl O^M) (Figures 4.5A and 4.6A), with the exception of the contractile
rate for the SAGS group which was significantly lower than for the control group
(P<0.05) (Table 4.9).
For the investigation of the effect of propranolol the same horses were used
for the duodenal and ileal regions, therefore comparisons between the two regions
were carried out using the Wilcoxon Signed Rank test. There was no statistically
significant difference between any of the groups, however, the probability of a
significant difference between the two regions for the control and SAGS rates was
P<0.06 so this may be of some biological importance. Figures 4.5A and 4.6A shows
an example of the lack of effect of propranolol on background motility.
When these results were compared with those obtained for background
contractions alone (Tables 4.2 and 4.4) only the amplitude for the ileal AGS group
was significantly lower (P<0.05).
4.3.2.4 Phentolamine
Following the addition of phentolamine (lxl O^M) there was no significant
difference between the rate or amplitude of the background contractions for duodenal
muscle strips between any of the groups, with the exception of the contractile rate for





contractions [g/g of tissue]
Control 5 5.9 (4.2-9.6) 8.4 (7.0-18.9)
Grass 15 4.3 (1.8-10.4) 12.0 (1.0-17.1)
Sickness
Table 4.10. Background contractile motility of equine duodenal smooth muscle strips
following addition of phentolamine (1x10"4M). Values are medians with the range of




contractions [g/g of tissue]
Control 5 5.9 (4.2-9.6)a 8.4(7.0-18.9)
AGS 5 3.3 (1.8-5.8)3 13.0(8.7-14.2)
SAGS 5 8.2(3.0-8.7) 12.3 (4.7-17.1)
CGS 5 5.8 (2.4-10.4) 6.1 (1.0-14.3)
Table 4.11. Background contractile motility of equine duodenal smooth muscle strips
following addition of phentolamine (1x10"4M). Values are medians with the range of
values shown in brackets. In this Table the grass sickness data are divided into
AGS,SAGS and CGS groups. Values with the same superscript are significantly





contractions [g/g of tissue]
Control 5 3.6(1.3-6.0) 15.2 (6.2-21.4)a
Grass 15 1.6(0.5-6.8) 5.4 (3.0-15.7)a
Sickness
Table 4.12. Background contractile motility of equine ileal smooth muscle strips
following the addition of phentolamine (lxlO^M). Values are medians with the range
of values shown in brackets. Values with the same superscript are significantly




contractions [g/g of tissue]
Control 5 3.6(1.3-6.0) 15.2 (6.2-21.4)a
AGS 5 1.4(0.6-2.4)* 8.0(3.7-15.7)*
SAGS 5 1.6(0.5-2.2)* 5.8 (3.5-10.4)3
CGS 5 3.3 (1.0-6.8) 3.7(3.0-15.3)
Table 4.13. Background contractile motility of equine ileal smooth muscle strips
following the addition of phentolamine (lxl O^M). The grass sickness data has been
divided into AGS, SAGS and CGS groups. Values are medians with the range of
values shown in brackets. Values with the same superscript are significantly different
from each other when analysed using the Mann-Whitney U-test (P<0.05). A ♦ symbol
indicates there was a significant difference for this value and the initial values before
pretreatment with phentolamine (i.e. Table 4.4) (P<0.05), this was analysed using the
Mann-Whitney U-test as it involved different horses. A * symbol indicates there may
be a difference ofbiological importance from the corresponding duodenal value (i.e.





Phentolamine 1x10"4M 1 min
Figure 4.5. With ileal preparations there was no effect on background
contractions following A) propranolol, this trace was from an ileal muscle strip
taken from a control horse and B) phentolamine, this trace was from an ileal
muscle strip taken from a horse suffering from acute grass sickness.
Figure 4.6. With some ileal preparations the background contractile activity
was more regular. However, there was still no effect on rate or amplitude of
the background contractions following the addition of A) propranolol and B)
phentolamine. Both these traces were taken from control horses.
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group (P<0.05) (Table 4.11). For ileal muscle strips there was no significant
difference in the rate or amplitude of the background contractions following
phentolamine ( lxl O^M) (Figures 4.5B and 4.6B), with the exception of the
contractile amplitude for the SAGS group which was significantly lower than for the
control group (P<0.05) (Table 4.13).
When the duodenal and ileal results were compared using the Wilcoxon
Signed Rank test there was no statistically significant difference between any of the
groups for contractile rate and amplitude, however, the difference between the two
regions for the AGS and SAGS rates was P<0.06 so although this is not statisically
significant, it may be of some biological importance.
When these results were compared with those obtained for background
contractions alone (Tables 4.2 and 4.4) only the amplitude for the ileal AGS group
was significantly lower (P<0.05).
Experiments using more selective alpha antagonists such as prazosin (al
antagonist) and yohimbine (a2 antagonist) also appeared not to have an effect on the
rate or amplitude ofbackground contractions for both control and grass sickness
groups and both regions of the small intestine (Figure 4.7).
4.3.3 Effect of storage on characteristics of background contractions
In this section, tissue from the same horses was used to establish the initial
rate and amplitude of the background contractions for both regions of the small
intestine. This tissue was then used to see if there were any alterations in the
characteristic ofbackground contractions in response to selected pharmacological
agents. As there were few significant differences found with fresh tissue, only the
effects of propranolol and phentolamine were investigated with stored tissue.
4.3.3.1 Duodenal preparations
The median rate of background contractions for the stored control tissue was
4.0 contractions per minute (Table 4.14) compared with 6.3 for fresh tissue (Table
4.1). The only significant difference between the groups of stored duodenal tissue was
34-
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Yohimbine 2.8x10~5M 1 min
Figure 4.7. Trace from a duodenal muscle strip taken from a horse
suffering from chronic grass sickness. It showed that A) the addition of
prazosin, an alpha 1 antagonist, and B) the addition of yohimbine,
an alpha 2 antagonist had no significant effect on the rate and amplitude





contractions [g/g of tissue)
Control 5 4.0 (3.2-4.8)a 22.1 (8.7-34.9)
Grass 15 1.8 (1.0-6.0)3 9.8 (4.9-35.6)
Sickness
Table 4.14. Background contractile motility of equine duodenal smooth muscle strips
following storage for 24 hours at 4°C. Values are medians with the range of values
shown in brackets. Values with the same superscript are significantly different from




contractions [g/g of tissue]
Control 5 4.0 (3.2-4.8)aV 22.1 (8.7-34.9)*
AGS 5 1.8 (1.2-4.4) 8.8 (5.7-30.0)
SAGS 5 2.2(1.0-6.0) 5.9(4.9-26.8)
CGS 5 1.8 (1.5-3.2)> 13.8 (9.8-35.6)
Table 4.15. Background contractile motility of equine duodenal smooth muscle strips
following storage for 24 hours at 4°C. The grass sickness data has been divided into
AGS,SAGS and CGS. Values are medians with the range of values shown in
brackets. Values with the same superscript are significantly different from each other
when analysed with the Mann-Whitney U-test (P<0.05).
A V or * symbol indicates there was a significant difference for this stored value from
the initial fresh values (i.e. Table 4.2) (V P<0.01, * P<0.05, this was analysed using
the Mann-Whitney U-test as it involved different horses).
J6
between the contractile rate for the CGS group which was significantly lower than the
control group (P<0.05) (Table 4.15).
The amplitude ofbackground contractions was largest in the stored tissues of
the control group and smallest in the AGS and SAGS grass sickness groups. This was
unlike duodenal fresh tissue where the largest median contractile amplitudes were
seen in the grass sickness groups. However, there were no significant differences
between any of the groups with regard to contractile amplitude (Table 4.15).
The rate of contractions for the control and CGS groups were significantly
lower compared with the equivalent fresh tissue groups (P<0.01). There was no
significant difference between the AGS and SAGS fresh and stored results. The
amplitude of contractions for the control tissue significantly increased following
storage (P<0.05).
The data for the stored control duodenal group were compared individually
with those for the fresh AGS, SAGS and CGS groups, to see if the neuronal death
which occurred during storage in control tissue caused the tissue to behave like fresh
grass sickness affected tissue. There was no significant difference between any of
them for both contractile rate and amplitude.
Following the addition of propranolol (lxl O^M) to stored tissue the AGS and
SAGS groups had significantly lower contractile rates compared with the control
group (P<0.05) (Table 4.17). There was no significant difference between any of the
groups with regard to contractile amplitude.
There was no significant effect on the rate and amplitude of the duodenal
background contractions following propranolol addition compared with stored tissue
alone (i.e. Table 4.15 compared with Table 4.17). Figure 4.8 shows that both
propranolol and phentolamine had no effect on the background contractions of
duodenal muscle strips taken from a control horse following storage for 24 hours.
With stored tissue, following the addition ofphentolamine (1x10~4M), the
AGS contractile rate was significantly lower than the control and CGS groups
(P<0.05). Also the control contractile amplitude was significantly higher than all three





contractions [g/g of tissuel
Control 5 4.0 (2.2-4.6)a 21.3 (12.6-33.2)
Grass 15 1.8 (0.8-3.8)a 8.2 (4.0-33.7)
Sickness
Table 4.16. Background contractile motility of equine duodenal smooth muscle strips
following storage for 24 hours at 4°C and treatment with propranolol (lxlO^M).
Values are medians with the range ofvalues shown in brackets. Values with the same





contractions [g/g of tissue]
Control 5 4.0 (2.2-4.6)ab 21.3 (12.6-33.2)
AGS 5 1.4 (0.8-2.6)a 11.3 (5.7-26.2)
SAGS 5 1.9 (1.2-3.8)b 6.8 (4.6-29.4)
CGS 5 2.2(1.3-2.6) 9.5 (4.0-33.7)
Table 4.17. Background contractile motility of equine duodenal smooth muscle strips
following storage for 24 hours at 4°C and treatment with propranolol (lxlO^M).
Values are medians with the range ofvalues shown in brackets. Values with the same






contractions [g/g of tissue]
Control 5 4.4(3.0-7.8) 30.4 (15.8-31.5)a
Grass 15 2.4(1.2-4.8) 7.7 (3.3-27. l)a
Sickness
Table 4.18. Background contractile motility of equine duodenal smooth muscle strips
following storage for 24 hours at 4°C and treatment with phentolamine (1x10"4M).
Values are medians with the range of values shown in brackets. Values with the same





contractions [g/g of tissue]
Control 5 4.4 (3.0-7.8)a 30.4 (15.8-31.5)cde
AGS 5 1.7(1.2-2.0)* 8.0 (5.9-27.l)c
SAGS 5 4.4(1.2-4.8) 3.9 (3.3-8.0)d
CGS 5 3.4 (2.4-4.8)b 10.2 (5.2-13.5)e
Table 4.19. Background contractile motility of equine duodenal smooth muscle strips
following storage for 24 hours at 4°C and treatment with phentolamine (lxlO^M).
Values are medians with the range ofvalues shown in brackets. Values with the same






Figure 4.8. Recording from duodenal muscle strip taken from a control horse
following storage for 24 hours at 4°C. It shows that both A) propranolol
and B) phentolamine had no effect on the rate or amplitude of the background
contractions.
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There was no significant difference between the rate and amplitude of the
background contractions following the addition ofphentolamine, compared with
stored tissue alone (i.e. Table 4.15 compared with Table 4.19).
4.3.3.2 Deal preparations
The initial median rate of background contractions for ileal control tissue, after
storage for 24 hours at 4°C, was 0.8 contractions per minute (Table 4.20). The CGS
group had a significantly larger contractile rate, at 1.9 contractions per minute, than
the control group (P<0.05) (Table 4.21). There was no significant difference between
any of the groups for contractile amplitude.
The rate of contractions was reduced in all four groups following storage.
However, only the control and AGS groups showed significant reductions at P<0.01
and P<0.05 respectively (Table 4.4 compared with Table 4.21). The contractile
amplitude of the control group significantly increased in stored tissue compared with
fresh tissue (P<0.05). For the grass sickness groups there was no significant change in
the amplitude of background contractions following storage.
The data for the stored control ileal group were compared with the fresh ileal
AGS, SAGS and CGS groups, to see if the neuronal death which occurred during
storage in control tissue caused the tissue to behave like fresh grass sickness affected
tissue. It was found that the stored contractile rate of control tissue was significantly
lower than the fresh grass sickness values (P<0.05 for all three groups). The
contractile amplitude for the stored ileal group was significantly higher than the fresh
grass sickness results (P<0.01 for AGS and P<0.05 for SAGS and CGS).
Following the addition of propranolol (1x10"4M) there was no significant
difference between any of the groups for both contractile rate and amplitude (Table
4.23). There was also no significant difference in contractile rate and amplitude
following propranolol addition and stored tissue alone (Table 4.21 compared with
Table 4.23).
Following the addition of phentolamine (1x KT4M) there was no significant





contractions [g/g of tissue]
Control 5 0.8 (0.7-0.8) 23.3 (16.9-36.5)
Grass 14 1.4(0.4-3.6) 13.0(2.5-38.1)
Sickness
Table 4.20. Background contractile motility of equine ileal smooth muscle strips





contractions [g/g of tissue]
Control 5 0.8 (0.7-0.8)a¥ 23.3 (16.9-36.5)*
AGS 4 1.1 (0.7-1.4)* 13.0(10.4-24.8)
SAGS 5 1.3 (0.4-2.4) 26.4 (2.5-38.1)
CGS 5 1.6 (0.8-3.6)a 8.4 (4.4-32.2)
Table 4.21. Background contractile motility of equine ileal smooth muscle strips
following storage for 24 hours at 4°C. Values are medians with the range of values
shown in brackets. Values with the same superscript are significantly different from
each other when analysed with the Mann-Whitney U-test (P<0.05). A ¥ or * symbol
indicates there was a significant difference for this stored value from initial fresh
values (i.e. Table 4.4 (¥ P<0.01, * P<0.05, this was analysed using the Mann-





contractions [g/g of tissue]
Control 5 1.8 (0.6-3.6) 20.5 (3.4-33.1)
Grass 14 1.7(0.4-4.2) 6.7(2.5-31.1)
Sickness
Table 4.22. Background contractile motility of equine ileal smooth muscle strips
following storage for 24 hours at 4°C and treatment with propranolol (1x10"4M).




contractions [g/g of tissue]
Control 5 1.8 (0.6-3.6) 20.5 (3.4-33.1)
AGS 4 0.6 (0.4-2.3) 12.4(3.4-31.1)
SAGS 5 1.0(0.5-3.8) 6.7(2.8-20.1)
CGS 5 2.2(1.9-4.2) 5.0 (2.5-8.0)
Table 4.23. Background contractile motility of equine ileal smooth muscle strips
following storage for 24 hours at 4°C and treatment with propranolol (lxlO"4M).





contractions [g/g of tissue]
Control 5 2.3 (0.6-4.6) 26.0 (12.2-42.0)3
Grass 14 2.0(1.0-4.0) 6.9 (1.0-16.0)3
Sickness
Table 4.24. Background contractile motility of equine ileal smooth muscle strips
following storage for 24 hours at 4°C and treatment with phentolamine (lxl0"4M).
Values are medians with the range of values shown in brackets. Values with the same





contractions [g/g of tissue]
Control 5 2.3 (0.6-4.6) 26.0 (12.2-42.0)ab
AGS 4 1.6(1.0-2.0) 10.4 (7.5-14.0)c
SAGS 5 2.0(1.0-4.0) 3.3 (1.0-16.0)a
CGS 5 2.6(1.2-3.8) 5.1 (3.2-8.2)bc
Table 4.25. Background contractile motility of equine ileal smooth muscle strips
following storage for 24 hours at 4 °C and treatment with phentolamine (lxlO^M).
Values are medians with the range ofvalues shown in brackets. Values with the same
superscript are significantly different from each other when analysed with the Mann-
Whitney U-test (P<0.05).
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control ileal contractile amplitude was significantly higher than the SAGS and CGS
groups. The AGS group had a significantly higher contractile amplitude than the CGS
group (P<0.05). Following the addition of phentolamine there was no significant
difference in rate or amplitude for any of the groups compared with their initial values
for background contractions following storage (Table 4.21 compared with Table
4.25).
4.4 Discussion
That background contractions could be recorded from all muscle strips
validated the collection method and experimental protocol and confirmed that the
tissue was arriving at the laboratory in a viable state. However, it cannot be said with
certainty that the in vitro observations exactly reflect in vivo activity.
The horses used to determine the characteristics of the background
contractions established that the data was not normally distributed because the median
values were not in the middle of the range of values and the upper value was often
more than three times the lowest value. Therefore all the results were analysed using
non-parametric tests.
As discussed in Chapter 1, intestinal smooth muscle undergoes rhythmic
changes in excitability referred to as slow waves. Slow waves bring the resting
membrane potential near to the threshold for the generation of action potentials
(spikes). When the threshold is reached voltage-dependent channels in the membrane
open, leading to the ionic movements responsible for the generation of spikes. The
amplitude of the background contractions is determined by the number of spikes
superimposed on each slow wave. The rate ofbackground contractions is limited by
the slow wave frequency (Grundy, 1985; Read, 1990). It has also been suggested that
the interstitial cells ofCajal may have an effect on the rate of background contractions
in certain regions of the gut (Thuneberg, 1982; Christensen, 1988).
This study of background motility demonstrated that contractile patterns in the
two regions of the small intestine were quite different. Fresh duodenal strips taken
from control horses had a significantly higher contractile rate than ileal control strips
(P<0.05). It has been reported that the intrinsic frequency of slow waves in vivo is
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greater in the more proximal regions of the equine gastrointestinal tract (Davies and
Gerring, 1983), therefore a greater contractile rate in the more proximal regions
would be expected. Ruckebusch et al. (1971) found the mean frequency of
background contractions in vitro to be 8.7 and 4.8 in equine duodenum and ileum
respectively compared with the median values of 6.3 and 3.2 in these experiments.
There were differences between these sample sites and those of Ruckebusch et al.
(1971).
There was no significant difference in the amplitude of contractions between
the two regions in control horses (Tables 4.1 and 4.3). There have been no reports of
the amplitude of background contractions in the horse in vitro, with the exception of
Malone, E.D., Brown, D.R., Trent, A.M. and Turner, T.A. (submitted for publication)
who only give absolute values which could therefore not be compared with the results
described here.
In both duodenal and ileal regions the difference in contractile rate between
the control and grass sickness groups was approximately a 50% reduction. However,
for the control and grass sickness groups, there was no significant difference between
their contractile rates and amplitudes for ileal tissue (Table 4.4). For the duodenal
preparations the AGS and SAGS groups had background contractile rates
significantly lower than the control group (P<0.05 and P<0.01 respectively). For these
two groups, the contractile amplitude was also significantly higher than the control
group (P<0.05). The reason both regions do not show the same differences is unclear.
There may be a reduction in slow wave frequency in the duodenal regions in grass
sickness cases, however, if this was the case a similar reduction would be expected in
the ileal region. Heeckt, Halfer, Schraut, Lee and Bauer (1993) noted a decrease in
spontaneous contractile activity whilst studying chronic rejection in intestinal smooth
muscle after small intestine transplantation. The mechanism for this was not
determined. The frequency of the slow waves was not significantly altered although
the amplitude of the slow waves was significantly decreased (P<0.0001). Another
explanation for the reduced contractile rate could be that the background contractile
activity is influenced by spontaneously released chemical transmitters from intrinsic
nerves. Kuriyama, Osa and Toida, (1967) concluded in their investigation of smooth
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muscle strips from guinea pig jejunum, that normal membrane activities may be
influenced by the release of acetylcholine. In cases of grass sickness where neuronal
death is known to occur there would be a reduction in this spontaneous
neurotransmitter release and therefore this may cause a reduction in the rate of
background contractions.
There have been a number of reports of the effect of pharmacological agents
on background contractions. A number of authors working with other species have
reported that, unlike the situation in nerves and skeletal muscle, the puffer fish venom,
TTX, fails to abolish the spikes which occur in smooth muscle (Narahashi, Moore and
Scott, 1964; Bulbring and Tomita, 1966; Kuriyama, Osa and Toida, 1966). TTX
selectively blocks the voltage-dependent sodium channels. The inward current of the
spikes in smooth muscle is therefore not carried by sodium ions , however, it is
blocked by interference with calcium entry into the cells. The spikes seen in smooth
muscle are therefore mainly, ifnot exclusively, dependent on the inward movement of
calcium ions (Grundy, 1985).
The insensitivity of the smooth muscle strips in control horses to TTX as
found in these experiments, indicates that the background motility of the small
intestine is independent of nervous elements. However, there have been some
conflicting reports in the literature. Furness (1970) reported that the addition of TTX,
in the guinea pig colon, caused a reduction in the rate of background contractions
suggesting that intrinsic nerves were having an excitatory effect on background
contractions. If this was the case in the horse, it would help to explain the lower
contractile rates observed in the duodenum from the AGS and SAGS groups, as
neuronal activity is depleted in grass sickness cases. However, Wood (1987) and
Read (1990) reported that TTX blocks the activity of inhibitory nerves which are
supressing the rate ofbackground contractions, therefore in the presence of TTX, the
background rate of contractions increases.
The concentration ofTTX chosen in these experiments may not have been
suitable to show a significant effect on background contractions. Indeed some traces
did appear to demonstrate that the TTX was having an effect on background
contractions (Figure 4.3A) although the differences were not significant when
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analysed. However, Malone, E.D, Brown, D R., Trent, A.M. and Turner, T.A.
(submitted for publication 1995) found that the baseline activity of strips of equine
jejunum was unaffected by TTX. They used a similar concentration of TTX to these
experiments (lxlCT^M compared with 4.5xlO^M).
Atropine appeared to have no effect on the contractile rate or amplitude of
control tissue. However, controlled experiments to provide sufficient data for
statistical analysis were not carried out. Malone, E.D, Brown, D.R., Trent, A.M. and
Turner, T.A. (submitted for publication 1995) reported that atropine (1pm) caused no
significant effect on the frequency of contractions, but that there was a significant
reduction in the contractile amplitude (P<0.05). Adams, Lamar and Masty (1984)
found that atropine decreased motility of the distal portion of the jejunum and pelvic
flexure in ponies. They found nearly a complete absence of spike potentials on the
slow waves. Roberts and Argenzio (1986) also found that increasing doses of atropine
reduced and then abolished intestinal sounds, provoked abdominal discomfort and
delayed defaecation in healthy ponies. The transit time of soluble markers was also
prolonged. It may be that higher concentrations ofatropine were needed in the in
vitro experiments described here and then a reduction in background contractile
activity may have been seen.
In these studies propranolol, a P antagonist (Jacob, Brandt, Farkas and
Frishman, 1983), had no significant effect on the rate or amplitude of background
contractions in either region of the small intestine from both control and grass
sickness tissue with one exception (Tables 4.7 and 4.9). The amplitude of the ileal
AGS group was significantly reduced (P<0.05). Phentolamine also had no significant
effect on background contractions in either region of the small intestine with the same
exception (Tables 4.11 and 4.13). As observed with propranolol the amplitude of the
ileal AGS group was significantly reduced (P<0.05) following the addition of
phentolamine. An explanation for this reduction in amplitude could not be given.
Adrenergic blockade has not been shown to have a significant effect on gut
motility in normal horses either clinically or experimentally (Gerring and Hunt, 1986).
Gerring and Hunt (1986) found propranolol was the least effective agent in improving
electrical and mechanical activity throughout the gut in an equine post operative ileus
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model. Smith, Kelly and Weinshilboum (1977) found combined a and |3 blockade
with propranolol and phentolamine in dogs improved gastric activity but not
propulsion. Malone, E.D, Brown, D.R., Trent, A.M. and Turner, T.A. (submitted for
publication 1995) also found little response to adrenergic blockade in equine jejunum
in vitro. They suggested that this indicated minimal baseline sympathetic tone in the
equine jejunum. However, in their study they did find that phentolamine caused a
significant decrease in the amplitude ofbackground contraction of the longitudinal
muscle, but they could not suggest a reason for this effect. When they used more
selective a antagonists, however, no reduction in the amplitude was seen.
In Tables 4.4, 4.9 and 4.13 the data for the duodenal and ileal regions were
from the same horses and were therefore analysed using the Wilcoxon Signed Rank
test. In some cases the P value was less than 0.06 which is not statistically significant.
This was probably due to the small numbers which were used and therefore could
suggest differences ofbiological importance.
The effect of storage was investigated to see if enteric neuronal death would
take place and produce alterations in motility which may be similar to that known to
occur in grass sickness (Chapter 4.3.3.1 and 4.3.3.2). The rate of background
contractions for the control duodenal and ileal groups was significantly reduced and
the amplitude of contractions was significantly increased following storage (P<0.05)
(Tables 4.15 and 4.21). This contrasts with equine grass sickness tissue where there
was no significant difference in the rate or amplitude of contractions following
storage, with the exception of the rates of contractions for the duodenal CGS group
(P<0.01) and the ileal AGS group (P<0.05).
This would suggest that intrinsic nerves must indeed have an excitatory effect
on the rate ofbackground contractions, as when denervation occurs to some degree
during storage, there is a reduction in contractile rate.
In the duodenal region, there were no significant differences for the control
tissue following storage, compared with fresh AGS, SAGS and CGS data. This
suggested that this storage period may have some potential for a model of grass
sickness. However, when the stored ileal data were compared with fresh AGS, SAGS
and CGS data, the rate of contractions was significantly lower and the amplitude
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significantly higher. This could suggest the rate of damage during storage was greater
in the thicker ileal tissue. It must therefore be concluded that storage for 24 hours
would not be a suitable model for the neuronal degeneration which occurs in grass
sickness.
With stored tissue, propranolol and phentolamine had no significant effect on
the rate or amplitude of background contractions compared with stored tissue alone.
This suggested that, as with fresh tissue, the adrenergic system is not involved in the
control ofbackground contractions.
In conclusion, these results demonstrate that in vitro, the characteristic
background contractions for control tissue and grass sickness tissue show some
significant differences. The responses to selected pharmacological agents suggest that
the background contractile rate and amplitude of the horse small intestine in vitro, is
mainly due to myogenic mechanisms although there is likely to be some influence
from intrinsic nerves, especially in the duodenal region.
The investigation of the characteristics of background contractions provides
useful information especially since the literature provides little information about in
vitro work with equine intestinal tissue. Now it is necessary to investigate some of the
intrinsic systems which control motility in more detail and establish how tissue is





The motor responses of the cholinergic and adrenergic systems, either acting
directly on the muscle or via the enteric nervous system, were examined using the in
vitro technique. The cholinergic system will be discussed first under three main
headings; responses to physostigmine (5.1), responses to bethanecol (5.2) and
responses to cisapride (5.3). The aims of the work were to investigate the extent of
damage to cholinergic neurones in cases of grass sickness and also to see whether
cholinergic receptor sensitivity was altered. In addition the prokinetic drug cisapride
was investigated in order to assess the potential for any therapeutic effect in the
treatment of grass sickness cases.
5.1 RESPONSES TO PHYSOSTIGMINE
5.1.1 Introduction
Physostigmine, also known as eserine, is a naturally occurring
anticholinesterase agent obtained from the Calabar bean (Schild, 1980).
Anticholinesterases prevent the breakdown of acetylcholine by cholinesterases. When
present, acetylcholine therefore accumulates at the cholinergic receptor sites.
Consequently anticholinesterases are capable of producing effects equivalent to
excessive stimulation of cholinergic receptors throughout the central and peripheral
nervous systems. In view of the widespread distribution of cholinergic neurones it is
not surprising that anticholinergic agents, as a group, have received extensive
application as toxic agents in the form of agricultural insecticides and potential
chemical warfare 'nerve gas' (Taylor, 1990b).
There are several mechanisms by which anticholinesterases exert their action.
For reversible inhibitors, such as physostigmine, their action is due to the formation of
a reversible complex between the cholinesterase enzyme and the inhibitor molecule.
As this complex is a carbamyl and not acetyl ester, it takes longer to hydrolyse (Pugh,
1985; Wilson, Hatch and Ginsburg, 1960). The duration of action of
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anticholinesterase depends on the rate of dissociation of the enzyme inhibitor complex
and the rate at which the free inhibitor is removed from the body by metabolism and
excretion. Irreversible inhibitors, such as the organophosphorous compounds,
probably exert their action by phosphorylation of the esteratic site of the active
enzyme centre of cholinesterase (Rang and Dale, 1991).
Although, due to its anticholinesterase properties, physostigmine increases gut
motility, it is not used clinically as it produces nausea and vomiting in man, it also
causes a slowing ofthe heart, a fall in blood pressure, muscular twitching and other
central nervous system effects (Schild, 1980). Physostigmine may be used to produce
miosis of the pupil and reduce intraocular pressure in the treatment of glaucoma
(Einstein, Jones, Rnifton and Starner, 1994). Physostigmine is not used
therapeutically in the horse. There has however, been one report of the use of
physostigmine in grass sickness cases (Masheter, 1922), although they were acute
type cases and showed no response to physostigmine.
5.1.2 Materials and methods
The apparatus for these experiments is described in Chapter 3. In this series of
experiments 25 control horses, ten horses suffering from AGS, eight horses suffering
from SAGS, and 12 horses suffering from CGS were used. Details of the horses are
given in Appendix C. Only the control, AGS and CGS groups were used to study the
effect of storage for 24 hours at 4°C. The drug used was physostigmine sulphate
(BDH Chemicals). When equine intestinal muscle is studied in vitro the response to an
accumulation of acetylcholine can be measured as an increase in the rate of
background contractions, an alteration in the amplitude of contractions, or an increase
in the tone of the muscle strip.
A ten minute period prior to the addition of physostigmine was used to
measure the initial rate ofbackground contractions and to establish the baseline tone.
The latency was the time before any alteration in rate or tone could be observed
following the addition of physostigmine. At this point the following seven minutes
were used to calculate any enhanced rate of contractions. At the end of this period the
increase in tone was measured if applicable.
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5.1.2.1 Statistical analysis
Results are presented as medians with the range of values shown in brackets.
The data were analysed firstly control tissue compared with all the grass sickness data
combined. Then the control data against the three grass sickness groups, AGS, SAGS
and CGS which depended on clinical signs and duration of illness. Also in Appendix D
the grass sickness data was divided into two groups depending on the time taken
before a response to physostigmine was observed. Differences between the groups
were analysed for statisical significance using the Mann-Whitney U-test. For
differences within a group the Wilcoxon Signed Rank test was used. Differences
between the two regions of the gut were analysed using the Wilcoxon Signed Rank
test. The effect of storage, for a particular group was also analysed using the
Wilcoxon Signed Rank test as samples from the same horses were used in
experiments on fresh and stored tissue.
5.1.3 Results
5.1.3.1 Duodenal preparations
In initial experiments, the responses of control tissue in terms of an increase in
contractile rate and tone of the smooth muscle strips to different concentrations of
physostigmine, established that there were final concentrations below which little
response could be found (below 8.6xlO"8M). Above 2.8xlO"3M muscle strips showed
increased tone, almost spasm and prolonged recovery time. In the intermediary range,
tissues responded with measurable changes in both rate and tone. It was therefore
decided to use a standard concentration of 8.6x10"^ and to compare responses
between the four different groups.
Typical responses to physostigmine for duodenal muscle strips taken from a
control horse and one affected by AGS are shown in Figure 5.1.1. In both traces there
was an increase in the rate of contractions and an upward shift of baseline. The results
for responses to physostigmine are shown in Table 5.1.1 and 5.1.2.
Following the addition ofphysostigmine (8 .6x10"^) the rate ofbackground
contractions significantly increased in the control duodenal group (P<0.0001). Figure
5.1.2A shows the increase in the rate of contractions following physostigmine
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Physostigmine




8.6 x 10"6 M
Figure 5.1.1. Effect of physostigmine (8.6x10"6M) on an longitudinal muscle
strip taken from A) the duodenum of a control horse, B) the duodenum of a




























































































Table5.1.2Effectofadditionphysost gmine(8.6xlO"6M)nis la dduo e almuscletripst kenr controlh r sd thosesufferingfromacutegrasssi kn ss(AGS),subacutegrickn s(SAGS),a dhro icgra sickn s(C ).V l aremedianswiththrangeofv lueshownibr ck t .Val swi htsameup rscripts ificantlydiff entfr ach otherd=P<0.0001,e,g<0.f. 5whenanalysedusi gWilcoxonS gneR nke t,m=P< . 00 ,1<0. 005, a=P<0.001,b. 5,j,n,o,pP<0. ,c,h,k=. 5w enanalysedusingtMann-WhitneyU-t s .
A


















Figure 5.1.2. The effect of physostigmine (8.6xl0"6M) on the rate of contractions of
A) duodenal smooth muscle strips taken from the control group, B) ileal smooth
muscle strips taken from the control group. On the y-axis i corresponds to the initial
rate of background contractions and p to the rate of contractions following treatment
with physostigmine.
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addition for the control duodenal group. The median rate increased from 6.5 to 9.2
contractions per minute for control duodenal strips (Table 5.1.1).
For all grass sickness affected duodenal tissue the initial rate ofbackground
contractions was significantly lower compared with duodenal control tissue (AGS
PO.OOl, SAGS P<0.005, CGS P<0.05) (Table 5.1.2). The addition of physostigmine
(8.6xlO"^M) produced a significant increase in the rate of contractions in all three
grass sickness groups compared with their initial rates (AGS and CGS P<0.01, SAGS
P<0.05). However, these increased rates were still lower than the enhanced rate for
the control group, significantly lower in the case of the AGS group (P<0.01) (Table
5.1.2).
The median percentage increase in rate was largest in the SAGS group
(168%), followed by the AGS group (130%), with the lowest percentage increase for
the control group (44%). For the AGS and SAGS grass sickness groups the
percentage rate increase was significantly higher than the control group (AGS P<0.01,
SAGS P<0.05).
Figure 5.1.3 illustrates the latency before a response to physostigmine for the
duodenal grass sickness groups compared with the duodenal control group. The
latency was significantly longer for all the grass sickness groups compared with the
control group (SAGS P<0.0001, AGS P<0.0005 and CGS P<0.01).
The median increase in tone was very similar for the control and CGS groups.
Only the AGS group was significantly lower than the control group (P<0.01) (Table
5.1.2).
5.1.3.2 Deal preparations
Typical responses to physostigmine for ileal control tissue and that from a
horse affected by AGS are shown in Figure 5.1.4. For both preparations the burst-like
pattern ofbackground contractions changed into more regular contractions following
physostigmine addition, thus causing a increase in the rate of contractions. For the
AGS muscle strip the latency before this increase in contractile rate was much longer
than for the control strip (Figure 5 .1.4). With the control ileal strip there was also an
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Figure 5.1.3. Distribution of the time period (latency) before a measurable response to
physostigmine (8.6xlCT6M) addition occurred. The solid histogram represents the
latency in seconds for the duodenal control group. The hatched histogram represents











8.6 x 10"6 M 1 min
Figure 5.1.4. Effect of physostigmine (8.6x10"6M) on an isolated longitudinal
muscle strip taken from A) the ileum of a control horse, B) the ileum of a
horse suffering from acute grass sickness.
W
increase in the tone of the preparation (upward shift of baseline), but with the AGS
muscle strip this was not seen (Figure 5.1.4).
The median results for ileal preparations in response to physostigmine are
shown in Tables 5.1.3 and 5.1.4. For control ileal preparations the rate of background
contractions significantly increased following the addition of physostigmine
(P<0.0001). Figure 5 .1.2B shows the increase in the rate of contractions for the
control ileal group.
All grass sickness affected ileal tissue had a lower, but non-significant, median
initial rate of background contractions compared with the control ileal group (Table
5.1.4). Following addition of physostigmine, they all showed significant increases in
their rate of contractions (AGS P<0.005, SAGS and CGS P<0.05). When compared
with the enhanced rate following physostigmine for the control ileal group, the
contractile rate for all three grass sickness ileal groups were significantly lower
(P<0.005). Figure 5.1.5 shows the increase in rate of contractions following
physostigmine for the duodenal and ileal AGS groups.
There was no significant difference between the percentage rate increase for
any of the ileal groups. In the ileal region, it was the AGS group which had the lowest
percentage rate increase following physostigmine addition, whereas in the duodenum
it was the control group which showed the lowest increase.
The latency before a response could be seen followed a similar pattern as was
found in the duodenum with AGS having the longest median latency of 228 seconds.
Only the latency of the AGS and SAGS groups was significantly longer than the
control ileal group (P<0.05) (Table 5.1.4).
In all AGS and SAGS muscle strips no increase in tone was ever observed,
thus a value of zero was used. There were therefore significant differences between
these two groups and the control and CGS groups (P<0.001) (Table 5.1.4). The
range ofvalues for increase in tone for the control and CGS ileal groups were very
similar.
Table 5.1.4 shows any significant differences between the responses to































































































p- XX X )XXX X
















Figure 5.1.5. The effect of physostigmine (8.6xlO'6M) on the rate of contractions of
A) duodenal smooth muscle strips taken from the AGS group, B) ileal smooth muscle
strips taken from the AGS group. On the y-axis i corresponds to the initial rate of
background contractions and p to the rate of contractions following treatment with
physostigmine.
5.1.3.3 Effect of 24 hour storage on responses of duodenal preparations
The initial rate of background contractions for control duodenal tissue was
significantly lower (P<0.05) for stored tissue compared with fresh tissue, with the
median rate reducing from 6.5 to 4.6 contractions per minute (Tables 5.1.1 and
5.1.5). There was also a trend for the AGS and CGS groups to have lower initial
contractile rates with stored tissue. Only the initial rate ofbackground contractions
for stored CGS tissue was significantly lower than the stored control group (P<0.05)
(Table 5.1.5).
Following treatment with physostigmine (8.6x lO"6M) the rate of contractions
for stored control tissue significantly increased (P<0.0001). This increased value was
not significantly different from the increased rate of contractions following
physostigmine for control fresh tissue. With both stored AGS and CGS tissue
following storage and physostigmine addition there was a non-significant increase in
the rate of contractions.
The CGS group had the largest percentage rate increase following
physostigmine although there were no significant differences between any of the
groups for this measurement (Table 5.1.6). Figure 5.1 6A shows the effect of
physostigmine on the rate of contractions for control duodenal tissue following
storage. The percentage increase for the duodenal control group following storage
was significantly higher than for fresh tissue (P<0.05).
The latency before a response was observed was significantly longer for
the stored control duodenal tissue than for fresh control tissue (P<0.05). The
stored AGS group had a significantly (P<0.05) longer latency than the stored
control group before a response to physostigmine could be seen (Table 5.1.6).
There were no significant differences between any of the groups for the
increase in tone measurement. The AGS group had the lowest median value of
3-lg-
When the effects of storage on the AGS and CGS groups were
compared with fresh AGS and CGS tissue there were no significant differences
for any of the parameters measured, although it should be noted that the number
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Figure 5.1.6. The effect of physostigmine (8.6x10"6M) on the rate of contractions of
A) duodenal smooth muscle strips taken from the control group following storage at
4°C for 24 hours, B) ileal smooth muscle strips taken from the control group
following storage at 4°C for 24 hours. On the y-axis i corresponds to the initial rate of
background contractions and p to the rate of contractions following treatment with
physostigmine.
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The stored control results were compared with fresh AGS, SAGS and
CGS values using the Mann-Whitney U-test to see if the neuronal damage
which occurred due to storage was similar to that known to occur in grass
sickness cases. There were significant differences between the stored control
latency value and that of fresh AGS and SAGS values (P<0.05). There was also
a significant difference in the tone results for the fresh AGS group compared
with the stored control duodenal group (P<0.01). There were no significant
differences between the values for contractile rate either before or after
physostigmine addition.
5.1.3.4 Effect of 24 hour storage on responses of ileal preparations
Although the median initial rate of contractions for stored control ileal tissue
was lower than for fresh tissue, the difference was not significant (Table 5 .1.3 and
5.1.8). There was also no significant difference between AGS and CGS stored and
fresh values with respect to their initial contractile rate. Following treatment with
physostigmine (8.6x10^'M) there was a significant (P<0.005) increase in the rate of
contractions for control stored ileal tissue. The addition of physostigmine produced a
non-significant increase in the median rate of contractions for both grass sickness
groups. The increased rate of contractions for the stored AGS group was significantly
lower (P<0.05) than for the stored control group. Figure 5.1.6B shows the effect of
physostigmine on the rate of contractions for control ileal tissue following storage.
As there was only a small increase in the rate of contractions, the medians of
the percentage rate increase were low for both the grass sickness groups. The
percentage increase for the stored control ileal group was significantly higher than for
fresh tissue (P<0.05).
The stored ileal AGS group had a significantly (P<0.005) longer latency than
the stored ileal control group.
As was found with fresh tissue there was no increase in tone following
physostigmine with the AGS group. The increase in tone for the CGS group
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When the stored ileal control data was compared with stored duodenal
control data there was a significant difference in the percentage increase
following physostigmine (P<0.05). Also in the initial contractile rate of control
tissue (P<0.05). There were no significant differences for the grass sickness
groups although again the number of experiments with stored tissue was low
(n=5 for AGS and n=3 for CGS).
When the stored ileal control group results were compared with fresh
ileal AGS, SAGS and CGS results, there were no significant differences in the
initial rate of contractions. There was a significant difference between fresh
SAGS and stored control results for rate of contractions following
physostigmine addition (P<0.05), with the stored control value been higher. For
the percentage rate increase there were significant differences between control
stored results and fresh AGS (PcO.Ol) and CGS groups (P<0.05). There were
no significant differences between the latency results. The tone of the ileal AGS
and SAGS groups were significantly different from the stored ileal control
group (P<0.01).
5.1.4 Discussion
The responses to physostigmine were measured as increases in the rate
of contractions and tone (baseline) of the smooth muscle strips. The traces
produced were similar to those described in laboratory animals (Perry, 1968).
The latency before an alteration in these parameters was also recorded.
Physostigmine enhanced the motility of all tissues studied from both
fresh and stored tissue, taken from both control horses and those affected by the
three clinical forms of grass sickness. The increase in contractile rate was
significant in all the fresh muscle strips and in control horses following storage
(P<0.05 or less). Although the median contractile rate increased in the AGS and
CGS groups following physostigmine addition after storage, this increase was
not significantly higher in either region of the small intestine. This may be
because there was already substantial neuronal damage due to grass sickness
(Doxey et al., 1992; Scholes et al.. 1993a) and that following storage there
were insufficient numbers of healthy neurones to produce enough acetylcholine
to alter motility significantly. There have been no reports of the type of
neurones damaged in grass sickness. There have been some
immunohistochemical studies which have reported a depletion of both peptide-
containing cells and nerves in grass sickness cases (Sabate et al., 1983; Bishop
et al., 1984; Vaillant, 1991; Pearson, G.T. and Woodman, M.P., personal
communication).
As the grass sickness tissue had low initial contractile rates, following
the addition of physostigmine the percentage increase in rate was significantly
higher for both the fresh duodenal AGS and SAGS groups than the duodenal
control group. For ileal tissue, the control group had the highest median
percentage increase value. This pattern continued with stored tissue i.e. in the
duodenal preparations the grass sickness groups had the highest median
percentage increase in contractile rate whereas in the ileal regions it was the
control group which had the highest value.
In the duodenal region only the AGS group had a significantly lower
rate of contractions following physostigmine than the control group, whereas in
the ileum all three grass sickness groups had a significantly lower enhanced rate
compared with the ileal control group. This suggests that the ileal region was
the worse affected in grass sickness.
Initially the absolute values for tone of the preparations were not known.
As discussed in Chapter 3 all duodenal preparations had a uniform tension of 2g
applied, and during the equilibration period these preparations relaxed and then
maintained a constant baseline with regular contractions. For ileal tissue the
situation was more complicated as the initial tension applied to the preparations
varied depending on animal size and muscle thickness. However, as with
duodenal strips, the tissue relaxed during the equilibration period to establish a
constant baseline.
All duodenal muscle strips showed a positive increase in tone in
response to physostigmine. Only duodenal AGS fresh tissue showed a
significantly lower increase in tone compared with the duodenal control group
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(P<0.01). This was probably due to a smaller accumulation of acetylcholine in
the AGS group. Indeed in the ileal region, no AGS or SAGS muscle strips
showed any increase in tone following physostigmine addition (Table 5.1.2).
This indicates that the number of surviving cholinergic neurones in grass
sickness cases may be lower in the ileum than in the duodenum i.e. that grass
sickness causes greatest damage in the ileum. This has indeed been suggested
(Scholes et al., 1993a; Doxey, D.L., Milne, E.M., Woodman, M.P., Gilmour,
J.S. and Chisholm, H.K. submitted for publication). However, it may be that
there are a lower number of cholinergic neurones in the ileal region of the horse
initially and that damage due to grass sickness is in fact uniform throughout the
small intestine. No references to the population of cholinergic neurones
throughout the length of the gastrointestinal tract could be found in any species.
The significantly prolonged latency before a response to physostigmine
with AGS and SAGS tissue provides further evidence for a functional deficit of
cholinergic neurones in grass sickness. Fewer surviving cholinergic neurones
would be expected to take longer to release enough acetylcholine to affect
motility.
The effect of storage was investigated to see if stored control tissue
would respond similarly to fresh grass sickness tissue and thus provide a model
for grass sickness in vitro research. As there were some significant differences
in the responses to physostigmine between control tissue following storage and
fresh grass sickness tissue, particularly AGS tissue, it must be concluded that 24
hour storage at 4°C is not a suitable model for grass sickness.
Following 24 hour storage, grass sickness tissue showed no significant
increase in the rate of contractions following treatment with physostigmine. This
may be because there was substantial neuronal damage already and that
following storage there were insufficient healthy neurones to produce sufficent
acetylcholine to alter motility.
The enhanced rate of contractions and increased tone of equine intestinal
tissue produced in vitro by physostigmine establish a pharmacological basis for
the observed therapeutic usefulness of certain prokinetic drugs which may
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activate or supplement the enteric cholinergic system in selected cases of grass
sickness. Milne. E.M., Doxey, D.L., Woodman, M.P., Cuadeford, D. and
Pearson, R.A. (in press) give details of the use of cisapride in the treatment of
selected cases of CGS (see Chapter 5.3).
In conclusion, physostigmine has been found to be a useful
pharmacological tool in showing differences between the control and grass
sickness groups. It allowed the accumulation of endogenously released
acetylcholine to be assessed. The effect of increased levels of acetylcholine is to
bring the membrane potential of smooth muscle to the threshold required for the
generation of spikes (action potentials) (Grundy, 1985). This causes an increase
in the rate and amplitude of contractions. For grass sickness tissue the results
suggest there was substantial cholinergic neuronal damage in the duodenum and
ileum with the result that the accumulation of acetylcholine was reduced,
therefore the increase in rate of background contractions and tone in response
to physostigmine was limited. There was also a significantly longer latency
before any responses could be observed.
5.2 RESPONSES TO BETHANECOL
5.2.1 Introduction
Acetylcholine has practically no therapeutic applications because of its
diversity of action and its rapid hydrolysis by acetylcholinesterase and plasma
butyrylcholinesterase (Taylor, 1990a). As a result, numerous derivatives have been
synthesized in an attempt to obtain cholinergic drugs with more selective and
prolonged actions. Of the many synthetic derivatives investigated only a few have had
a clinical application, for example, carbachol, used in the treatment of impacted colic
in the horse and bethanecol, used to stimulate gastrointestinal motility in post
operative ileus (POI) and to stimulate urinary bladder contractions. Bethanecol has
also been used to enhance gastric emptying and minimize gastro-oesophageai reflux in
foals with gastric ulceration (Allen, Pingle, Smith, Conlon and Burgmann, 1993).
Bethanecol is a cholinergic agonist which largely has muscarinic actions. It
also acts with some selectivity on the smooth muscle of the gastrointestinal tract and
urinary bladder (Taylor, 1990a). It is an unsubstituted carbamyl ester which is totally
resistant to hydrolysis by acetylcholinesterase or nonspecific cholinesterases. The
muscarinic action of bethanecol is selectively blocked by atropine (Pugh, 1985).
Bethanecol is capable of producing increases in the amplitude of contractions
and tone in the gut, thereby increasing peristaltic activity (Taylor, 1990a). It also
enhances the secretory activity of the gastrointestinal tract. However, the results of
studies using dogs, by Summers and Flatt (1988), indicate that bethanecol may cause
smooth muscular contractions without resulting in coordinated propagating
contractions that are necessary for the movement of ingesta. Gerring and Hunt (1986)
used bethanecol in combination with yohimbine in their investigation to restore
propulsive activity in an experimental model of POI in horses. They concluded that
there was some increase in electromechanical activity with these drugs although
metoclopramide had a more beneficial effect.
In human gastrointestinal disorders, bethanecol is of value in certain cases of
postoperative abdominal distension and gastric atony or gastroparesis (Malagelada,
Rees, Mazzotta and Go, 1980; Taylor, 1990a; Rang and Dale, 1991). It has also been
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In skeletal muscle following denervation, hypersensitivity or supersensitivity of
the muscle may occur (Janig, 1987). There are a few reports of denervation
hypersensitivity in smooth muscle, for example parasympathetic and sympathetic
hypersensitivity of the iris in ocular hypertension in humans (Clark and Mapstone,
1987; Clark, 1989). Experiments have also been carried out using laboratory animals,
where denervation of regions of the gastrointestinal tract have been induced
pharmacologically, to study the responsiveness of denervated tissue to selected
pharmacological agents (Herman and Bass, 1990; Osinki and Bass, 1993; 1994).
Wright and Shepherd (1965) suggested that denervation hypersensitivity may occur in
Hirschsprung's disease in humans.
In this Chapter, a series of experiments was conducted on equine intestine to
investigate the sensitivity of the smooth muscle strips to bethanecol. In grass sickness,
alteration of cholinergic sensitivity may be expected if equine gastrointestinal muscle
behaves like other excitable tissue following denervation, with hypersensitivity
occurring.
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5.2.2 Materials and methods
The in vitro method was used (Chapter 3). Smooth muscle strips were taken
from the duodenum and ileum from eight control horses, nine horses suffering from
AGS. and nine horses suffering from CGS (see Appendix E for details). Molar
concentrations of bethanecol chloride (Sigma) were added to the smooth muscle
strips (the range of final concentrations was 3mM-0.0001mM). The individual data
for each experiment was normalised as a percentage of its maximum response. For
each individual experiment the objective was to find the concentration of bethanecol
which gave 50% of the maximum contractile response evoked by bethanecol. There
was not, therefore, a measurement for every concentration of bethanecol for every
experiment. Dose response curves were then constructed for a) control data vs all the
data for grass sickness tissue and b) control vs AGS and CGS tissue using the median
value for each of the concentrations used. Responses at each concentration were
analysed separately using the Mann-Whitney U-test to see if there were any significant
differences between the groups. To assess the maximum contractile response the
defletion in mms was converted into grams using the calibration curves for each
transducer/pen recorder combination (see Chapter 3.2). The value was then divided
by the wet weight of the muscle strip to try to reduce some of the variation between
animal size and muscle thickness.
5.2.3 Results
5.2.3.1 Duodenal muscle strips
With in vitro preparations of equine small intestine, the response to bethanecol
was to produce a rapid contraction (Figure 5.2.1). The addition of bethanecol
produced dose dependent contractions in all duodenal smooth muscle strips from both
control horses and those affected by grass sickness. When all the grass sickness data
were combined for both the duodenal and ileal regions and compared with the
duodenal and ileal control data respectively there were no significant differences in the
results. The dose response curves for the log of the concentration of bethanecol
versus the percentage maximum response for the control, AGS and CGS duodenal







Figure 5.2.1. Response of duodenal muscle strip taken from a control horse to 0.1
mM bethanecol. The contractile response occurs within 10 seconds.
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values. Details of the numbers involved and the range of values are given in Tables
5.2.1 A, 5.2. IB and 5.2.1C. The maximum contraction obtained in each experiment
was either at 3mM or ImM bethanecol (equivalent to -2.52 or -3 on the log scale
respectively). At 3mM bethanecol 62.5% of control duodenal strips had their
maximum response compared with 50% for AGS duodenal strips and only 30% for
CGS duodenal strips. The maximum responses for smooth muscle strips in grams per
gram ofwet tissue (median and range) were 39.4 (30.8-61.5) for the control group,
54.8 (32.7-82.2) for the AGS group and 54.9 (18.9-85.6) for the CGS group.
However, there were no significant differences between any of the groups for this
maximum contractile response.
The sensitivity of the three groups to bethanecol varied. The median values for
the AGS group for the range of concentrations were consistently to the left of the
control group, suggesting an increased sensitivity to bethanecol for AGS tissue,
especially at lower bethanecol concentrations. When these data were analysed using
the Mann-Whitney U-test there was only a significant difference (P<0.05) between the
control and AGS groups at the 0.0ImM concentration (-5 on the log scale). This was
because at some concentrations there were no actual data for either groups for
reasons explained in 5.2.2 and at other points the data were only a mean of two
experiments.
The CGS group tended to be less sensitive than the control group at higher
concentrations of bethanecol. However, at lower concentrations of bethanecol the
tissue became more sensitive than the control tissue, with median values again lying to
the left of the control values. Although, there were no significant differences between
the control and CGS groups at any concentrations.
At O.lmM and O.OOlmM bethanecol (-4 and -6 on the log scale respectively)
there was a significant difference betweeen the AGS and CGS duodenal groups
(P<0.05).
A reference line was drawn at the 50% level so the ED50 values could be
measured. These were calculated at 0.00094mM for the AGS group, 0.02mM for the
control group and 0.071mM for the CGS group.
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A)
Concentration log of n median (range)
mM concentration % of maximum response
3 -2.52 5 100.0(100.0-100.0)
1 -3 8 92.5 (72.4-100.0)
0.6 -3.22 2 83.6 (82.1-85.0)
0.3 -3.52 2 69.6 (57.1-82.1)
0.1 -4 7 66.0 (50.0-71.7)
0.03 -4.52 7 55.3 (52.2-62.5)
0.01 -5 8 41.2(28.6-50.0
0.001 -6 2 27.3 (26.4-28.2)
B)
Concentration log of n median (range)
mM concentration % of maximum response
->
3 -2.52 5 100.0(100.0-100.0)
i -3 9 95.0(75.0-100.0)
0.1 -4 5 72.2 (58.3-78.4)
0.03 -4.52 J 57.1 (50.0-69.4)
0.01 -5 5 55.2 (41.7-67.6)
0.001 -6 5 51.4 (40.0-58.9)
0.0003 -6.52 3 36.1 (28.6-44.3)
0.0001 -7 2 25.1 (18.8-31.3)
C)
Concentration log of n median (range)
mM concentration % of maximum response
3 -2.52 ->J 100.0 (100.0-100.0)
1 -3 9 100.0 (69.6-100.0)
0.6 -3.22 2 80.1 (78.3-81.8)
0.3 -3.52 5 63.6 (56.5-73.1)
0.1 -4 7 50.0(30.4-75.0)
0.06 -4.22 2 49.4 (45.7-53.1)
0.03 -4.52 2 46.8 (42.4-51.1)
0.01 -5 6 41.5 (33.3-63.6)
0.003 -5.52 J 46.7(31.3-48.6)
0.001 -6 4 31.1 (29.7-37.8)
Table 5.2.1. The normalized contractile response of duodenal muscle strips to
bethanecol. Values are medians of the maximum response, A) for the control group,





































log of concentration of bethanecol (mM)
Figure 5.2.2. Dose response curves for bethanecol on strips of equine duodenum. The
points shown are median values. 'Control' refers to horses euthanased owing to
diseases unrelated to grass sickness. AGS and CGS refers to horses suffering from
acute and chronic grass sickness respectively.
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5.2.3.2 Ileal muscle strips
Figure 5.2.3 shows the dose response curves for bethanecol for ileal muscle
strips divided into control, AGS and CGS groups. The median values at each
concentration are plotted. The range and population size are shown in Tables 5.2.2A,
5.2.2B, and 5.2.2C. As was found with duodenal tissue, the maximum contractile
response was observed at ImM or 3mM for all ileal groups. At 3mM only 14.3% of
control ileal strips had their maximum response compared with 42.9% for the ileal
AGS group and 50% for the CGS group. The maximum responses of ileal smooth
muscle strips in grams per gram of tissue (median and range) were 33.9 (29.3-49.6)
for the control group, 61.0 (43.9-88.9) for the AGS group and 51.1 (25.9-108.8) for
the CGS group. The maximum values found for the AGS ileal group was significantly
higher than for the control ileal group (P<0.05).
Also, as was observed with the duodenal preparations, the median values for
the ileal AGS dose response curve were located to the left side of the control group.
There were significant differences between the AGS and control groups at 0.03mM
and O.OlmM bethanecol (equivalent to -4.52 and -5 on the log scale) (P<0.05). The
results for the ileal CGS group were situated to the right side of control values at high
concentations ofbethanecol but crossed over to the left side of control values at lower
bethanecol concentrations. This 'cross over' occurred at a higher concentration of
bethanecol than for the duodenal CGS group. As was observed with the duodenal
region there were no significant differences between the CGS and control groups at
any of the concentrations of bethanecol. There were also no significant differences
between the AGS and CGS values at any point on the dose response curves.
The ED5o values for the ileal groups did not follow the same ranking as the
duodenal groups. The values were 0.0022mM for the AGS group, O.OlmM for the
CGS group and 0.04mM for the control group.
The statistical comparison of the responses to the same concentration of
bethanecol between the two regions of the small intestine for each of the three groups
was carried out using the Mann-Whitney U-test. Although some of the values for the
two regions were from the same horses, there were insufficient numbers to use a
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A)
Concentration log of n median (range)
mM concentration % of maximum response
3 -2.52 1 100.0(100.0-100.0)
1 -3 7 100.0 (93.8-100.0)
0.3 -3.52 2 78.7 (76.4-81.0)
0.1 -4 6 59.7 (45.2-73.2)
0.06 -4.22 2 58.5 (56.3-60.7)
0.04 -4.4 2 50.0 (50.0-50.0)
0.03 -4.52 6 44.4 (36.0-58.5)
0.01 -5 6 36.1 (31.3-68.8)
B)
Concentration log of n median (range)
mM concentration % of maximum response
3 -2.52 3 100.0(100.0-100.0)
1 -3 7 98.4 (79.3-100.0)
0.3 -3.52 2 88.4 (85.6-91.2)
0.1 -4 3 68.2 (61.8-93.3)
0.03 -4.52 4 60.9 (52.9-70.8)
0.01 -5 6 58.2 (49.5-74.5)
0.003 -5.52 2 53.3 (49.9-56.7)
0.001 -6 3 42.7(40.0-43.3)
0.0001 -7 2 34.7 (28.9-40.5)
C)
Concentration log of n median (range)
mM concentration % of maximum response
3 -2.52 5 100.0 (100.0-100.0)
1 -3 9 100.0 (77.3-100.0)
0.3 -3.52 3 65.8 (62.2-74.1)
0.1 -4 3 60.7 (56.7-78.8)
0.03 -4.52 5 55.7 (35.5-69.2)
0.01 -5 7 55.8 (28.6-63.1)
0.003 -5.52 4 40.9 (38.5-60.6)
0.001 -6 4 37.2 (31.1-45.5)
Table 5.2.2. The normalized contractile response of ileal muscle strips to bethanecol.
Values are medians of the maximum response, A) for the control group, B) for the
AGS group and C) for the CGS group. The range of values are shown in brackets.
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log of concentration of bethanecol (mM)
Figure 5.2.3. Dose response curves for bethanecol on strips of equine ileum. The
points shown are median values. 'Control' refers to horses euthanased owing to
diseases unrelated to grass sickness. AGS and CGS refers to horses suffering from
acute and chronic grass sickness respectively.
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paired statistical test. There were no significant differences between the two regions in
terms of contractile reponse to different concentrations ofbethanecol, for both the
AGS and CGS groups. The control ileal tissue had a significantly lower response than
duodenal tissue at 0.03mM bethanecol (P<0.05).
5.2.4 Discussion
As proposed in the introduction, hypersensitivity of muscarinic receptors in
the gut may be expected to occur in the horse, following an attack of grass sickness.
A number of studies have investigated the effects of denervation with regard
to tissue sensitivity and the mechanisms involved. Most work has concentrated on
skeletal muscle, but some work has been carried out using smooth muscle in
laboratory animals (Herman and Bass, 1990; Osinski and Bass, 1993; 1994).
In skeletal muscle when a nerve is cut and its terminals allowed to degenerate,
the structure supplied by it becomes supersensitive to the transmitter substance
released by the terminals. Several mechanisms are known to contribute to this
denervation supersensitivity depending on the organ involved. For example, a change
in the number or affinity of cellular receptors may occur. It has been reported that the
number of nicotinic cholinergic receptors increases following surgical denervation.
They also spread from the narrow locality of the end plate to cover the whole muscle
membrane i.e. the receptors are no longer localized (McConnell and Simpson, 1976).
Fambrough (1979) recorded the appearance of extrajunctional nicotinic receptors
seemed to be a major factor in the development of supersensitivity in denervated
skeletal muscle. Nilvebrant, Ekstrom and Malmberg (1986) reported that the density
of muscarinic receptors was increased in denervated hypertrophied urinary bladders in
rats. However, denervation supersensitivity of the iris of the cat has been reported
without any changes in receptor density (Sachs, Kloog, Korczyn, Heron and
Sokolovsky, 1979). Therefore, it must be concluded that in some cases, post
junctional cells become supersensitive without a corresponding increase in the number
of receptors (Rang and Dale, 1991). Herman and Bass (1990) measured isometric
responses in vitro of naive and myenterically denervated rat jejunal circular muscle 15
and 30 days following denervation. Their results suggested that there were differences
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in tissue sensitivity, but that within 30 days reinnervation had occurred to some
degree. They thought this was most likely to be due to neurones located in the
submucous plexus.
Loss of the mechanism for transmitter removal may also lead to
supersensitivity. When sensitivity occurs as a result of the loss of uptake or
degradation mechanisms for a specific neurotransmitter it is sometimes known as
deviation supersensitivity. This develops within 24-48 hours and is specific for a given
neurotransmitter and chemically related agonist (Trendelenburg, 1966; Osinski and
Bass, 1994). There may be some alteration in ion channels. Powers and Colucci
(1985), in their studies with rats treated with reserpine, suggested that voltage
dependent calcium channel numbers may be modulated by the cell during
supersensitivity.
There may also be some changes in the electrophysiological properties of the
denervated tissue. Goto, Westfall and Fleming (1978) found that, while the resting
potential of the smooth muscle cells of the guinea pig vas deferens is reduced by
denervation, the threshold membrane potential for action potential generation is not
changed.
The relative importance of these mechanisms is not known but there is
evidence that several changes occur in the physiological status which render smooth
muscle more sensitive to stimuli (Fleming, 1976; Westfall, 1981). Osinski and Bass
(1994) describe how the mechanism responsible for the change in sensitivity depends
on the particular animal species and tissues examined, as well as on the method of
denervation used. Goto et al. (1978) suggested that in smooth muscle two
mechanisms appeared to be particularly important; changes in electrical properties and
cellular binding and/or movement of calcium.
Supersensitivity can also occur, but is less marked, when neural transmission is
interrupted, for example by pharmacological agents. Long term blockade of post
synaptic receptors causes receptors to proliferate leaving the post-synaptic cell
supersensitive when the blocking agent is removed. Phenomena such as this are
important in the central nervous system where such supersensitivity can cause
rebound effects when drugs are given for some time and then stopped abruptly.
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The characteristics of the population of muscarinic receptors in the
gastrointestinal tract of the horse have not been reported to date. Osinski and Bass
(1994) suggest that the smooth muscle cells of the longitudinal muscle layer of the rat
ileum contain a mixture of muscarinic subtypes. Utilizing ligand-binding techniques
Candell, Yun, Tran, and Ehlert (1990) reported that the majority (84%) of muscarinic
receptors in the rat gut displayed properties of the M2 subtype and the remaining
(16%) appeared to be M3 receptors. Bethanecol works on all these receptor subtypes.
In the present study measurement of the peak contractile amplitude produced
by equimolar concentrations of bethanecol demonstrated significant differences in the
sensitivity of tissue taken both from control horses and those affected by acute and
chronic grass sickness. One problem encountered with ileal experiments was that the
background amplitude of contractions were already large and therefore when low
concentrations of bethanecol were applied it was difficult to distinguish between the
contractile response to bethanecol and these background contractions.
The maximum response to bethanecol for all tissue occurred at either 3mM or
ImM. In the duodenum 63% of the control group had its maximum response at 3mM
compared with only 14% in the ileum control group. This suggested that in the ileum
there may be a lower number of muscarinic receptors. Therefore in most samples the
maximum contractile response could be obtained at ImM bethanecol in this ileal
region. The results for the grass sickness groups are more difficult to interpret. In
AGS about 50% of the preparations in both regions had their maximum response at
3mM, whereas with the CGS in the duodenum 30% had their maximum response at
3mM compared with 50% in the ileum. If the damage caused by grass sickness is not
uniform throughout the length of the small intestine as has been suggested (Scholes et
al., 1993a; Doxey, D.L., Milne, E.M., Woodman, M.P., Gilmour, J.S. and Chisholm,
H.K. submitted for publication), more damage to the ileum, which already appears to
have a lower population of muscarinic receptors, would mean that a higher
concentration of bethanecol would be needed to produce the maximum response.
With duodenal preparations, there may be less damage to cholinergic neurones and
less of an effect on the sensitivity of muscarinic receptors.
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It was interesting that for the two regions the median values for the maximum
contractile response for the three groups was very similar. The AGS group had the
largest maximum contractile response to bethanecol, followed by the CGS group and
finally the control group in both regions. Osinski and Bass (1994) reported that
increased sensitivity of a tissue may result in an increase in the maximum response
observed. The AGS ileal group maximum response was significantly higher than the
control ileal group (P<0.05). Fleming and Westfall (1988) state that this increase in
the maximum response to drugs is due to improved electrical coupling between the
smooth muscle cells. The fact that the maximum response of both regions of the small
intestine was not depressed in grass sickness cases suggests that grass sickness does
not change the contractile mechanism of the smooth muscle (McPhillips. 1969).
When a tissue becomes supersensitive it causes a leftward shift of the dose
response curve and a lower ED50 value (Osinski and Bass, 1994). This certainly was
the case for AGS tissue compared with control tissue in both regions of the small
intestine. In the ileal region the CGS group also had a lower ED50 value than the
control group, which suggested that the ileum may be damaged primarily in grass
sickness.
In conclusion, these results provide evidence for altered muscarinic receptor
sensitivity in grass sickness, but that the contractile mechanism remains unaltered.
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5.3 RESPONSES TO CISAPRIDE
5.3.1 Introduction
Cisapride is a synthetic substituted benzamide with the formula:
It is a prokinetic drug which is used clinically as it enhances gastrointestinal motility
along the entire length of the gastrointestinal tract. King and Gerring (1988) reported
that cisapride restores electrical and mechanical activity, improves coordination
between gastric and small intestinal activity cycles and decreases the stomach to anus
transit time in clinically normal horses. This was also observed in ponies in which post
operative ileus (POI) has been induced experimentally (Gerring and King, 1989). The
successful use of cisapride in reducing the incidence of POI following colic surgery
has also been reported (Gerring and King, 1989; De Geest, Vlaminck, Muylle,
Deprez, Sustronck and Picavet. 1991; Van der Velden and Klein. 1993), particularly
in the prevention of idiopathic POI (Gerring, King, Edwards, Pearson, Walmsley,
Greet, 1991). However, its mechanism(s) of action is uncertain.
It is thought to act selectively on the gut, appearing to have no central nervous
system effects (McCallum, Prakash, Campoli-Richards and Goa, 1988). In studies of
guinea pig ileum in vitro, cisapride does not shift the dose response curve for
acetylcholine and methacholine to the left as occurs with neostigmine. This finding
tends to eliminate the possibility that cisapride acts by acetylcholinesterase inhibition
or by sensitisation of muscarinic receptors in smooth muscle (Schuurkes, Van Nueten,
Van Daele, Reynjens and Janssen, 1985).
The effects of cisapride are not abolished by ganglion-blocking concentrations
of hexamethonium. therefore a postganglionic target for cisapride is implicated
(Schuurkes et al., 1985). It seems likely that cisapride acts principally by an indirect
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cholinomimetic mechanism which facilitates acetylcholine release by the post
ganglionic nerve endings in the myenteric plexus of the gut (Lee, Chey, You, Shah
and Hamilton, 1984; Schuurkes et al., 1985; Chen, Wiley and Owyang, 1986).
However, contractions of colonic muscle strips caused by cisapride are insensitive to
atropine and tetrodotoxin, suggesting that cisapride stimulates the smooth muscle
directly in this region (Chen et al., 1986; Van Nueten and Schuurkes, 1984).
What follows is an introductory study of responses to cisapride in vitro of
equine small intestinal strips taken from horses with and without equine grass
sickness. Tissue from surviving horses with CGS were not available.
5.3.2 Materials and Methods
Fresh tissue was used from five control horses, five horses suffering from AGS
and five horses suffering from CGS to study the responses to cisapride (Janssen
Pharmaceutica) [see Appendix F for details]. In early experiments the solubility of
cisapride was found to be a problem, as in order to make up solutions with high
concentrations, the solvents used (such as acetone or methanecol) had an effect on the
background contractions of the preparations. At low concentrations (2.8xlO"7M) no
response to cisapride could be detected during a 45 minute monitoring period. A
standard final concentration was therefore used of 2.8xlO""M.
Following the addition of cisapride and a 15 minute incubation period the
effects on the rate and amplitude of background contractions were measured over a
seven minute period. The results are again expressed as medians with the range also
shown. Initially the data from the control horses were compared with all the grass
sickness data. Then the grass sickness data were divided into AGS and CGS groups.
No horses suffering from SAGS were used in these experiments. The initial
contractile rate and amplitude for each group compared with those following the
addition of cisapride were analysed using the Wilcoxon Signed Rank Test. Between
the three treatment groups (i.e. control, AGS, CGS) the analysis of results was carried
out using the Mann-Whitney U-test. As the same horses were used to investigate the
two regions of the small intestine, analysis within a group but between the two
regions was also carried out using the Wilcoxon Signed Rank Test.
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5.3.3 Results
5.3.3.1 Duodenal muscle strips
Figure 5.3.1 shows the response of two strips of duodenal smooth muscle to
cisapride, one from a control horse and the other from a horse suffering from AGS. In
the trace taken from a control horse there appeared to be an increase in the rate and
amplitude of the contractions, whereas in the trace taken from the horse suffering
from AGS only the rate of contractions appeared to increase following the addition of
cisapride. In some control duodenal preparations there appearred to be a reduction in
contractile amplitude. The responses of fresh duodenal tissue to cisapride are shown
in Tables 5.3.1 and 5.3.2. There was a trend for an increase in rate of background
contractions and a decrease in amplitude of contractions in both control and grass
sickness groups. There was a significant increase in contractile rate following
cisapride for the grass sickness group (P<0.01) (Table 5.3.1).
Between the three groups only the rate following cisapride for the control and
AGS groups were significantly different from each other (P<0.05).
5.3.3.2 Ileal muscle strips
Figure 5.3.2 shows the response of ileal control and AGS preparations to
cisapride. In the control tissue it appeared that cisapride disrupted the characteristic
pattern of the background contractions. The responses for ileal tissue to cisapride are
shown in Tables 5.3.3 and 5.3.4. As was found with duodenal strips there was a
significant difference in the rate of background contractions following cisapride
addition for the grass sickness group (P<0.01) (Table 5.3.3).
There was a significant difference in the rate of contractions following
cisapride between the ileal control and AGS groups (P<0.05). When the results were
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Figure 5.3.1. Responses of duodenal smooth muscle strips to cisapride
2.8x10"5M, A) taken from a control horse and B) taken from a horse suffering
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Control 5 5.3 12.4 6.3 11.9
(2.7-10.2) (6.2-18.5) (3.9-10.9) (3.9-19.9)
Grass 10 2.9 a 13.5 3.6 a 11.3
Sickness (1.1-5.9) (4.4-26.7) (1.5-7.4) (4.1-25.5)
Table 5.3.1. The effect of cisapride (2.8x10"5M) on the rate and amplitude of
background contractions of equine duodenal muscle strips. Values are medians with
the range shown in brackets. Values with the same superscript are significantly



















Control 5 5.3 12.4 6.3a* 11.9
(2.7-10.2) (6.2-18.5) (3.9-10.9) (3.9-19.9)
AGS 5 3.0 17.6 3.3a 10.4
(1.1-5.0) (4.4-26.7) (1.5-5.7) (4.1-25.5)
CGS 5 2.7 13.4 4.0 * 11.6
(2.1-5.9) (10.1-24.0) (3.1-7.4) (9.8-12.0)
Table 5.3.2. The effect of cisapride (2.8xlO"5M) on the rate and amplitude of
background contractions of equine duodenal muscle strips. Values are medians with
the range shown in brackets. Values with the same superscript are significantly
different from each other when analysed using the Mann-Whitney U-test (P<0.05).
When the data were analysed using the Wilcoxon Signed Rank test for the effect of
cisapride within a particular group there was no statistical significance, however,





















Control 5 2.2 12.7 2.93* 7.8
(1.2-5.6) (5.3-23.9) (2.4-7.1) (4.0-11.5)
Grass 10 1.8 3 10.7 2.1 3 8.1
Sickness (0.7-4.5) (2.9-27.5) (0.9-7.0) (2.0-36.4)
Table 5.3.3 The effect of cisapride (2.8xlO"5M) on the rate and amplitude of
background contractions of equine ileal muscle strips. Values are medians with the
range shown in brackets. Values with the same superscript are significantly different


















Control 5 2.2 12.7 2.93* 7.8 *
(1.2-5.6) (5.3-23.9) (2.4-7.1) (4.0-11.5)
AGS 5 1.8 12.2 2.0a* 11.6
(0.7-2.0) (2.9-27.5) (0.9-2.1) (2.0-31.3)
CGS 5 1.8 8.1 3.0 * 8.1
(1.5-4.5) (3.0-21.4) (1.6-7.0) (2.0-36.4)
Table 5.3.4. The effect of cisapride (2.8xlO"5M) on the rate and amplitude of
background contractions of equine ileal muscle strips. Values are medians with the
range shown in brackets. Values with the same superscript are significantly different
from each other when analysed using the Mann-Whitney U-test (P<0.05). When the
data were analysed using the Wilcoxon Signed Rank test for the effect of cisapride
within a group there was no statistical significance between any of the values,
however, values which have a * are likely to indicate a biological significance as their
P values were <0.06.
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5.3.4 Discussion
It is thought that cisapride exerts its action by increasing acetylcholine
release from enteric post ganglionic nerve endings. As some morphologically normal
neurones can still be found in the myenteric plexus of the gut in certain cases of
equine grass sickness (Doxev, etal., 1992, Pogson etal., 1992, Doxey, D.L., Milne,
E.M., Woodman, M.P., Gilmour, J.S. and Chisholm, H.K. submitted for publication,
also see Chapter 7) it was thought that cisapride might be of therapeutic benefit in the
treatment of selected cases of CGS (Milne, E.M., Doxey, D.L., Woodman, M P.,
Cuddeford, D. and Pearson. R.A. in press) who showed that cisapride therapy was
associated with an increased rate of passage of ingesta and increased gut sounds in
chronic grass sickness cases. Gerring and King (1989) found that cisapride seemed to
be active in two presumed cases of grass sickness in their study, however, a precise
diagnosis could not be confirmed in the case that recovered.
The results of these in vitro experiments do not provide any statistical
support that cisapride has a prokinetic effect on equine intestinal motility from control
horses. However, Tables 5.3.1 and 5.3.3 showed a significant increase in contractile
rate for grass sickness tissue (P<0.01) following cisapride addition. Also in other
cases the effect of cisapride approached a significant difference (P<0.06) and it may
be the case that with a greater number of experiments more statistically significant
differences would be found. Indeed many of the traces appeared to show changes in
rate and/or amplitude but when analysed there was no statistical significance (Figures
5.3.1 and 5.3.2). In conclusion, there appeared to be more of an effect on the
contractile rate than amplitude following cisapride addition in these experiments.
The 15 minutes allowed for incubation before the response to cisapride was
measured, may not have been suitable. With experiments using guinea pig ileum in
vitro, following the addition of cisapride the effect was measured for the initial 15
minutes (Schuurkes etal., 1985). In their study they found that cisapride enhanced the
contractile response to electrical stimulation over a range of cisapride concentrations.
They used a range of concentrations 10"6 - 10"9M compared with 2.8xlO~5M in these
experiments.
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More recent work in the guinea pig, investigating the mechanism of action of
cisapride, has suggested that the effect of cisapride is mediated via serotonergic 5-
hydroxytrytamine receptors, which results in facilitation of cholinergic transmission
(Meulemans and Schuurkes, 1992). It would be interesting to carry out further
experiments using equine intestine in vitro and cisapride to see if this mechanism of
action was the same in the horse. De Ridder and Schuurkes (1993) suggested that
serotonergic 5-hydroxytrytamine receptors were not involved in cisaprides action in





Greig (1928) first reported the similarity of some of the clinical signs of grass
sickness with those of sympathicotonia i.e. patchy sweating, muscle tremors, rapid
pulse rate and reduced gut activity. Histopathological lesions have been found in
sympathetic regions of the peripheral and central nervous systems in grass sickness
affected tissue (Barlow, 1969; Gilmour, 1973a; Hodson, Wright, Edwards, Mescall
and Suswillo, 1984; Pogson et al., 1992). There is also an increase in plasma
catecholamine levels in horses suffering from grass sickness (Hodson. Causon and
Edwards, 1984; Hodson, Wright and Hunt, 1986). It was therefore thought that there
may be some differences in the responses of small intestinal tissue to selected
adrenergic agents between control horses and those affected by grass sickness, which
could be investigated using the in vitro technique.
In most laboratory species, catecholamines cause a relaxation of the smooth
muscle of the small intestine. This inhibition of motility can be observed both in vitro
and in vivo. However, there are two exceptions: isolated terminal ileum of the guinea
pig (Munro, 1951; 1952) and the entire small intestine of the horse (Tanaka and
Ohkubo, 1941; Brunaud and Labouche, 1947; Ruckebusch et al., 1971). In both
species adrenaline and noradrenaline added to isolated intestine in an organ bath cause
a contraction. This observation was also thought to be worthy of further investigation.
The aims of this Chapter were to investigate the in vitro responses of equine
small intestine to catecholamines and determine which receptors were involved, also
to see whether there was any significant alteration in responses with tissue taken from
horses suffering from grass sickness.
6.2 Materials and Methods
Strips of smooth muscle from the duodenum and ileum of control horses and
those affected by grass sickness were set up in organ baths and the contractile activity
measured isometrically as described in Chapter 3. The numbers of horses used in this
series of experiments were 25 controls, 9 with AGS, 12 with SAGS and 12 with CGS.
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Details of the horses used can be found in Appendix G. The drugs used were
noradrenaline hydrochloride (Aldrich), adrenaline hydrogen tartrate (BDH), atropine
sulphate (Sigma). These were superfiised with the tissue and the response recorded.
The adrenergic antagonists used were (S)-propranolol hydrochloride (Sigma), a p
antagonist, phentolamine hydrochloride (Sigma), an a antagonist, prazosin
hydrochloride (Sigma), a selective al antagonist, and yohimbine hydrochloride
(Sigma), a selective a2 antagonist. These were added 15 minutes prior to the addition
of the catecholamines. To facilitate comparison between horses and to correct for the
variation in tissue thickness, which varied with the size of horses, the peak force in
grams of the contractile response to noradrenaline was divided by the wet weight of
the muscle strip. To measure the effect of noradrenaline on the rate of contractions,
following the initial contractile response, a seven minute period was used and the
number of contractions counted by hand.
6.2.1 Statistical analysis
The results are expressed in terms of medians with the range of values shown
in brackets. For each set of results there is one Table which shows control tissue
verses all the grass sickness data combined and a second Table where the grass
sickness data is divided into AGS, SAGS and CGS groups. Muscle strips used to
investigate responses to noradrenaline (both contractile response and effect on
contractile rate) following treatment with antagonists, were from the same horses as
those used to investigate the effect of noradrenaline alone, therefore differences in the
responses for a particular group were analysed using the Wilcoxon Signed Rank test.
Differences between the control and grass sickness groups were analysed using the
Mann Whitney U-test. The effect on responses to adrenergic agents following storage
of tissue for 24 hours at 4°C in unoxygenated modified Krebs was also investigated
(see Chapter 3.4). Differences in the responses for a particular group between fresh
and stored results were analysed using the Wilcoxon Signed Rank test.
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6.3 Results
6.3.1 Contractile response to noradrenaline
In initial experiments it was found both regions of the small intestine
contracted dose dependantly to noradrenaline and adrenaline. Noradrenaline was then
used for further investigation of the adrenergic system. At low concentrations of
noradrenaline (e.g. 7.1xlO"8M) it was difficult to distinguish between this contractile
response from that of the background contractions. It was therefore decided to use a
standard final concentration of 7.1xlO~6M as responses could clearly be seen in both
control and grass sickness affected tissue and were very repeatable.
Figure 6.1 A shows a typical response to noradrenaline (7.1xlO"6M) in a
duodenal muscle strip taken from a control horse. There is an immediate contraction
with enhanced tone (upward shift of baseline) which lasts two to three minutes after
which the background contractions continue, but at a reduced rate. Figure 6.IB
shows a typical response to noradrenaline of an ileal strip taken from a control horse;
again there was an immediate contraction. After a few minutes the background
contractile activity returns to its characteristic burst-like pattern (see Chapter 4.3.2.2).
The pattern of response to noradrenaline of strips of grass sickness affected tissue was
similar to that of control horses with an immediate contraction (Figure 6.2A),
although with some ileal AGS and SAGS muscle strips no contractile response to
noradrenaline was observed at all (Figure 6.2B). Also with about 50% of grass
sickness affected tissue from both regions of the small intestine, after the initial
contractile response to noradrenaline, the background activity was inhibited until the
muscle strip was washed. The results of the peak contractile response to
noradrenaline for both control and grass sickness affected horses are shown in Table
6.1.
For control horses the range of values for both regions for the response to
noradrenaline was very similar, although the median value was larger in the ileum at
43g compared with 32g in the duodenum. The median and range of contractile values
in response to noradrenaline for the grass sickness groups were also similar in both
regions, with the exception of the ileal AGS group. With the ileal AGS muscle strips,










Figure 6.1. Smooth muscle strips taken from the small intestine of










Figure 6.2. Smooth muscle strips taken from the small intestine of horses
suffering from acute grass sickness; A) duodenum, B) ileum. Arrow indicates
the addition of noradrenaline (7.1x10~6M).
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Control 20 32.1 (8.4-115.3) 11




Table 6.1. Median peak contractile response to noradrenaline (7.1x10"^) in grams
per gram of tissue, of muscle strips taken from the duodenum from control horses and
those suffering from grass sickness. The range of values is shown in brackets. Values
with the same superscript are significantly different from each when analysed using the
Mann-Whitney U-test b = P<0.005 and a = P<0.05.
Table 6.2 Median peak contractile response to noradrenaline (7.1x10"^) in grams
per gram of tissue, of muscle strips taken from the duodenum from control horses and
those suffering from grass sickness. AGS: acute grass sickness, SAGS: subacute grass
sickness, CGS: chronic grass sickness. The range of values is shown in brackets.
Values with the same superscript are significantly different from each other; a =
P<0.05 when analysed using the Wilcoxon Signed Rank test, b = P<0.01 and c =
P<0.05 when analysed using the Mann-Whitney U-test.
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Control 20 32.1 (8.4-115.3) 11
AGS 6 24.4 (16.0-31.2) 6
SAGS 12 27.0 (16.2-52.3) 8














Control 16 43.0 (13.8-118.3)a 9 25.3 (7.0-122.9)
Grass 31 24.7 (0.0-65.6)a 21 21.7(0.0-58.7)
Sickness
Table 6.3. Median peak contractile response to noradrenaline (7. lxlO^M) in grams
per gram of tissue, of muscle strips taken from the ileum from control horses and
those suffering from grass sickness. The range of values is shown in brackets. Values
with the same superscript are significantly different from each other when analysed









Control 16 43.0 (13.8-118.3)d 9 25.3 (7.0-122.9)
AGS 7 3.2 (0.0-33.9)def 5 19.8 (5.9-36.2)
SAGS 12 27.6 (0.0-62.l)e 8 23.0 (0.0-58.7)
CGS 12 30.8 (4.5-65.6)f 8 23.6 (3.5-58.4)
Table 6.4. Median peak contractile response to noradrenaline (7. lxl0~6M) in grams
per gram of tissue, of muscle strips taken from the ileum from control horses and
those suffering from grass sickness. AGS: acute grass sickness, SAGS: subacute grass
sickness, CGS: chronic grass sickness. The range of values is shown in brackets.
Values with the same superscript are significantly different from each other d,f=
P<0.01 and e = P<0.05 when analysed using the Mann-Whitney U-test.
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group had a low median contractile value of 3.2g (Figure 6.2B). The contractile
responses for the ileal control, SAGS and CGS groups were therefore all significantly
higher than the ileal AGS group (P<0.01 for the control and CGS groups and P<0.05
for the SAGS group) (Table 6.4). For the duodenal strips there was no significant
difference in contractile response to noradrenaline between the three grass sickness
groups and the control group.
When the results were analysed between the two regions of the small intestine
there were found to be no significant differences between the contractile response to
noradrenaline for any of the four groups.
The contractile response to noradrenaline was not due to an indirect
cholinergic effect as the response occurred in the presence of atropine (8.6xlO"ftM) at
a concentration capable of blocking muscarinic receptors (Malone, Brown, Trent and
Turner, submitted for publication). Therefore, to investigate which adrenoceptors
4 6
were involved in this response, propranolol, a beta antagonist (1x10" M - 1x10" M)
4 6
and phentolamine, an alpha antagonist (1x10" M -1x10" M), were used. Following
pretreatment with propranolol a similar contractile response to noradrenaline and
adrenaline was recorded (Figure 6.3).
There was no significant alteration in contractile response to noradrenaline
(7. lxlO^M) following pretreatment with propranolol (1 x10"'M) in any of the groups
for both regions of the small intestine, with the exception of the duodenal CGS group
in which the contractile amplitude was significantly reduced following pretreatment
with propranolol (P<0.05) (Table 6.2). With duodenal tissue, the response to
noradrenaline following treatment with propranolol showed there were significant
differences between the AGS and CGS groups and the control group (P<0.01 for the
AGS group and P<0.05 for the CGS group) (Table 6.2).
There was no significant difference between any of the four groups for the
contractile response of the ileum to noradrenaline following pretreatment with
propranolol (Table 6.4). There was no significant difference between the duodenal







Figure 6.3. Duodenal muscle strip taken from a control horse. Arrow
indicates the addition of noradrenaline (7.1x10"6M) following pretreatment
for 15 minutes with propranolol (1 x10~4M). After the initial contractile response,
the rate and amplitude of the spontaneous activity was greater than after











Figure 6.4. Smooth muscle strips taken from the duodenum of control horses;
A) shows the response to noradrenaline (7.1x10"6M) following
pretreatment with phentolamine (1x10"6M) for 15 minutes, B) shows
the response to noradrenaline (7.1x10"6M) following pretreatment with
phentolamine (1x10"4M) for 15 minutes.
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Following pretreatment with phentolamine (1x10"4M) for 15 minutes, there
was no contractile response on the addition of noradrenaline with either control or
grass sickness affected tissue. This was the case in both regions of the small intestine
(Figure 6.4B). Following the addition of noradrenaline (7. lxlO^M) background
contractions either continued at a reduced rate and amplitude, or after a few minutes,
there was complete inhibition of this activity until the preparation was washed. At
lower concentrations of phentolamine (lxlO^M) a contractile response could be
obtained (Figure 6.4A).
In the presence of an alpha 1 antagonist, prazosin (2.8x1 the contractile
response was observed (Figure 6.5). However, in the presence of yohimbine
(2.8xlO°M), an alpha 2 antagonist, the contractile response to noradrenaline was
absent (Figure 6.6).
6.3.2 Effect of noradrenaline on rate of background contractions
As described in Chapter 4, the rate of background contractions in control
duodenal preparations was significantly greater than for control ileal preparations.
Also the median rates of background contractions in grass sickness affected tissue
were lower than for the control groups in both regions of the small intestine.
Tables 6.5 and 6.6 show the initial rate of background contractions and the
rates following noradrenaline alone (rate 1), noradrenaline after pretreatment with
propranolol (rate 2) and noradrenaline after pretreatment with phentolamine (rate 3).
For the control duodenal group rates 1, 2, and 3 were all highly significantly lower
compared with the initial rate of contractions (P<0.0001, P<0.01, P<0.001,
respectively) (Table 6.6). With duodenal strips from all three grass sickness affected
groups only rate 1 was significantly lower than their initial rates (P<0.01). For
duodenal muscle strips there was no significant difference for rate 1, rate 2, or rate 3
between the control and grass sickness groups.
For the control ileal group only rate 1 was significantly lower than the initial
rate of contractions (P<0.01). For grass sickness ileal tissue only the SAGS and CGS
tissue had a significantly lower contractile rate following the addition of noradrenaline
than the initial contractile rate (P<0.05) (Table 6.6). There were no significant
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Figure 6.5. Duodenal muscle strip taken from a control horse. Arrow
indicates the addition of noradrenaline (7.1 x10"6M) following pretreatment




Figure 6.6. Duodenal muscle strip taken from a control horse. Arrow indicates
the addition of noradrenaline (7.1x10"6M) following pretreatment with
yohimbine (2.8x10"5M), an alpha 2 antagonist, for 15 minutes. No contractile
response was observed. The background contractions were also inhibited

















































3)rateafter phentolaminea d noradrenaline
Control AGS SAGS CGS
7.1(2.6-11.2)abcde{20} 3.2(1.3-5. )af{9} 4.1(2.3-9.0)B{12} 3.2(0.4-9.6)bh{1 }
0.6(0.0-6.8)c{20} 0.6(0.0-2.4/(9} 0.8(0.0-2.4)8{1 } 0.0(0.0-2.0/12}
2.0(1.2-5.4/(13} 1.8(1.2-4.4){8} 3.7(1.8-10.4){8} 2.6(1.0-6.2)(8}





3)rateafter phentolaminea d noradrenaline
Control AGS SAGS CGS
2.5(0.0-10.0/(20} 1.1(0.3-3.0)9} 1.9(0.0-3.0)'{} 2.0(0.0-9.3/(12}
0.2( .0-2.3)1 9} 0.0(0.0-3.2)(9} 0.0(0.0-1.2/(10} 0.4(0.0-2.2/(12}
0.7(0.0-1.8/(12} 1.3(0.9-2.0)m(4} 0.8(0.0-2.4)5} 2.2(1.9-5.9)lm{6}
1.2(0.0-2.7)(14} 1.2(0.6-6.6)(8} 1.8(0.0-6.6){7} 2.7(0.0-7.6){6}
Table6.6.Medianratofcontractionsperminutf rus lstripstak nromA)hdu denum,Bile ,c t ol horsesandthoseffectedbygrassickn s,AGS:a ug si ,SAGSsub utCch o ica sickness.Thrangeofv luis ownnbracket .{}t umbermuscltripus d.V lw thhsupers ript aresignificantlydifferentfromachth r,c,=P<0.0001, ,g ,i. 1andj k05whn lys dus gth WilcoxonSignedRa ktest.,b,l=P<0.001dm.05wh nanalyseu i ghMan -WhitneyU-test
differences between the initial rate and rate 1 for the ileal AGS group (Table 6.6).
Rate 2 was significantly higher in the ileal CGS group compared with control and
AGS ileal groups (P<0.001 and P<0.05 respectively). There were no significant
differences between any of the other rates between the control and grass sickness
groups.
There was no significant difference between rate 1, rate 2 or rate 3 for each
group between the duodenal and ileal samples, with the exception of rate 1 (P<0.01)
and rate 2 (P<0.05) for the control group. It should be noted that the addition of
propranolol or phentolamine themselves caused no significant change in the rate of
background contractions in both control and grass sickness affected groups (see
Chapter 4.3.3.3).
6.3.3 Effect of tissue storage
6.3.3.1 Effect of storage on contractile response
The contractile responses to noradrenaline (7. lxlO^M) following storage for
24 hours at 4°C for control and grass sickness tissue are shown in Tables 6.7-6.10.
The responses were very similar to those for fresh tissue. The responses of duodenal
tissue from the AGS group to noradrenaline were significantly lower than in both the
control and CGS groups (P<0.05). Following pretreatment with propranolol (1x10"
4M), as with fresh tissue, only the duodenal tissue from the CGS group showed a
significant reduction in contractile response (P<0.05).
In two of the seven AGS ileal preparations no contraction in response to
noradrenaline was obtained. Following pretreatment with propranolol, all the ileal
AGS preparations showed a contractile response (Table 6.10). There was a significant
difference (P<0.05) between the control group and the SAGS group in the ileal
preparations in the response to noradrenaline following pretreatment with
propranolol. There were no significant differences between the two regions of the
small intestine for the contractile response to noradrenaline alone and noradrenaline
following pretreatment with propranolol.
Following storage there was still no contractile response to noradrenaline
following pretreatment with phentolamine (lxl O^M) in any of the groups.
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6.3.3.2 Effect of storage on background contractions
Following storage, for duodenal preparations, the rate of background
contractions following noradrenaline (rate 1) was significantly lower than the initial
rate of contractions for the control and SAGS groups (P<0.05) (Table 6.12). The rate
of contractions of duodenal tissue following the addition of noradrenaline was
significantly higher for duodenal tissue from the control group than all the grass
sickness groups (P<0.05 for AGS and SAGS, P<0.001 for CGS). There was also a
significant difference between the AGS and CGS groups for rate 2 (P<0.05).
With the ileal tissue used in this series of experiments the initial rate of
contractions for the CGS group was significantly higher than the control, AGS and
SAGS groups (P<0.01 for control, P<0.05 for AGS and SAGS). There was no
significant alteration in contractile rate following the addition of noradrenaline for any
of the ileal groups (Table 6.12). There were no significant differences between rate 1,
rate 2, rate 3 between the two regions for each group with the exception of rate 1 for
the control (P<0.01) and SAGS (P<0.05) groups.
Where results were available for responses to noradrenaline before and after
storage for the same horses, the analysis was carried out using the Wilcoxon Signed
Rank test. For amplitude of the contractile response to noradrenaline alone and
noradrenaline following pretreatment with propranolol, there were no significant
differences between fresh and stored tissue for both regions of the small intestine. For
the rate of contraction the only significant difference was between the initial rate for










Control 12 39.0(5.9-105.1) 9 35.5 (13.9-74.9)a
Grass 20 23.5 (4.9-76.8) 18 12.8 (4.4-63.l)a
Sickness
Table 6.7. Median peak contractile response in grams/gram of tissue to noradrenaline
(7. lxl O^M) for duodenal muscle strips taken from control horses and those affected
by grass sickness following storage for 24 hours at 4°C. The range of values are
shown in brackets. Values with the same superscript are significantly different from









Control 12 39.0 (5.9-105.l)a 9 35.5 (13.9-74.9)cd
AGS 6 14.3 (4.9-28.2)ab 5 11.4 (4.4-30.5)ce
SAGS 8 19.8 (6.1-58.0) 7 10.6 (5.7-62.9)df
CGS 6 35.1 (15.2-76.8)bg 6 31.8 (14.3-63.l)efg
Table 6.8. Median peak contractile response in grams/gram of tissue to noradrenaline
(7. lxlO^M) for muscle strips taken from the duodenum from control horses and those
affected by grass sickness following storage for 24 hours at 4°C. AGS: acute grass
sickness, SAGS: subacute grass sickness, CGS: chronic grass sickness. The range of
values are shown in brackets. Values with the same superscript are significantly
different from each other; g = P<0.05 when analysed using the Wilcoxon Signed Rank










Control 14 37.1 (13.3-88.9) 5 59.6 (12.3-75.9)b
Grass 23 27.9(0.0-85.9) 17 13.0 (3.0-45. l)b
Sickness
Table 6.9. Median peak contractile response in grams/gram of tissue to noradrenaline
(7.1x10"6M) for ileal muscle strips taken from control horses and those affected by
grass sickness following storage for 24 hours at 4°C. The range of values are shown in
brackets. Values with the same superscript are significantly different from each other









Control 14 37.1 (13.3-88.9)h 5 59.6(12.3-75.9)'
AGS 7 33.6 (0.0-85.9) 4 17.1 (10.4-45.2)
SAGS 10 13.0 (0.0-57.4)h 9 9.2 (5.4-45.1)'
CGS 6 30.4 (13.3-49.0) 4 23.8 (8.5-30.7)
Table 6.10. Median peak contractile response in grams/gram of tissue to
noradrenaline (7. lxlO^M) for muscle strips taken from the ileum, from control horses
and those affected by grass sickness following storage for 24 hours at 4°C. AGS:
acute grass sickness, SAGS: subacute grass sickness, CGS: chronic grass sickness.
The range ofvalues are shown in brackets. Values with the same superscript are






















































































Table6.12.Medianratofcontractionsperminutef rusclst ipsA)r mthduode mdBil ,ke controla dgrasssicknessffectedhorsefoll wing24urt rage4°C.AGS:cuti kness,SAGS:bacuter sickness,CGS:chro icgrasssicknes .{}itnumb rofmusclet ipus dTra gvaluerwnbra t . Valueswiththsameuperscriptignificantlydifferentfro cth r;b,=P<0.05h nanalys dsi gWilcoxon SignedRanktest,f,h=P<0.01,d,e,g,i,j,k5w nnalysedu ghMan -WhitneyU-t t.Vindic t s significantdifferencefromtheequilvaleshvaluwhaterana ys dt isicaldiff su i gWilcoxon SignedRanktest(P<0.01).*indicatesherewasignificantdiff r ncefromqu valentdu den lv lu(P<0.01).♦ indicatestherwasignificantdiffer n efromthequivaledu den lv lu(P<0.05).
6.4 Discussion
These results agree with the reports in the literature that in vitro equine small
intestine contracts in response to catecholamine addition (Tanaka and Ohkubo, 1941;
Brunaud and Labouche, 1947; Ruckebusch et al., 1971; Malone, E.D., Brown, D.R.,
Trent, A.M. and Turner, T.A. [submitted for publication]). The isometric traces
shown here of horse intestine in vitro in response to noradrenaline are similar to those
presented by Ruckebusch et al. (1971). Ruckebusch used similar concentrations of
noradrenaline (0.5-1 xlO~6M) and adrenaline (1x10"6M-1x10 7) as these present studies.
Unfortunately none of the other studies have quantified the amplitude of the
contractile response, with the exception of Malone and co-workers who gave absolute
amplitude values, with no account of tissue size, therefore their data could not be
easily compared with the results from this study.
The results using adrenergic antagonists suggest that this contractile response
to noradrenaline in equine small intestine was due to excitatory a2 receptors. Malone,
E.D., Brown. D.R.. Trent. A.M. and Turner. T.A. (submitted for publication) also
report that the contractile response to noradrenaline in their study was selectively
inhibited by pretreatment with yohimbine, an a2 antagonist. Ruckebusch reported that
both propranolol and phentolamine caused a reduction in the amplitude of the
contractile response. However, this observation was not quantified by Ruckebusch.
Tanaka and Ohkubo (1941) and Brunaud and Labouche (1947) reported that
ergotamine (an alpha antagonist) prevents the contractile response to adrenaline in
vitro in the horse. Bailey (1968) found a biphasic response to adrenaline or
noradrenaline using strips of smooth muscle from the stomach wall of the.guinea pig,
in which relaxation was followed by a contraction. On analysis with adrenergic
antagonists he found the inhibitory component appeared to be mediated via (3
receptors and the excitatory component via a receptors.
In conclusion, it would appear that the contractile response in the horse was
due to a2 excitatory receptors. Noradrenaline appeared to have two effects; when the
excitatory one was blocked, the [3 response was to reduce the rate of background
contractions. It may also cause a relaxation of tone, however, with the low
sensitivities chosen to measure the contractile response, no alteration was seen in
these experiments.
Grass sickness affected tissue responded similarly to tissue taken from control
horses in that, there were no significant differences for the contractile response to
noradrenaline between any of the grass sickness groups and the control group for the
duodenal region. For the ileal region only the AGS group had a significantly lower
contractile response to noradrenaline from the other grass sickness groups and the
control group (control and CGS P<0.01, SAGS P<0.05). However, there were no
significant differences between the duodenal and ileal AGS groups.
In about 40% of ileal AGS cases, no contractile response to noradrenaline
could be achieved until pretreatment with propranolol, thus causing this group to have
a low median value of 3.2g/g of tissue. Other grass sickness muscle strips also showed
no contractile response to noradrenaline (Tables 6.2 and 6.4). The reason for this is
unclear. The increased levels of circulating catecholamines found in grass sickness
(Hodson et al1984; Hodson et al., 1986) may have desensitized the adrenergic
receptors in ileal tissue of AGS cases. Alternatively it may be an actual consequence
of the disease that receptor number or availability is reduced. An alteration of receptor
populations in certain diseases have been reported. For example, a decrease in cardiac
beta-adrenoceptor function is a general phenomenon in all kinds of human heart
failure (Brodde, Zertowski, Borst, Maier and Michel, 1989). Wright and Shepherd
(1965) suggested there may be alteration in receptor sensitivity in Hirschsprung's
disease in humans. After propranolol treatment a contractile response was evoked in
nearly all muscle strips. Propranolol may have the property ofunmasking or revealing
a receptors responsible for the excitatory effect of noradrenaline. Gagnon, Deuroede
and Belisle (1972) suggested this could be the explanation for the action of
oxprenolol, a P antagonist, in their experiments using isolated strips of human colon.
As there was no significant difference between the contractile response to
noradrenaline alone, or noradrenaline following pretreatment with propranolol
between the two regions of the small intestine, it would suggest that the population of
a receptors was relatively uniform throughout the length of the small intestine in
horses (see Chapter 5.1.4).
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The rate of contractions was significantly reduced in all four groups and both
regions of the small intestine following the addition of noradrenaline with the
exception of the ileal AGS group. In this ileal AGS group the initial rate of
contractions was already low. Tanaka and Ohkubo (1941) and Ruckebusch et al.
(1971) also reported that background activity was supressed following the contractile
response to noradrenaline. The addition ofnoradrenaline following pretreatment with
propranolol and phentolamine caused no significant effect on the rate of contractions
compared with initial rates with the exception of the duodenal control group where
both median rates were significantly lower than initially. If there was an inhibitory (3
effect of noradrenaline, following a blockade, a decrease in the rate of contractions
would be expected. With several preparations following phentolamine and
noradrenaline addition, background contractions were inhibited until the preparation
was washed (Figure 6.6).
Following storage for 24 hours at 4°C there were no significant differences in
the contractile response to noradrenaline alone and noradrenaline following
pretreatment with propranolol for all four groups and both regions of the small
intestine. This would suggest the contractile response is independent of nervous
elements. Gagnon et al. (1972) also found this storage period had no effect on
responses to adrenaline in their study using isolated preparations of human colon.
Although within the ileal AGS group there were still some preparations which showed
no contractile response to noradrenaline, the median value was now not significantly
different from the other ileal groups. Following storage there was still no contractile
response to noradrenaline in the presence of phentolamine for all four groups.
The only significant effect on contractile rates following storage was on the
initial contraction rates of the control duodenal and ileal groups, which significantly
reduced (P<0.01). There have been other reports of storage for 24 hours at 4°C
having no significant effect on the contractile response to noradrenaline, following P
blockade with oxprenolol, on strips of human sigmoid colon (Gagnon et al., 1972).
With regards to the increased levels of circulating catecholamines observed in
grass sickness cases. It is known that most of the plasma adrenaline in the horse
comes from the adrenal medulla and that the increase in plasma adrenaline is most
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likely to be caused by stress (Hodson et al., 1984). However, Hodson, et al. (1986)
showed that the levels of noradrenaline, adrenaline, Cortisol and adrenocorticotrophic
hormone were significantly higher in grass sickness cases than in control, stressed and
colic cases (P<0.05 or less). Most plasma noradrenaline, in those species studied, is
released from vasomotor nerves (Vane, 1969). Therefore, some of the increase in
plasma noradrenaline in grass sickness cases may be caused by increased
noradrenergic activity. Infusion of adrenaline in the horse has been reported to cause
muscle tremors (Snow, 1977) and sweating (Evans, 1966). Snow (1977; 1979)
reported that sweating is mediated by P2 receptors in the horse, in contrast to a-
mediation in the cow, sheep and goat (Findlay and Robertshaw, 1965; Robertshaw,
1968). Adrenaline has been given intramuscularly to resting horses without adverse
long term effects (Anderson and Aitkon, 1977). There have been a number of studies
on the effect of exercise on plasma catecholamines in the horse (Martinez, Godoy,
Naretto and White, 1988; Snow, Harris, MacDonald, Forster and Marlin, 1992).
From the findings of these studies it therefore seems likely that the increase in plasma
catecholamines seen in grass sickness is a consequence rather than a cause of the
disease.
In summary, it would appear that in equine small intestine in vitro, the
addition of noradrenaline causes a contractile response due to excitatory al receptors,
which are probably located within the smooth muscle itself. If these receptors are
blocked, the rate of background contractions is reduced following the addition of
noradrenaline due to the inhibitory effects of P adrenoceptors.
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CHAPTER 7
HISTOLOGY OF THE ENTERIC NERVOUS SYSTEM
7.1 Introduction
It has been clear for many years that neuronal degeneration occurs in cases of
equine grass sickness within the autonomic ganglia and enteric plexuses (Obel, 1955;
Barlow, 1969; Gilmour, 1973a). However, many of these reports are conflicting in
their interpretation of the relationship between neuronal damage and clinical illness.
Obel (1955) reported degenerative changes of autonomic ganglia to be extensive in
both acute and chronic cases of grass sickness in her study of 14 cases. Chromatolytic
and vacuolated cells were predominantly found in the submucous ganglia, and only
slight changes were seen in the myenteric plexus. Barlow (1969) observed that the
severity of the degenerative changes in the ganglia was directly proportional to the
duration of the clinical illness in his group of five cases. Gilmour (1973a) did not
agree with this; he found that degenerative cells were more extensive and severe in
acute and subacute cases than in chronic cases. Quantification of the extent of damage
to the enteric nervous system has only recently been carried out (Doxey et al., 1992;
Pogson et al., 1992; Doxey, D.L., Milne, E.M., Woodman, M.P., Gilmour, J.S. and
Chisholm, H.K. submitted for publication). Pogson et al. (1992) examined the
jejunum of grass sickness cases and found a reduction in the number of myenteric and
submucous neuronal cell groups in AGS. Also, the proportion of damaged and dead
cells was significantly greater in all three grass sickness groups compared with control
animals (P<0.01-P<0.001). Scholes et al. (1993a) has also studied the enteric nervous
system of control horses and those affected by grass sickness, reporting that the ileal
region showed neuronal damage in all grass sickness cases.
This Chapter describes a light microscopical investigation, of the enteric
nervous system, of samples of small intestine adjacent to those used in the
pharmacological experiments described in the previous Chapters. The relationship
between selected pharmacological results and the histological findings is also
discussed.
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7.2 Materials and methods
Sections of equine duodenum and ileum (4cm) adjacent to the sample used for
the pharmacological experiments were fixed in Bouins solution (Culling, Allison and
Barr, 1985) within 45 minutes of euthanasia, during which time they were continually
aerated with 95% oxygen and 5% carbon dioxide and kept in chilled modified Krebs
solution (see Chapter 3.2). After 16-24 hours fixation the samples were washed and
then stored in 70% alcohol at room temperature until further use. The material
examined was taken from five control horses, five horses suffering from AGS and five
horses suffering from CGS. Details of the horses used are shown in Appendix I.
The samples were trimmed, dehydrated and embedded in paraffin wax.
Transverse 5pm sections were then cut using a rotary microtome (American Optical,
Milton Keynes, UK). Every tenth section was examined allowing 50pm intervals
between the sequential sections. This technique was used to avoid observing the same
neurones twice. Pearson (1994) reported the mean diameter of neurones in the
myenteric plexus of equine small intestine was 41pm. Five sections per horse were
examined. The circumference of some samples of gut made it necessary for the sample
to be cut in two, thus requiring ten half sections to be examined per horse. The tissue
was then stained using Ehrlich's haematoxylin and eosin (Culling et al., 1985).
Sections were examined using a light microscope (Vickers M15C binocular,
York, UK). The entire section was examined and a subjective scoring system was
applied to each section using the following parameters: 1) number of all neurones, 2)
size of all normal neurones, and 3) proportion of abnormal neurones. Slides were
coded and examined 'blind' to prevent bias. The range of scores used was zero to
five, including half marks.
7.2.1 Scoring system
See Appendix K for further details of the scoring system used.
1) Number of neurones
Normal enteric ganglia contained nerve cell bodies full ofNissl substance. On
staining they were basophilic and had a stippled appearance. Figure 7.1 shows a
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ganglion within the duodenal myenteric plexus of a control horse containing clear
nerve cell bodies. Figure 7.2 shows a ganglion within the duodenal submucous plexus
of a control horse. The presence of normal neurones lead to a score in the range of 2-
5 depending on the number of ganglia and nerve cell bodies within the plexus; the
lower the score, the more severe the damage. Where it was evident that neurones had
been destroyed leading to low numbers of neurones remaining, scores as low as 0.5
were given. Figures 7.3 and 7.4 shows a duodenal myenteric ganglion and an ileal
submucous ganglion taken from a horse suffering from AGS. Note the reduced
number of nerve cell bodies.
2) Size of neurones
In grass sickness, neuronal degeneration occurs, nerve ceils lose their nuclei
and Nissl substance and cell bodies often appeared swollen. Only the neurones with
normal morphology were considered when scoring for the size of neurones to see if a
certain neuronal size (i.e. small or large) was preferentially damaged in grass sickness.
There was little variation of size of normal neurones between the three groups
therefore the scores given were between 1.5 and 4.
3) Proportion of abnormal neurones
Sections taken from horses suffering from grass sickness showed a number of
abnormal nerve cells. Abnormalities varied from vacuolation of the nerve cell body to
complete loss of neurones. Morphological changes observed in grass sickness affected
tissue included pyknosis, cytoplasmic vacuolation and loss of Nissl substance. If
greater than 75% of the remaining neurones were abnormal the score of 4 was given.
Several abnormal neurones lead to a score in the range of 1.5-2.5. If only one or two
abnormal cells or no abnormal cells were observed throughout the whole section, a
score of 0.5 or zero was given respectively. Figure 7.4 shows abnormal nerve cells
within a ganglion in the ileal submucous plexus of a horse suffering from AGS.
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Figure 7.1. Myenteric plexus from the duodenal region of the small intestine of a
control horse. Can see three normal neurones characterized by clear nuclei and Nissl
sustance; LM = longitudinal muscle layer, N= neurone, CM = circular muscle layer.
Haematoxylin and eosin. bar = 20pm
Figure 7.2. The submucous plexus from the duodenal region of the small intestine of a
control horse. The neurones are located around the edge of the ganglia: S=
submucosa. N= neurone. Haematoxylin and eosin. bar - 20um
Ikb
Figure 7.3. Group of neurones in the myenteric plexus from the duodenal region of
the small intestine from a horse suffering from acute grass sickness. There is marked
depletion of nerve cells, although the one remaining neurone appears normal; LM=
longitudinal muscle, N= neurone. D = position where would have expected to see
neurone. Haematoxylin and eosin, bar = 20|im
Figure 7.4. Group of neurones in the submucous plexus from the ileal region of the
small intestine from a horse suffering from acute grass sickness. There is extensive
chromatolysis (swelling of cells, loss of Nissl, eccentricity and pyknosis of nucleus).
D= position would have expected to see neurone, S= submucosa. Haematoxylin and
eosin, bar = 20|im
 
7.2.2 Statistical analysis
For each group in each region of the small intestine (duodenum and ileum) and
each plexus (myenteric and submucous) data was available from five horses in the
form of five or ten sections per horse. The median score for each horse was used in
the Mann-Whitney U-test analysis for differences between the three groups (control,
AGS and CGS) and between the two regions of the gut. For differences between the
two plexuses within the same region of the gut the Wilcoxon Signed Rank test was
used, also using the median score for each horse within a group.
For each of the three parameters subjectively scored, the Kruskal Wallis test
was used to determine whether there were significant differences between the five
sections used from each horse i.e. the within group variation.
7.2.3 Repeatability of scoring system
Initially 30 slides were scored 'blind'. This was repeated a few days later.
Twenty six of the 30 were given second scores the same or 0.5 different from their
initial scores. In the remaining four slides the difference in scores was 1 score.
7.3 Results
7.3.1 General observations
Several submucous and myenteric ganglia were observed in every transverse
section. The structure of both ganglia was similar in both regions of the small
intestine. Large ganglia were recognisable as elongated clusters of nerve cell bodies.
Smaller ganglia merged with the surrounding connective tissue. The submucous
plexus appeared to contain a higher proportion of large ganglia containing more nerve
cell bodies than the myenteric plexus (Figure 7.1 and 7.2). These larger submucous
ganglia were situated near the circular muscle, whereas small submucous ganglia lay
close to the muscularis mucosae. In the submucous ganglia the neurones appeared to
have a more peripheral position than in the myenteric plexus (Figures 7.1 and 7.2).
Myenteric ganglia were located between the circular and longitudinal muscle layers,
although they were also observed within the innermost longitudinal muscle. With
horses suffering from grass sickness, degeneration and loss of enteric neurones to
some degree were observed in all sections (Figures 7.3 and 7.4). However, even in
control horses some abnormal cells were seen.
The initial Kruskal Wallis tests showed that there were significant differences
between the three groups and between the 15 horses used for all three parameters
which were scored. There was no significant difference between the five (or ten)
sections scored for each horse. To find out between which sets of data the
significance lay, the Mann-Whitney U-test and Wilcoxon Signed Rank test were used.
The results are shown in Tables 7.1, 7.2 and 7.3. Values with the same superscript are
significantly different from each other.
7.3.2 Variation between horses within a group
The actual probability values, for the within group variation and the between
group variation, for the three parameters which were scored, for the control and grass
sickness groups are shown in Tables 7.4, 7.5 and 7.6. The AGS group showed the
greatest within group variation. For neuronal numbers, the ileal myenteric plexus in
the control horses had greater within group variation than between group variation.
The ileal submucous plexus in the control horses also had significant within group
variation but this was lower than the between group variation. This was found to be
caused by the results for one particular horse which was 18 years old and suffering
from Cushing's disease (hyperadrenocorticalism) (see Appendix E). For the AGS
group, both regions of the gut and both plexuses showed significant within group
variation, this was because the range of scores for the AGS horses was wide. For the
CGS group there was no significant within group variation for neuronal number for
either plexus or region.
For neuronal size there was no significant within group variation for the
control and CGS groups. For the AGS group the duodenal myenteric plexus and the
ileal submucous plexus showed significant within group variation.
For the proportion of abnormal cells, there was a significant difference
between the horses used in the control group. With the AGS and CGS groups there
was a significant difference between all the horses used with the exception of the ileal
1
1) Number of neurones
Duodenum/ Ileum/
Myenteric plexus Myenteric plexus
Control 3.8 (2.5-5.0)abc Control 3.0 (1.5-4.0)cde
AGS 1.5 (0.5-3.0)a AGS 1.5 (0.5-3.0)d
CGS 1.8 (1.0-2.5)b CGS 1.5 (1.0-2.0)6
Duodenum/ Ileum/
Submucous plexus Submucous plexus
Control 3.0 (2.0-4.0)*8 Control 3.0 (1.8-4.0)hj
AGS 1.5 (0.8-2.0)f AGS 1.8 (0.8-2.5)hl
CGS 2.0 (1.0-2.8)8 CGS 1.5 (0.8-2.3^
Table 7.1. The number of neurones present in the myenteric plexus and submucous
plexus of 5 pm transverse sections of equine duodenum and ileum. Values are the
median scores with the range of values shown in brackets (The score presented in the
table is the median value of the median scores for the five horses used for each group,
the range presented in the table is the entire range of scores for five or ten sections for
each of five horses). Values with the same superscript are significantly different from
each other when analysed using the Mann-Whitney U-test (P<0.05).
c = P<0.06 when analysed using the Wilcoxon Signed Rank test.
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2) Size of normal neurones
Duodenum/ Ileum/
Myenteric plexus Myenteric plexus
Control 3.0 (2.5-4.0)3 Control 3.0 (2.0-4.0)c
AGS 2.5 (1.5-3.0) AGS 2.5 (1.8-3.0)
CGS 2.5 (1.8-3.5)ab CGS 2.0 (1.5-2.5)bc
Duodenum/ Ileum/
Submucous plexus Submucous plexus
Control 2.5 (2.0-3.0)ed Control 2.5 (1.5-3.5)8
AGS 2.0(1.0-2.0)d AGS 2.0(1.5-3.0)h
CGS 2.0 (1,5-3.0)ef CGS 1.5 (1.3-2.3)fgh
Table 7.2. The sizes of neurones in the myenteric and submucous plexuses of
transverse sections of equine duodenum and ileum. Values are the median scores with
the range ofvalues shown in brackets (The score presented in the table is the median
value of the median scores for the five horses used for each group, the range
presented in the table is the entire range of scores for five or ten sections for each of
five horses). Values with the same superscript are significantly different from each
other e,g = P<0.01, a,c,d,h = P<0.05 when analysed using the Mann-Whitney U-test,
b,f = P<0.06 when analysed using the Wilcoxon Signed Rank test.
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3) Proportion of abnormal neurones
Duodenum/ Ileum/
Myenteric plexus Myenteric plexus
Control 0.5 (0.0-1.5)ab Control 0.5 (0.0-1.5)d
AGS 2.0 (1.0-4.0)a AGS 1.8 (0.5-2.5)de
CGS 3.0 (1.5-4.0)^ CGS 1.3 (0.5-1.5)ce
Duodenum/ Ileum/
Submucous plexus Submucous plexus
Control 0.5 (0.0-1.0)tg Control 0.5 (0.3-1.5)1
AGS 2.3 (1.0-3.5)f AGS 1.5 (0.5-2.5/
CGS 3.0(2.0-4.0)^ CGS 0.5 (0.3-1.5)hj
Table 7.3. The number of abnormal neurones in the myenteric and submucous
plexuses of 5 pm transverse sections of equine duodenum and ileum. Values are the
median scores with the range of values shown in brackets. (The score presented in the
table is the median value of the median scores for the five horses used for each group,
the range presented in the table is the entire range of scores for five or ten sections for
each of five horses). Values with the same superscript are significantly different from
each other when analysed using the Mann-Whitney U-test (P<0.05),
c,h = P<0.06 when analysed using the Wilcoxon Signed Rank test.
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1) neuronal number
region/ within group between group variation
plexus variation
AGS CGS
Duo/mp NS P=0.0122 P<0.0122
Ile/mp P=0.007 P=0.0163 P=0.0122
Duo/sp NS P=0.0122 P=0.0122
Ile/sp P=0.048 P=0.0122 P=0.0122
2) neuronal size
region/ within group between group variation
plexus variation
AGS CGS
Duo/mp NS NS P=0.0472
Ile/mp NS NS P=0.0367
Duo/sp NS P=0.0283 NS
Ile/sp NS NS P=0.0196
3) Proportion of abnormal neurones
region/ within group between group variation
plexus variation
AGS CGS
Duo/mp P=0.012 P=0.0122 P=0.0122
Ile/mp P=0.008 P=0.0122 NS
Duo/sp P=0.018 P=0.0122 P=0.0122
Ile/sp P=0.002 P=0.0472 NS
Table 7.4. The probabilities for the within and between group variation for the control
group for the subjective scoring carried out on histological sections of equine small
intestine taken from horses with and without grass sickness. Key; Duo= duodenum,
Ile= ileum, mp= myenteric plexus, sp= submucous plexus, AGS= acute grass sickness,
CGS= chronic grass sickness, NS= not significant, P= probability, P<0.05 is taken to
be of statistical significance.
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1) neuronal number
region/ within group between group variation
plexus variation
Control CGS
Duo/mp P=0.015 P=0.0122 NS
Ile/mp P=0.006 P=0.0163 NS
Duo/sp P=0.001 P=0.0122 NS
Ile/sp P=0.020 P=0.0122 P=0.0472
2) neuronal size
region/ within group between group variation
plexus variation
Control CGS
Duo/mp P=0.039 NS NS
Ile/mp NS NS NS
Duo/sp NS P=0.0283 NS
Ile/sp P=0.043 NS P=0.0122
3) proportion of abnormal neurones
region/ within group between group variation
plexus variation
Control CGS
Duo/mp P=0.001 P=0.0122 NS
Ile/mp NS P=0.0122 P=0.0216
Duo/sp P=0.010 P=0.0122 NS
Ile/sp P=0.052 P=0.0472 P=0.0122
Table 7.5. The probabilities for the within and between group variation for the AGS
group for the subjective scoring carried out on histological sections of equine small
intestine taken from horses with and without grass sickness. Key; Duo= duodenum,
Ile= ileum, mp= myenteric plexus, sp= submucous plexus, CGS= chronic grass
sickness, Control= control horses, NS= not significant. P= probability, P<0.05 is
taken to be of statistical significance.
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1) neuronal number
region/ within group between group variation
plexus variation
Control AGS
Duo/mp NS P=0.0122 NS
Ile/mp NS P=0.0122 NS
Duo/sp NS P=0.0122 NS
Ile/sp NS P=0.0122 P=0.0472
2) neuronal size
region/ within group between group variation
plexus variation
Control AGS
Duo/mp NS P=0.0472 NS
Ile/mp NS P=0.0367 NS
Duo/sp NS NS NS
Ile/sp NS P=0.0196 P=0.0122
3) proportion of abnormal neurones
region/ within group between group variation
plexus variation
Control AGS
Duo/mp P-0.020 P=0.0122 NS
De/mp P=0.026 NS P=0.0216
Duo/sp P=0.020 P=0.0122 NS
Ile/sp NS NS P=0.0122
Table 7.6. The probabilities for the within and between group variation for the CGS
group for the subjective scoring carried out on histological sections of equine small
intestine taken from horses with and without grass sickness. Key; Duo= duodenum,
Ile= ileum, mp= myenteric plexus, sp= submucous plexus, AGS= acute grass sickness,
Control= control horses, NS= not significant, P= probability, P<0.05 is taken to be of
statistical significance.
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myenteric plexus for the AGS group and the ileal submucous plexus for the CGS
group.
7.3.3 Variation between the groups
1) Number of neurones
The score for the number of neurones in the control group was significantly
higher (P<0.05), in both plexuses and both regions of the small intestine, compared
with the grass sickness groups (Table 7.1). The largest median score for the number
of neurones for control tissue was given to the duodenal myenteric plexus. For grass
sickness affected tissue, the largest median score was given to the duodenal
submucous plexus in the CGS group.
There were no significant differences between the scores given to the two
grass sickness groups in the myenteric plexus. For the submucous plexus there was a
significant difference between the AGS and CGS groups in the ileal region (P<0.05).
The duodenal myenteric plexus from the control group had a significantly higher
score, for number of neurones, than the ileal myenteric plexus in the same horses
(P<0.05). When comparing the two plexuses within the same region of the gut. there
were no significant differences in the number of neurones for any of the groups.
2) Neuronal size
Only the neurones which looked morphologically normal were taken into
consideration when scoring for neuronal size. Often damaged cells became swollen
and therefore would have complicated the interpretation of the results. The variation
in scores for neuronal size between the three groups was not as large as the variation
of scores for neuronal number (Table 7.2). In the myenteric plexus, the size of the
neurones for the CGS group, for both duodenal and ileal regions, was significantly
smaller than the control group (P<0.05). There was no significant difference between
the control and AGS groups for this region with regard to neuronal size. In the
duodenal submucous plexus both the AGS and CGS groups scores were significantly
lower than the control group (P<0.05). In the ileal submucous plexus only the CGS
group had a significantly lower score than the control group (P<0.01). This was also
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significantly lower than the AGS ileal submucous score (P<0.05). The size of
neurones in the ileal myenteric plexus of the CGS group and ileal submucous plexus
was significantly smaller than the duodenal myenteric plexus and duodenal submucous
plexus, respectively (P<0.05). When comparing the two plexuses within the same
region of the gut, there were no significant differences in size of neurones for either
the control or grass sickness groups.
3) Proportion of abnormal neurones
The control group had a low median score for the proportion of abnormal
neurones; only occasional abnormal cells were observed in this group (Table 7.3).
Therefore, for the duodenal sections, the scores for the control group were
significantly lower than the two grass sickness groups (P<0.05). In the ileal region the
AGS group had a significantly higher score than both the control and CGS groups for
both plexuses (P<0.05). There was a significant difference between the CGS duodenal
and ileal values for both the myenteric and submucous plexus (P<0.05). In the
duodenum there was no significant difference between the scores for the myenteric
and submucous plexuses for the control and both grass sickness groups. When
comparing the two plexuses, within the same region of the gut, there were no
significant differences in the proportion of abnormal neurones for the control and both
grass sickness groups.
7.3.4 Comparison of histological results with pharmacological findings
It was decided that the physostigmine results would be the most suitable to
compare with the histological data as it was thought that these results showed a
correlation with the number of active cholinergic neurones present in the in vitro
preparations. Bethanecol and noradrenaline cause their contractile responses by their
action on muscarinic and adrenergic receptors respectively and are therefore not as
good an indicator of neuronal activity.
The results for responses to physostigmine (8.6x10"6M) for the horses used in
the histological study are shown in Table 7.7 and 7.8.
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initial rate rate after percentage latency increase
n [con/min] physos. increase [s] in tone
[con/min] [%] [g]
Control 5 6.3a 9.3ab 44.8 94.0 6.0
(4.4-7.2) (7.8-10.2) (33.3-90.91) (68.0-96.0) (3.3-12.1)
AGS 5 4.1 8.1 132.2 198.0 1.8
(1.6-6.0) (4.3-11.5) (43.3-168.8) (92.0-336.0) (1.1-5.0)
CGS 5 4.4 7.3b 83.0 144.0 3.6
(2.0-7.8) (5.2-8.6) (0.0-245.4) (86.3-192.0) (3.0-18.0)
Table 7.7. Responses to physostigmine (8.6x1 O^M) of isolated equine duodenal
smooth muscle strips. Values are medians with the range of values shown in brackets.
Values with the same superscript are significantly different from each other; a =
P<0.05 (Wilcoxon Signed Rank test) and b = P<0.05 (Mann-Whitney U-test).
con/min = number of contractions per minute, physos. = physostigmine.
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initial rate rate after percentage latency increase
n [con/min] physos. increase [s] in tone
[con/min] [%] [g]
Control 5 3.3° 7. lcef 75.4 101.0 1.6g
(1.4-8.3) (3.2-8.8) (6.7-271.4) (84.0-208.0) (0.0-17.0)
AGS 5 1.6d 2.9de 82.7 208.0 0.0^
(0.8-2.9) (1.2-4.6) (30.0-180.4) (112.0-384.0) (0.0-0.0)
CGS 5 1.3 2.2f 76.2 182.0 OO OO ST
(1.0-4.7) (2.2-6.0) (27.7-120.0) (60.0-304.0) (0.0-20.8)
Table 7.8. Responses to physostigmine (8.6x10"6M) of isolated equine ileal smooth
muscle strips. Values are medians with the range of values shown in brackets. Values
with the same superscript are significantly different from each other;
c.d = P<0.05 (Wilcoxon Signed Rank test) and e.f,g,h = P<0.05 (Mann-Whitney Li¬
test). con/min = number of contractions per minute, physos. = physostigmine.
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Comparing Tables 7.7 and 7.8 with Tables 5.1.1 and 5.1.2 in Chapter 5.1
suggest that the horses chosen for the histological study were a representative sample
of the control, AGS and CGS groups. The initial rate of background contractions, for
which the maximum rate was found in the control tissue, corresponds to the group
which was given the largest score for number of neurones in the enteric plexuses.
There was a significantly (P<0.01) lower score, for the number of neurones, in
both plexuses, for control ileal compared with the control duodenal tissue in the
histological studies. In the pharmacological experiments the background rate of
contractions for ileal tissue was lower than for duodenal tissue.
In the myenteric plexus the AGS group had a significantly higher score for
proportion of damaged cells than the control and CGS groups, this would therefore
support the pharmacological results which suggested greatest damage in cases of
AGS as they took longer to respond to the addition of physostigmine.
7.4 Discussion
The observations that enteric ganglia were numerous and consistently present
in the myenteric and submucous plexuses of the small intestine in the control horses
are in agreement with previous reports on the equine enteric nervous system
(Hultgren, 1982; Vonderfecht et al., 1983; Scholes et al., 1993a).
There are varied reports on the number of cells per ganglion. Scholes et al.
(1993a) reported that the structure of both the submucous and myenteric plexus was
broadly similar throughout the gastrointestinal tract. They found 1-20 nerve cell
bodies in the submucous ganglia and 1-10 nerve cell bodies in the myenteric ganglia of
control horses. Pearson (1994) reported a mean of 20 cells per ganglion in the jejunal
submucous plexus of young control horses (< eight weeks old). Pogson et al. (1992)
reported the mean number of cells per ganglion to be five for the submucous plexus
and 3.5 for the myenteric plexus in the equine jejunum. Doxey et al. (1992) and
Pogson et al. (1992) found a higher number of ganglia per section in the submucous
plexus compared with the myenteric plexus in equine jejunum. In this present study
the variation in scored values for neuronal number between the plexuses, of a
particular region, was not significantly different for both the control and grass
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sickness groups. In grass sickness cases, the number of neurones was significantly
reduced compared with control values (P<0.05) (Table 7.1). This is in agreement with
other reports (Doxey et al., 1992, Pogson et ai, 1992, Scholes et al., 1993a).
In a report on the variation in neuronal size between the enteric plexuses in the
horse, Pearson (1994) recorded that the mean diameter for neurones in the external
submucous plexus (ESP) and internal submucous plexus (ISP) were 25+/-5jim and
26+/-6|im respectively. In the myenteric plexus they were found to be larger at 41+/-
7p.m. The results reported here are in agreement with those findings. In both the
control and grass sickness groups, a larger score for the size of normal neurones was
given to the myenteric plexus, compared with the submucous plexus (Table 7.2). The
size of neurones was scored to determine whether larger or smaller neurones were
differentially affected in cases of grass sickness. As the median scores for neuronal
size for each plexus and region are significantly smaller (P<0.05) in the CGS group,
than the control groups, it would suggest that it is the larger neurones that are
affected in CGS. With AGS cases there was only a significant difference from the
control group for the duodenal submucous plexus where larger neurones also seemed
to be preferentially damaged.
As CGS cases had survived for a minimum of eight days before euthanasia, it
is possible that all significant neuronal damage or degeneration has taken place by this
stage. These results therefore suggest that it is the smaller neurones that survive an
attack of grass sickness. There have been no previous reports of the size of neurones
that are affected by grass sickness.
Pogson et al. (1992), in a study of autonomic and enteric ganglia found a
relationship between the size of a ganglion and the size of the horse. In this present
study no account of the size of the animals was taken. This relationship may have had
an effect on the score for the size of neurone in the CGS group, as four out of the five
horses were relatively small (see Appendix E).
Some abnormal neurones were present in the myenteric plexus of control
horses. Degenerative changes of the myenteric plexus in the horse have been reported
in other diseases (Brownlee, 1959; Gilmour, 1973a; Murray et al., 1988; Burns,
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Karcher and Cummings, 1990). Pogson et al. (1992) reported that 97% of cells
uppCSTvd normal in their control group.
Scholes et al. (1993a) found with grass sickness affected horses, that some
cells showed no morphological changes, whereas other preparations showed
occasional vacuolation of nerve cell bodies and others had a complete loss of
neurones. The most severe neuropathy was recorded in AGS ileal samples. Those
authors also reported that in some acute cases no neurones could be recognised.
In these results, in the duodenum, the CGS group showed the greatest
proportion of damaged cells although there was no significant difference between the
CGS and AGS groups. In the ileum, the AGS group had the largest proportion of
abnormal cells, which was significantly higher than the control and CGS groups
(P<0.05). It may be that the ileum is the first site to be affected in most severe cases
of AGS. With cases of CGS, which have a longer clinical duration, the damage may
have spread to the duodenum thus giving this group the greatest proportion of
abnormal cells in this region. With AGS, where euthanasia occurs within 48 hours,
cell degeneration may still be in progress at the time of death and result in a lower
score than in CGS for proportion of abnormal cells, in the duodenum regions. Doxey
et al. (1992) found the greatest percentage of abnormal cells (74%) in the AGS group
in their study, but their investigation was confined to the jejunum.
Pogson et al. (1992) found the degree of neuronal damage in grass sickness is
related to the type/severity of clinical dysautonomia and concluded that both the rate
of neuronal loss and the extent of neuronal damage, may influence the clinical
manifestations of grass sickness.
As only a small number of horses were studied in each group there were
sometimes significant differences in scores awarded between horses within a group.
Tables 7.4-7.6 compared the within group variation with the between group variation.
There are some cases where the within group variation was highly significant. A
natural reduction in neuronal number with advancing age has been reported in
laboratory species (Gabella, 1989). Should such a phenomenon occur in the horse,
this may account for the variation in neuronal number in the ileal myenteric plexus of
the control group, where one horse was 18 years old.
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The proportion of abnormal neurones showed significant differences within the
control group. Some horses had no abnormal cells, whereas in others several
abnormal cells were seen. These may have been secondary to the conditions for which
they were euthanased (Brownlee, 1959).
The histological results supported pharmacological studies with
physostigmine, which indicated that the most severe neuronal damage occurred in
cases of AGS. The percentage increase in the rate of contractions following
physostigmine was greatest for the AGS group for both the duodenal and ileal region
although there were no significant differences between the groups. The latency before
a response was detected was also longest for the AGS group (although not
significantly so), suggesting that the AGS group had the least number of active
cholinergic neurones out of the three groups (see Chapter 5.1.4). The histological
studies also suggest that the AGS group had the lowest number of neurones, with the
exception of the ileal submucous plexus where the CGS group had a slightly lower
median score for the number of neurones. The proportion of abnormal neurones in the
AGS group had a similar median score in both plexuses and both regions, whereas the
values for the CGS group was much higher in the duodenal region than the ileal
region.
In conclusion, differences in the number of neurones, size of neurones, and the
proportion of abnormal cells were evident using a simple scoring system on
histological sections. Although there were some significant differences in the values
awarded for horses within a particular group, particularly the AGS group, these
results showed interesting differences between the control and grass sickness groups.
These results confirm that extensive damage occurs to the enteric neurones in cases of
grass sickness and there was some evidence that the smaller neurones may be least
affected. Interestingly, there was good correlation between functional cholinergic




The overall aim of this thesis was to study equine intestinal motility using an in
vitro technique. It must be remembered however, that isometric recording of intestinal
contractile activity, while it represents the final physiological output of the intestinal
smooth muscle, is only an indirect measure of earlier events, such as an increase in
membrane conductance, depolarization or hyperpolarization and changes in spiking
activity (Paton, 1975). It also cannot be said with certainty that in vitro observations
exactly reflect in vivo activity.
The function of the smooth muscle of the small intestine is to contract and
relax in such a way as to provide propulsion and mixing of the contents (Bolten,
1989). This is achieved by the activity of the enteric nervous system, the extrinsic
autonomic nervous system and the endocrine system (Kutchai, 1993).
In the disease grass sickness in horses there is a dysfunction of the autonomic
nervous system, primarily affecting the alimentary tract (Gilmour, 1989).
Degenerative changes are found within the autonomic ganglia, including those found
within the myenteric and submucous plexuses in the intestinal wall (Obel, 1955;
Gilmour, 1973a). Acute cases of grass sickness usually have dysphagia and intestinal
stasis (Milne, 1991). Animals die, or require euthanasia, within 48 hours of the onset
of clinical signs. In subacute cases the clinical signs are less intense but rapid loss of
condition including weight loss are marked features. Most horses with SAGS die, or
require euthanasia, within two to seven days of the onset of the disease. A few cases
progress to the chronic form of the disease, classified as lasting eight days duration or
more.
The aetiology of grass sickness is unknown, one theory is a neurotoxin is
present (Gilmour, 1973b). If this is the case, does the neurotoxin have a selective
action on certain types of neurones. As the disease causes such disruption to the
function of intestinal smooth muscle it was thought that in vitro studies of responses
to selected pharmacological agents would provide useful information on the extent of
damage occurring to the enteric nervous system.
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Like intestinal smooth muscle in other species, strips of equine small intestine
showed regular background contractile activity. It was found that ileal muscle strips
showed a burst-like pattern of background contractions whereas in duodenal tissue
the contractions were more regular with a significantly higher contractile rate
(Murray et al., 1994). A higher contractile rate would be expected in the more
proximal regions of the gastrointestinal tract (Davies and Gerring, 1983).
There was no significant difference in the amplitude of contractions between
the two regions of the small intestine in control horses. With grass sickness tissue
there was a trend for a lower rate of contractions and a higher amplitude of
contractions, although the differences were not always statistically different. The
addition of tetrodotoxin, atropine, propranolol, phentolamine, prazosin and
yohimbine had no significant effects on the characteristics of the background
contractions with both control and grass sickness tissue.
The addition of physostigmine demonstrated that the ileal region was most
affected in cases of grass sickness. In the duodenal region only the AGS group had a
significantly lower rate of contractions than the control group following the addition
of physostigmine, whereas in the ileum all three grass sickness groups had
significantly lower enhanced rates compared with the ileal control group (P<0.05).
The duodenal AGS group showed a significantly lower increase in tone compared
with the duodenal control group (P<0.01). In the ileal region no AGS or SAGS
muscle strips had any increase in tone following the addition of physostigmine. There
was a significantly prolonged latency with AGS and SAGS tissue before a response
could be seen.
The effect of storage for 24 hours at 4°C was investigated to see if stored
control tissue would respond similarly to fresh grass sickness tissue and thus provide
a model for grass sickness in vitro research, however, there were found to be
significant differences in some responses so it was concluded this would be an
unsuitable model.
Dose response curves in response to bethanecol were constructed for the
control, AGS and CGS groups. They showed that AGS tissue was supersensitive to
this cholinergic agonist, indicated by a leftward shift of the dose response curve and a
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lower ED?o value. In the ileal region the CGS group also had a lower EDS0 value than
the ileal control group. There have been a number of reports in the literature of
denervation hypersensitivity in both skeletal and smooth muscle (Clark and
Mapstone, 1987; Janig, 1989; Osinski and Bass, 1994).
Cisapride is a prokinetic drug which has been reported to enhance
gastrointestinal motility along the entire gastrointestinal tract (King and Gerring,
1988). The results with cisapride in this study showed a trend to an increase in
contractile rate (P<0.06) with both control and grass sickness affected tissue,
although it must be concluded that more experiments to study the mechanism of
action should be carried out.
In vitro equine small intestine contracts in response to catecholamine
addition. It was concluded this was due to a2 adrenergic receptors and independent
of nervous elements. There were no significant differences in the responses of grass
sickness affected tissue to noradrenaline in these experiments, with the exception of
the ileal AGS group, which had a significantly lower contractile response from the
other grass sickness groups and the control group (P<0.05 or less). It may be an effect
of the disease that receptor number or availability is reduced, as has been reported in
other diseases (Wright and Shepherd, 1965; Brodde, Zerkowski, Borst, Maier and
Michel, 1989).
There have been no previous attempts to correlate enteric neuronal damage
with any functional responses. In these experiments a subjective histological scoring
system established significant differences between the two plexuses and the two
regions examined with regard to neuronal number, size of normal neurones and
proportion of abnormal cells. The control, AGS and CGS groups were examined.
Both grass sickness groups had a significantly lower score for neuronal number than
the control group (P<0.05). There was also some evidence that it was the larger
neurones that were effected by grass sickness. In the ileum the AGS group had a
significantly higher proportion of abnormal cells than both the control and CGS
groups. In the duodenum there was no significant difference between the AGS and
CGS groups although they both had a significantly higher proportion of abnormal
cells compared with the control group (P<0.05).
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The histological results supported the pharmacological studies with
physostigmine, which suggested that the most severe neuronal damage occurred in
cases of AGS.
In conclusion, in vitro investigations of small intestinal motility can provide
some useful information on the functional deficits which occur in horses suffering
from grass sickness. The damage to the excitatory cholinergic enteric nervous system
appears to be so great in cases of AGS that any therapeutic treatment would be of
limited benefit. In CGS cases, treatment with prokinetic drugs such as cisapride have
been shown to be of benefit in selected cases (Milne, E.M., Doxey, D.L., Woodman,
M.P., Cuddeford, D. and Pearson, R.A., in press). However, it must be remembered
that other non-intestinal factors will affect the horses chances of survival such as its
ability to swallow, level of depression and degree of rhinitis.
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Appendix A.
Within animal repeatability of organ bath experiments.
Chapter 3 describes the experimental protocol for the in vitro organ bath
experiments. A limitation of this work was there was no investigation of the within
animal repeatability with regard to responses to pharmacological agents. A constraint of
clinical research, especially involving horses, is that there is a limited availability of
suitable material. Experiments needed to be carried out on fresh tissue and therefore for
each horse only one smooth muscle strip from a specific area of the small intestine was
used to investigate the responses to a particular pharmacological agent. In the tables of
results the total number of horses used to determine the response to a pharmacological
agent are shown.
It was thought reasonable to expect that responses from adjacent strips of
gastrointestinal tract would be similar. In the literature work in laboratory species on
morphology, histology and immunohistology has found uniformity within a particular
area of gut (Schultzberg, 1986; Furness and Costa. 1987). Gabella (1990) stated how the
structure of the ganglionic network, size and shape of the meshes were strikingly regular
and consistent in a particular segment of the gut of the guinea pig. In the jejunum-ileum
the pattern of the myenteric plexus was uniform both around the circumference and
along the length, showing no obvious gradient in any structural parameter. She found
differences in the extent of the myenteric plexus in different species. If the structure and
distribution of enteric nerves was the same in the horse within a particular region it
would be likely that the in vitro response to pharmacological agents would be the same.
The two sites used for sampling were well defined the caudal flexure of the
duodenum and the terminal ileum 10cm proximal to the ileocaecal fold. This would
IbS
reduce the possible variation between horses attributable to variations in sampling sites.
It should also be noted that the order drugs were added to the smooth muscle
preparations was randomised so that responses were not affected by the timing of the
drug addition (Perry. 1968).
In summary within animal repeatability could have been investigated more
thoroughly, however, the sample sites were accurately defined and there was no
evidence that the responses of an adjacent strip of smooth muscle would have been any
different. The number of horses used to investigate the responses to pharmacological
agents were sufficient to show statistically significant differences between the control
and grass sickness groups.
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Appendix B. Horses used to investigate characteristics of background contractions
(Chapter 4).
BREED AGE SEX REASON FOR
EUTHANASIA
DRUG TREATMENT
pony 16 yrs gelding ragwort poisoning none
hunter 9 yrs mare laminitis PBZ 3days previously
Welsh pony 4 yrs stallion ventricular septal none
defect
Clydesdale 10 yrs mare gut torsion PBZ few hours before
pony 9 yrs mare liver disease none
TB x 14 yrs gelding large colon buscopan day before, PBZ
displacement day died
Welsh pony 10 yrs mare liver disease/ none
eosinophilic
gastroenteritis
Welsh x 16yrs mare volvulus of small xylazine, PBZ
intestine
Welsh pony 15 yrs mare orthopaedic none
Shetland 9 mths * orthopaedic none
Hanovarian 6 yrs gelding mitral value none
incompetence
TB 12 yrs mare pyelonephritis flunixin, penicillin
pony type * gelding experimental pony none
TB x Welsh 4yrs mare AGS buscopan, butorphanol,
finadyne day before
Shetland 3yrs stallion AGS none
Highland 6mths colt AGS flunixin
Highland 4 yrs mare AGS none
Highland 5yrs filly AGS none
TB x 7yrs mare AGS finadyne day euthanasia
TB 12yrs stallion AGS none
pony 4yrs mare AGS flunixin on day of
euthanasia
Highland x 4yrs gelding AGS none
Welsh x C/mara lOyrs gelding AGS flunixin on day of
euthanasia
Arab x Welsh lOyrs gelding AGS buscopan on day of
euthanasia
Welsh 4yrs gelding AGS none
Clydesdale 3yrs gelding AGS none
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Appendix B continued
TB x 5yrs * SAGS none
Highland x 7yrs mare SAGS none
TB x 5yrs mare SAGS equipalazone day before
TB x 6yrs mare SAGS buscopan 3 days before,
penicillin, dexamethazone day
before
polo pony 7yrs mare SAGS none
Highland x lOmths stallion SAGS none
pony type 6yrs gelding SAGS finadyne
Clydesdale 2yrs filly SAGS none
Highland * gelding SAGS none
TB 9yrs gelding SAGS finadyne 2 days before
TB x 7yrs gelding SAGS finadyne on day euthanasia
TB x lOyrs mare SAGS none
Welsh 12yrs gelding SAGS finadyne until day before
euthanasia
Norwegian 7yrs mare CGS cisapride stopped 3 days
Fjord before euthanasia
pony type 8yrs mare CGS none
3/4 TB 13yrs gelding CGS none
Clydesdale 2yrs filly CGS depocillin upto euthanasia
Warmblood 2yrs filly CGS cisapride upto day of
euthanasia
TB x 2yrs stallion CGS cisapride until day before
euthanasia
Shetland 4yrs filly CGS synulox day before euthanasia
Arab x 2yrs gelding CGS none
Shetland lOyrs mare CGS none
TB yearling mare CGS cisapride, finadyne day before
euthanasia
Highland 3yrs gelding CGS none
pony 6yrs mare CGS cisapride until day of
euthanasia
pony 18yrs mare CGS equipalazone, depocillin,
crystapen until day of
euthanasia
Key: TB = Thoroughbred, x = crossbreed, C/mara = Connemara, yrs = years old,
mths = months old, AGS = acute grass sickness, SAGS = subacute grass sickness,
CGS = chronic grass sickness, PBZ = phenylbutazone, * = unknown data.
171
Appendix C. Horses used in physostigniine experiments (Chapter 5.1).
BREED AGE SEX REASON FOR
EUTHANASIA
DRUG TREATMENT
pony 16yrs gelding ragwort poisoning none
Hunter type 9yrs mare laminitis PBZ 3 days previously
Welsh pony 4yrs stallion ventricular septal none
defect
Gelderlander 12yrs gelding heart disease frusemide for 11 days
TB x 7yrs gelding lung abscess none
Clydesdale 2mths filly immuno- gentamicin, blood
incompetence transfusion,
corticosteriods, penicillin
Dutch WB 17mths gelding orthopaedic 2g PBZ daily
TB x 1 lyrs mare gastric rupture halothane, ketamine
anaesthesia
TB 12yrs mare pyelonephritis flunixin, penicillin
pony 18yrs gelding cushings disease none
pony
* gelding experimental pony none
pony
* gelding experimental pony none
pony
* gelding experimental pony none
welsh x Arab 20mths * liver disease *
Icelandic 14yrs mare ruptured prepubic none
tendon of
abdominal cavity
TBx 17yrs gelding colic- stangulation buscopan, flunixin,
by lipoma butorphanol, PBZ
Dartmoor x 24yrs mare stenosis of small buscopan
intestine
TBxDartmoor 3yrs mare bilateral laryngeal penicillin
chondritis
TB x 3yrs mare pharyngeal none
paralysis
TB 6yrs mare orthopaedic flunixin, PBZ, penicillin
Welsh 15yrs mare orthopaedic none
Hanovarian 6yrs gelding mitral value none
incompetence
Shetland 9mths * orthopaedic *
TB 3yrs gelding wobbler none
Shetland * gelding experimental pony none
Clydesdale 3yrs gelding AGS none
Welsh pony 4yrs gelding AGS none
TB 12yrs stallion AGS none
Highland 2yrs filly AGS finadyne day before
Highland 5yrs filly AGS none
Highland 6mths stallion AGS flunixin
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Appendix C continued,
pony 4yrs gelding AGS none
Arab x Welsh lOyrs gelding AGS buscopan few hours
Mountain before euthanasia
WelshxC/mara lOyrs gelding AGS flunixin on day of
euthanasia
pony 4yrs mare AGS flunixin on day of
euthanasia
TB x 7yrs gelding SAGS finadyne on day of
euthanasia
pony 7yrs mare SAGS none
Welsh 12yrs gelding SAGS finadyne until day before
euthanasia




Highland x lOmths stallion SAGS none
TB 9yrs gelding SAGS finadyne 2 days before
euthanasia
Clydesdale 2yrs filly SAGS none
Highland x 7yrs mare SAGS none
Warmblood 2yrs filly CGS cisapride upto euthanasia
Shire x 6yrs mare CGS none
Shetland 4yrs filly CGS ampocillin/clavulanic acid
TB yearling mare CGS cisapride and finadyne day
before euthanasia
Norwegian 7yrs mare CGS cisapride stopped 3 days
Fjord before euthanasia
Clydesdale 5yrs mare CGS cisapride until day before
euthanasia
TB x 2yrs stallion CGS cisapride until day before
euthanasia
Halflinger 5yrs gelding CGS cisapride until 5 days
before euthanasia
pony 18yrs mare CGS equiphazone, depocillin
and crystapen until
euthanasia
Arab 2yrs gelding CGS none
Highland 3yrs gelding CGS none
pony 6yrs mare CGS cisapride until euthanasia
Key: TB = Thoroughbred, x = crossbreed, WB = Warmblood, yrs = years old, mths =
months old, AGS = acute grass sickness, SAGS = subacute grass sickness, CGS =
chronic grass sickness, PBZ = phenylbutazone, * = unknown data.
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Appendix D. Analysis of physostigmine data when the grass sickness data are
divided into different groups. There are now only two grass sickness groups. When
the results were plotted there appearred to be a division in relation to latency before a
response to physostigmine was observed, therefore a latency of 250 seconds was used
as a dividing line. Horses with a longer latency period were put into the AGS group










increase [%] latency [s]
tone
increase [g]
Con 25 6.5ab 9.2de 43.7fg 90.0* 5.r
(0.6-8.3) (6.2-15.0) (4.4-177.8) (30.0-168.0) (1.4-12.1)
AGS 7 3.2ac 7.5d 175.0th 280.0'' 2.0m
(0.8-3.8) (4.3-9.0) (113.2-512.5) (264.0- (1.0-5.0)
420.0)
23 4. lbc <DoOO 100.0gh 140.0kl 3.5
CGS (1.4-8.6) (5.2-12.0) (0.0-360.0) (60.0-224.0) (0.9-18.0)
Effect of addition of physostigmine (8.6x10"6M) on isolated duodenal muscle strips
taken from control horses (Con) and those suffering from acute grass sickness (AGS)
and chronic grass sickness (CGS). Values are medians with the range of values shown
in brackets. Values with the same superscript are significantly different from each
other, a, f, k, j, 1 = PcO.OOl, b, m = P<0.01, c, d, e, g, h = P<0.05 when analysed












increase [%] latency [s]
tone
increase [g]
Con 23 2.6ab 7.4cd 118.3 112.0f 1.2
(0.0-8.6) (3.2-16.4) (2.3-363.2) (72.0-208.0) (0.0-21.0)
AGS 8 1.7a 2.9C 122.0 342.0fg 0.0
(0.7-2.3) (1.6-5.6) (20.0-245.4) (268.0- (0.0-2.0)
384.0)
14 1.7b 3.4d 58.7 140.0s 0.0
CGS (0.6-4.7) (1.2-8.4) (3.2-300.0) (60.0-248.0) (0.0-20.8)
Effect of addition of physostigmine (8.6x10"6M) on isolated ileal muscle strips taken
from control horses (Con) and those suffering from acute grass sickness (AGS) and
chronic grass sickness (CGS). Values are medians with the range of values shown in
brackets. Values with the same superscript are significantly different from each other,
c, f, g = PcO.OOl, d = PcO.Ol, a, b = P<0.05 when analysed using the Mann-Whitney
U-test.
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Appendix E. Horses used in bethanecol experiments (Chapter 5.2).
BREED AGE SEX REASON FOR
EUTHANASIA
DRUG TREATMENT
Welsh pony 15yrs mare orthopaedic none
pony 20yrs mare thyroid adenoma none
Shetland 9mths * orthopaedic *
pony 18yrs gelding cushings disease none
Hanovarian 6yrs gelding heart disease none
Dartmoor x 24yrs mare colic buscopan
Shetland * gelding experimental none
Welsh x Arab 20mths * liver disease *
Arab x Welsh 1 Oyrs gelding AGS buscopan day euthanasia
WelshxC/mara lOyrs gelding AGS flunixin day euthanasia
TB 12yrs stallion AGS none
Highland 5yrs filly AGS none
Shetland 3yrs stallion AGS none
pony 4yrs gelding AGS none
Highland x 4yrs gelding AGS none
pony 4yrs mare AGS flunixin day euthanasia
Highland 6mths colt AGS flunixin
Welsh M/tain 4yrs gelding CGS none
3/4 TB 13yrs gelding CGS none
Clydesdale 2yrs gelding CGS depocillin
Shire x 6yrs filly CGS none
Arab x 2yrs mare CGS none
Shetland 4yrs gelding CGS synulox day before
TB x 2yrs gelding CGS PBZ day before
Shetland lOyrs mare CGS none
Warmblood 2yrs filly CGS cisapride upto euthanasia
Key: TB = Thoroughbred, x = crossbreed, C/mara = Connemara, M/tain, yrs = years
old, mths = months old, AGS = acute grass sickness, CGS = chronic grass sickness,
PBZ = phenylbutazone, * = unknown data.
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Appendix F. Horses used in cisapride experiments (Chapter 5.3).
BREED AGE SEX REASON FOR
EUTHANASIA
DRUG TREATMENT
Dartmoor x 3yrs mare bilateral laryngeal penicillin
TB chondritis
TB x 3yrs mare respiratory disease none
TB 6yrs mare orthopeadic flunixin, penicillin, PBZ
Dutch WB 17mths gelding orthopaedic 2g PBZ daily
TB x 7yrs gelding lung abcess none
Fell 4yrs filly AGS none
Highland 4yrs mare AGS none
pony x 8yrs mare AGS none
TB x 5yrs mare AGS none
TB x 7yrs mare AGS finadyne
Shire x ID 6yrs mare CGS none
TB x 2yrs gelding CGS PBZ day before euthanasia
Halflinger x 5yrs gelding CGS cisapride until 5 days before
euthanasia
TB x 5yrs stallion CGS none
3/4 TB 13yrs gelding CGS none
Key: TB = Thoroughbred, x = crossbreed, yrs = years old, mths = months old, ID =
Irish Draught, WB = Warmblood, AGS = acute grass sickness, CGS = chronic grass
sickness, PBZ = phenylbutazone, * = unknown data.
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Appendix G. Horses used in adrenergic experiments (Chapter 6).
BREED AGE SEX REASON FOR
EUTHANASIA
DRUG TREATMENT
Welsh pony lOyrs mare eosinophilic none
gastroenteritis/ liver
disease
TB 3yrs gelding wobbler none
TB x 7yrs gelding lung abcess none
Clydesdale 2mths filly immuno- incompetence corticosteriods, penicillin,
gentamicin, blood
transfusion
Dutch WB 17mths gelding orthopaedic 2g PBZ daily
TB x 1 lyrs mare gastric rupture halothane, ketamine
anaesthesia
TB 12yrs mare pyelonephritis flunixin, penicillin
pony 18yrs gelding cushings disease none
pony
* gelding experimental pony none
pony
* gelding experimental pony none
pony
* gelding experimental pony none
Welsh x Arab 20mths * liver disease/thrombosis *
pony 23yrs mare tapeworm cyst of liver PBZ same day as
euthanasia
Icelandic 14yrs mare ruptured prepubic *
tendon of abdominal
cavity
TB x 17yrs gelding colic-strangulation by buscopan, flunixin,
lipoma butorphanol, PBZ
Welsh x 16yrs mare colic-volvulus of SI xylazine, PBZ
TB x 14yrs gelding large colon buscopan day before,
displacement PBZ day of euthanasia
pony 9yrs mare liver disease none
pony 20yrs mare thyroid adenoma none
Gelderlander 12yrs gelding heart disease frusemide for 1 1 days
TB x 7yrs mare AGS finadyne
TB x lOyrs mare AGS equipalazone
Highland 2yrs filly AGS finadyne day before
pony x 8yrs mare AGS none
Highland 6mths colt AGS flunixin
pony 4yrs gelding AGS none
TB x Welsh 4yrs mare AGS buscopan, torbugesic,
finadyne
TB 9yrs gelding AGS none
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Appendix G continued,
Highland 4yrs mare AGS flunixin on day of euthanasia
pony 2yrs filly SAGS finadyne 2 days before
euthanasia
Highland * mare SAGS finadyne
pony 4yrs mare SAGS none
pony type 6yrs * SAGS none
TB x 7yrs gelding SAGS finadyne on day of euthanasia
pony 7yrs mare SAGS none
Welsh 12yrs gelding SAGS finadyne until day before
euthanasia
TB x 6yrs mare SAGS buscopan 3 days before,
penicillin and dexamethazone
day before euthanasia
Highland x 1 Omths stallion SAGS none
TB 9yrs gelding SAGS finadyne 2 days before
euthanasia
Clydesdale 2yrs filly SAGS none
Highland x 7yrs mare SAGS none
TB x 5yrs * CGS none
Clydesdale 2yrs filly CGS depocillin until euthanasia
Welsh M/tain 4yrs gelding CGS none
TB yearling mare CGS cisapride and finadyne day
before euthanasia
TB x 2yrs gelding CGS PBZ 1 day before euthanasia
Clydesdale 5yrs mare CGS cisapride until day before
euthanasia
TB x 2yrs stallion CGS cisapride until day before
euthanasia
Halflinger 5yrs gelding CGS cisapride until 5 days before
euthanasia
pony 18yrs mare CGS equiphazone, depocillin and
crystapen until euthanasia
Shetland lOyrs mare CGS none
Highland 3yrs gelding CGS none
pony 6yrs mare CGS cisapride until euthanasia
Key: TB = Thoroughbred, WB = warmblood, x = crossbreed, M/tain = mountain, yrs
= years old, mths = months old, SI = small intestine, AGS = acute grass sickness,
SAGS = subacute grass sickness, CGS = chronic grass sickness, PBZ =
phenylbutazone, * = unknown data.
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Appendix H. Analysis of noradrenaline data when the grass sickness data are divided
into different groups. There are now only two grass sickness groups. When the results
were plotted there was no clear dividing line therefore the grass sickness groups were
separated on duration of illness.
A) Duodenum
initial response to contractile contractile rate contractile
contractile noradrenaline rate following after rate after
response to following noradrenaline propranolol and phentolamine
noradrenaline pretreatment with addition noradrenaline and
[g/g of tissue] propranolol [contractions/ [contractions/m noradrenaline
[g/g of tissue] min] in] [contractions/
min]
Con 32.1a 34.3cd 0.6 2.0 1.6
(8.4-1 15.3) (8.4-93.8) (0.0-6.8) (1.2-5.4) (0.0-10.6)
AGS 20.1ab 16.6C 0.9 2.0 2.8
(16.0-31.2) (10.3-26.4) (0.0-2.4) (1.2-4.4) (0.0-7.8)
CGS 37.7b 24.6d 0.2 2.6 4.6
(10.8-90.9) (0.0-63.2) (0.0-2.0) (1.0-6.2) (1.0-9.6)
B) Ileum
initial response to contractile contractile rate contractile
contractile noradrenaline rate following after rate after
response to following noradrenaline propranolol and phentolamine
noradrenaline pretreatment with addition noradrenaline and
[g/g of tissue] propranolol [contractions/ [contractions/ noradrenaline
[g/g of tissue] min] min] [contractions/
min]
Con 43.0e 15.8 0.2 0.7h 1.2
(13.8-118.3) (0.0-72.2) (0.0-2.3) (0.0-1.8) (0.0-2.7)
AGS 9.8ef 19.0 0.0s 0.9' 1.0
(0.0-34.6) (0.0-36.2) (0.0-3.2) (0.0-2.0) (0.0-6.6)
CGS 44.7f 26.9 0.6s 2.2hi 2.7
(4.5-65.6) (3.5-58.7) (0.0-2.2) (1.9-5.9) (0.0-7.6)
Median peak contractile response in grams/gram of tissue and rate of contractions per
minute in response to noradrenaline addition (7.1x10"6 M) for muscle strips taken
from A) the duodenum and B) the ileum, from control horses (Con) and those
affected by AGS (duration of illness 3 days or less) and CGS (duration of illness 4
days or more). The range of values are shown in brackets. Values with the same
superscript are significantly different from each other when analysed using the Mann-
Whitney U-test e, f, h = PcO.OOl, b, c, i = P<0.01, a, d, g = P<0.05.
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Appendix I. Horses used for the histological study of enteric nervous system
(Chapter 7).
BREED AGE SEX REASON FOR
EUTHANASIA
DRUG TREATMENT
TB 12yrs mare pyelonephritis flunixin, penicillin
pony 18yrs gelding cushings disease none
pony
* gelding experimental pony none
Welsh x Arab 20mths * liver disease *
pony 23yrs mare tapeworm cyst of
liver
PBZ
Highland 5yrs filly AGS none
Highland 6mths colt AGS flunixin
Shetland 3yrs stallion AGS none
pony 4yrs gelding AGS none
TB x lOyrs mare AGS equipalazone
Shetland 4yrs filly CGS amoxyci 1 lin/clavu 1 anic
acid day before euthanasia
Arab x 2yrs gelding CGS none
Clydesdale 5yrs mare CGS cisapride until day before
euthanasia
Halflinger 5yrs gelding CGS cisapride until 5 days
before euthanasia
pony 18yrs mare CGS equipalazone, depocillin,
crystapen
Key: TB = Thoroughbred, x = crossbreed, yrs = years old, mths = months old, PBZ =
phenylbutazone, * = unknown data.
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Appendix J. Possible effects of previous drug horses may have received on
gastrointestinal motility.
It should be noted that as discussed in Chapter 3.2.3 initial experiments were
carried out to see whether the barbiturates used for euthanasia could be washed off
the smooth muscle preparation. It was found that they could be washed off after
several minutes of washing with fresh modified Krebs solution. It was therefore likely
that any previous drug treatment that the horses may have received pre-euthanasia
would also have been removed during the one hour eqilibration period. Horses
received any drug treatment several hours before euthanasia, also the half-lives of the
drugs used were relatively short. Possible actions on the gastrointestinal tract of the
drugs used to treat any of the horses used in the in vitro experiments are discussed
below.
1. Non steriodal anti-inflammatory drugs (NSAIDS)
Phenylbutazone (Equipalozone)
Phenylbutazone has analgesic, anti-inflammatory, antipyretic and mild
uricosuric properties. The proposed mechanism of action is by inhibition of cyclo-
oxgenase thereby decreasing prostaglandin synthesis (Rang and Dale, 1991). The
serum half-life in horses is 3.5-6 hours and is dose dependant. Contraindications that
are of relevance to the gastrointestinal tract, suggests that in foals and ponies there
may be increased incidence of gastrointestinal ulceration (Plub, 1995). Buscopan is a
NSAID related to phenylbutazone.
Flunixin
Flunixin has analgesic, anti-inflammatory and antipyretic properties. Flunixin
does not appreciably alter gastrointestinal motility in the horse. Its serum half-life is
about 1.6 hours in the horse. When used to treat colic flunixin may mask the
behavioural and cardiopulmonary signs associated with endotoxemia or intestinal
devitalization (Plub, 1995). In dogs gastrointestinal distress is the most likely adverse
reaction to flunixin. It appears to be a relatively safe agent for use in the horse.
Flunixin is also known as Finadyne.
2. Antibiotics
Penicillins
Penicillins act by inhibiting mucopeptide synthesis in the cell wall resulting in a
defective barrier and an osmotically unstable spheroplast. They are extremely effective
antibiotics and are widely used. A side effect of penicillins particulary the broad
spectrum type given orally is the alteration of the bacterial flora in the gastrointestinal
tract. This may be associated with gastrointestinal disturbances (Brander, Pugh,
Bywater and Jenkins, 1991).
Gentamicin
Gentamicin belongs to the aminoglycoside antibiotic group. Its elimination




While the precise mechanism by which inhalent anaesthetics exert their general
anaesthetic effect is not known some key pharmacological effects noted with
halothane include; CNS depression, depression of body temperature regulating
centres, increased cerebral blood flow, respiratory depression, hypertension,
vasodilation and myocardial depression. The contraindications do not list any effects
on the gastrointestinal tract (Plub, 1995; Data sheet, 1995/1996).
Ketamine
Ketamine is also a general anaestheic agent which has significant analgesic
activity and a lack of cardiopulmonary effects. No effects on the gastrointestinal tract
have been reported.
Xvlazine
Xylazine is an alpha 2 adrenergic agonist, classified as a sedative/analgesic
with muscle relaxant properties.
Butorphanol (Torbugesic)
Butorphanol is a synthetic opiate partial agonist, it is related structurally to
morphine but exhibits pharmacologic actions similar to other partial agonists such as
pentazocine and nalbuphine. It is considered to be a more potent an analgesic than
morphine. It also pocesses significant antitussive activity. The duration of action is
upto 4 hours in the horse. Adverse effects in horses may include transient ataxia and
sedation. It also has the potential to decrease gastrointestinal motility especially at
very high doses, although these effects are considered tranitory in nature (Barragry,
1994).
4. Cisapride
Cisapride is a prokinetic agent which increases gastrointestinal activity. Its
mechanisms of action are discussed in Chapter 5.3.1 (Schuurkes et al., 1985). Its
elimination half-life is about 8-10 hours in the horse. Any grass sickness cases which
had been treated with cisapride received their last dose of cisapride at least 12 hours
before euthanasia.
5. Dexamethazone
Dexamethazone is a synthetic glucocorticoid. In the literature there are no
reports of corticosteriods having an effect on gastrointestinal motility (Barragry,
1994).
6 Furosemide
Furosemide is used for its diuretic activity. It may induce fluid and electrolyte
abnormalities. Other potential adverse effects include ortotoxicity, gastrointestinal
abnormalities, haematological effects , weakness and restlessness.
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Appendix K. Histological scoring system.
1) Number of neurones
Score Description
1 very few neurones observed throughout entire section
2 some ganglia contained neurones which had normal appearance
3 at least one neurone in every ganglia
4 several ganglia containing neurones seen in both plexuses
5 numerous neurones throughout enteric plexuses
2) Size of normal neurones
The score awarded for size was very subjective, only the scores 1.5 to 4 were
awarded. The animals size or age was not taken into account. The scoring system was
however repeatable as described in Chapter 7.2.3
3) Proportion of abnormal neurones
Score Description
0 no abnormal cells seen
1 only 1-3 abnormal cells observed throughout the whole section
2 25% neurones abnormal
3 50% nerones abnormal
4 75% or greater neurones abnormal, extensive chromatolysis
5 only the occasional neurone could be seen
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The Post Mortem Findings In 213 Equines
With Special Reference To Lesions Of The
Gastrointestinal Tract.
F Howie H Pirie", H Thompson". 1
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PENICL'IK, EH26 OQE. "Department oi Veterinary
Pathology. Glasgow University Veterinary School.
Bearsdcn Road. Glasgow G61 1QH.
Equine gastrointestinal disease is well recognised,
however, lew studies have been made into its
significance as a cause of death or of subclinical
lesions. To this end the lesions present at necropsy
of all equines examined by the Glasgow University
Veterinary School. Department of Veterinary
Pathology over the period 1987-1991 were
reviewed. This study revealed that the
gastro-intcstinai tract was by far the most frequently
affected anatomical system in terms of both
significant lesions, ic. those considered to have been
the cause of deatn. and incidental lesions. The
findings will be presented and those concerning the
gastrointestinal tract discussed in detail.
Histopathol(*>ical Chanties In Brain Stem
Nuclei Of Horses With "Mai Seco' And With
Grass Sickness.
UzaL FA Doxcv, D.L.", Robles. CA1,
Woodman. MJV, and Milne. E2M."
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Argcnnna and "Dept Vctennary Clinical Studies.
R(D)SVS. Edinburgn
'Mai seco' is a disease of unknown aenology
affecting horses in Argentina. A histopathological
study of the brain stem nuclei of 3 horses with 'mai
seco' and of 4 horses with grass sickness was
pertormed. Another 3 horses with a
clinico-pathological diagnosis other than 'mal seco'
or grass sickness were used as controls. At least one
peripheral autonomic ganglion from each horse was
also investigated. Degenerative nistoioeicai changes
were found in several brain stem nuclei and in the
permnerai autonomic ganglia of all the 'mal seco
ana grass sickness horses. No such cnanges were
found in the brain stem nuclei and peripheral gangiia
of the controls. The changes found in the brain stem
nuclei and in the gangiia of both 'mal seco' and
grass sickness cases were similar and consisted of
chromatoiysis. cytoplasmic vaeuoiation, intercellular
and mtracytoplasmanc eosinophilic bodies, pyknonc
and eccentric nuclei and ncuronopnagia. These
results provide further evidence to tne hypothesis
that mal scco' and grass sickness may be the same






Damaqe To The Enteric Nervous System In
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Histological examinanon of the myenteric and
submucosal plexuses of the lejunum, ileum and
small colon of normal horses and those suffering
from dysautonomia was undertaxen. Quantitative
assessments were made of neurone numbers and the
type of damage thev had sustained. Both ceil loss
and damage occurred. It was particularly severe in
the iieum and some animals had less than 5% of
their normal neurone population left.
Taken from the Proceedings of the
Association of Veterinary Teachers and
Research Workers. Scarborough, U.K. 1994
An In Viiro Study Of Small Intestinal
Motility In Horses With And Without Grass
Sickness.
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Equine grass sickness is a painfui and usually fatal
disease characterized by dysfuncnon of the
autonomic nervous system, primarily of the
alimentary tract. Degeneration of enteric neurones in
the gastrointestinal tract have been demonstrated in
grass sickness and to investigate differences in
intestinal motility an in vitro technique was used.
Responses to pharmacological agents arc compared
for normal and grass sickness affected tissue. To test
the viability and capacity of enteric cholinergic
neurones to produce acetycholine. an
anticholinesterase agent and a muscarinic agonist
were used. The phenomenon thai noradrenaline
when added to isolated small intestine of the horse
causes contraction 11 was also invesngated.
"'Ruckebusch M.. Grivel M.L. and Fargeas MJ.
(1971). Surl'Action Paradoxaie de I"Adrenaline au
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CHOLINERGIC ACTIVITY OF INTESTINAL MUSCLE IN VITRO
TAKEN FROM HORSES WITH AND WITHOUT EQUINE GRASS
SICKNESS
A. MURRAY1, D.F. COTTRELL1 AND M.P. WOODMAN2
'Department of Preclinical Veterinary Sciences, Summerhall, Edinburgh, EH9 1QH,
UK
2Department of Veterinary Clinical Studies, Easter Bush, Roslin, EH25 9RG, UK
ABSTRACT
Murray, A., Cottrell, D.F. and Woodman, M.P., 1994. Cholinergic activity of intestinal muscle in vitro
taken from horses with and without equine grass sickness. Veterinary Research Communications, 18 (3),
199-207
Equine grass sickness (EGS) is a pan-dysautonomia of horses that involves central and peripheral
neuronal degeneration and ultimately depletion. This is the first reported functional study on the
motility of equine intestine taken immediatelypost mortem from horses with EGS. Strips of smooth
muscle from the small intestine of healthy and EGS-affected horses were suspended in an organ bath
and their motility was measured isometrically. The activity of the cholinergic system was studied.
Physostigmine enhanced the motility of all muscle strips. Tissues taken from horses suffering from
acute grass sickness (AGS) had the longest latency before a measurable response could be obtained
(p<0.05). The ileum appeared to be damaged by EGS to a greater extent than the duodenum. For
the duodenal strips the enhanced rate of spontaneous contractions was significant (p < 0.05) for both
normal tissue and that affected by grass sickness but this was not the case for the ileal strips.
Muscarinic receptor sensitivity investigation using bethanecol suggested a hypersensitivity of
receptors with AGS material,
Keywords: cholinergic, dysautonomia, grass sickness, horse, intestinal motility, in vitro
Abbreviations: AGS, acute grass sickness; CGS, chronic grass sickness; ED , median effective dose;
EGS, equine grass sickness; VIP, vasoactive intestinal peptide
INTRODUCTION
Equine grass sickness (EGS) is a serious clinical disease in which horses suffer
widespread dysautonomia. Although the cause of EGS is unknown, it is characterized
by dysfunction of the autonomic nervous system, primarily affecting the alimentary
tract (Greig, 1928). Histological examination of autonomic ganglia shows evidence of
neuronal degeneration and ultimately depletion (Obel, 1955; Gilmour, 1973), and it is
thought that a neurotoxin may be involved in the aetiology (Pollin and Griffiths,
1992). Neuronal damage is also observed in the enteric nervous system (Sabate et al,
1983) with the greatest damage to neurons in the ileum (Scholes et al., 1993). Motility
of equine small intestine from clinically normal tissues has previously been studied by
Ruckebusch and colleagues (1971). We have extended this technique to study tissue
taken from horses in various clinical categories of EGS. In particular we tested the
viability of the enteric cholinergic neurons and their capacity to release endogenous
acetylcholine, as well as the sensitivity of the cholinergic receptors.
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MATERIALS AND METHODS
Horses and ponies (100-450 kg) of each sex were killed by overdosage with
barbiturate and then bled out. Samples of smooth muscle were taken from 20 normal
and 12 grass sickness-affected horses. Horses were classified as 'normal' when
euthanasia was due to reasons unrelated to EGS (orthopaedic (4), ragwort poisoning
(1), laminitis (3), cardiovascular conditions (2), respiratory disease (2), immuno-
incompetence (1), experimental pony (3), urinary tract infection (1), trauma (1), liver
disease (2)); as 'acute' when they had nasogastric reflux, intestinal stasis and were
euthanized within 48 h of the initial diagnosis of equine grass sickness (AGS); and as
'chronic' when they had less severe clinical signs and had survived for 7 days or more
(CGS). Diagnosis of EGS was confirmed by post-mortem histological identification of
characteristic lesions in the caeliacomesenteric ganglia.
Samples of intestine were removed within 15 min of death and placed in modified
Krebs solution (sodium chloride 119.8 mmol/L, potassium chloride 3.4 mmol/L,
calcium chloride 3.0 mmol/L, magnesium chloride 0.6 mmol/L, sodium
hydrogencarbonate 26.2 mmol/L, sodium hydrogenphosphate 1.3 mmol/L, glucose
6.7 mmol/L). The Krebs solution was maintained at 37°C and aerated continuously
with a mixture of 95% oxygen and 5% carbon dioxide. The two sampling sites were
the caudal flexure of the duodenum and the terminal ileum proximal to the ileocaecal
fold. Strips of mucosa-free smooth muscle (3x0.5 cm) were cut parallel to the
longitudinal muscle layer and suspended vertically in an organ bath (35 ml) that
contained modified Krebs. Duodenal strips were loaded with a force of 2 g. The force
used for the ileal strips was more variable as these were more muscular and had a
tendency to coil tightly; for large horses the force needed was as high as 35 g. Tissue
taken from horses affected with EGS required a lower tension, the maximum being 10
g-
Motility was measured isometrically (Ruckebusch el al, 1971) using a Washington
Type D strain gauge transducer and recorder (Washington 400 MD2 ink writing
oscillograph). The parameters measured were rate of contraction (contraction peaks
over a 10-min period, amplitude (isometric force in grams of an individual contraction
that returned to the baseline), and tone (change in baseline). Latency was the time
before these parameters altered following the application of a drug. A 1-h
equilibration period was allowed. The drugs used were physostigmine sulphate (BDH
Chemicals) and bethanecol chloride (Sigma); the concentrations given in the text are
final concentrations. The data were analysed for statistical significance using the
Mann-Whitney U-test and analysis of variance.
Samples of gut adjacent to the test strips were also fixed for histology, but the
results from this work will be presented in a further paper comparing the histological
and physiological results.
RESULTS
When samples of small intestine were collected post-mortem the following
observations were made. 'Normal' intestine contained digesta, and spontaneous
contractile activity with segmentation was apparent. AGS-affected small intestine was
distended with fluid and there was very little visible movement of the gut.
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CGS-affected gut was flaccid with very little digesta present, although there often
appeared to be an increase in intestinal secretion.
Intestinal muscle strips were set up in organ baths and spontaneous contractions
developed within the 1-h equilibration period. The pattern of motility in the duodenal
strips was continuous spontaneous contractions (Table I), whereas the spontaneous
contractions of the ileal strips occurred in bursts alternating with periods of
quiescence (Figure lc). The pattern of spontaneous activity was the same for normal
and EGS-affected tissue.
TABLE I










Duodenum Normal 6.79 ± 0.53 7.35 ± 2.95
AGS 3.12 ± 0.68 12.25 ± 4.95
CGS 4.68 ± 1.02 14.35 ± 4.40
Ileum Normal 3.66 ± 0.53 12.73 ± 3.57
AGS 3.96 ± 0.76 15.48 ± 1.72
CGS 2.90 ± 1.08 8.95 ± 2.45
Physostigmine
There was little response by normal tissue to concentrations of physostigmine below
8.6 x 1(T8 mol/L. Above 2.8 x 10~5 mol/L, the tissues went into atony, with
sustained contraction and a prolonged recovery time. In the intermediate range, tissue
responded with measurable changes in both rate and tone (Figure la). It was
therefore decided to use a concentration of 8.6 x 10~6 mol/L to compare the
responses of the various tissues.
On addition of physostigmine, the rate of spontaneous contractions was enhanced
(Table II). Physostigmine caused a significantly greater proportional increase in the
rate of contraction of tissues from horses with AGS compared to preparations from
normal horses (p<0.05).
The rates of contractions after the addition of physostigmine to AGS or CGS
preparations of the ileum were not significantly different from their initial rates,
whereas with preparations from the duodenum the rate of contractions increased
significantly in all three groups (p < 0.05) after physostigmine was added.
For the duodenal strips, the latency before a response increased with the severity



















Figure 1. (a) Isometric trace from a duodenal muscle strip taken from a normal horse,
showing regular spontaneous activity. On addition of physostigmine (8.6 x 10"
mol/L), there is a short latency followed by an increase in both rate of contractions
and tone (baseline), (b) Isometric trace from a duodenal muscle strip taken from a
horse suffering from AGS; the initial rate of spontaneous contractions is much lower
than that for normal horses. On addition of physostigmine (8.6 x 1CT6 mol/L), the
latency before a response is observed is much longer and, although there is a rate
increase, there is little increase in tone, (c) Isometric trace from an ileal muscle strip
taken from a normal horse, showing two bursts of spontaneous contractions. After the
addition of physostigmine (8.6 x 10~fi mol/L), the interburst interval is shortened and
the spontaneous activity becomes more regular. There is also a small increase in tone,
(d) Isometric trace from an ileal muscle strip taken from a horse suffering from AGS.
A similar response as above (c) is observed but there is no increase in tone on the
addition of physostigmine (8.6 x 10~6 mol/L)
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AGS. An increase in tone in the intestinal strips was usually observed in response to
physostigmine, with the exception of ileal AGS preparations. In both duodenal and
ileal strips, the largest increase in tone was observed with tissue from horses suffering
from CGS (p<0.05).
Bethanecol
Bethanecol caused dose-dependent contractions with all smooth-muscle strips (Figure
2). However, the sensitivity of the tissues varied. Figure 3 shows the dose-response
curves with bethanecol. To calculate the ED5Q values, the individual data for each
experiment were normalized as a percentage of its maximal response. The maximum
response of the tissues as contraction amplitude in grams per gram of tissue (mean ±
SEM) were normal 38.6 ± 5.1, AGS 45.2 ± 9.1 and CGS 29.9 ± 4.8. AGS tissue was
also more sensitive to lower concentrations of bethanecol than normal or CGS tissue.
At 1 x 10"5 mol/L bethanecol (equivalent to -5 on the log scale, Figure 3), the
effects for the three different tissues were significantly different (p< 0.05). At other
concentrations the differences between the tissues were not significant, possibly
because of the small sample sizes. The ranking of the response at each concentration
of bethanecol showed the same trend: AGS, followed by normal, then CGS. AGS
material contracted to 50% of its maximum response at a much lower concentration
of bethanecol (8.7 x 10 7 mol/L) than normal (1.5 x 10 5 mol/L) or CGS (5.6 x
10"5 mol/L) material. The duration of the response to bethanecol was more
prolonged with material from AGS cases.
Figure 2. The response of a duodenal muscle strip taken from a normal horse to 0.1
mmol/L bethanecol
DISCUSSION
This in vitro preparation of equine small intestine demonstrated the presence of active
cholinergic mechanisms that were impaired in EGS. There were differences in the
sensitivity between tissues taken from normal horses and those with acute or chronic
EGS with both an anticholinesterase drug (physostigmine) and a muscarinic agonist
(bethanecol). It therefore appears that these results provide functional correlates with
the enteric neuronal cell degeneration known to occur in EGS (Sabate et al., 1983).
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log of concentration of bethanecol
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Figure 3. Dose-response curves with bethanecol for strips of equine duodenum.
'Normal' refers to horses euthanized owing to diseases unrelated to equine grass
sickness (n = 5). 'AGS' and 'CGS' refer to horses suffering from acute and chronic
equine grass sickness (n = 3 and n = 7, respectively)
Physostigmine
Physostigmine enhanced the motility of all the tissues studied, demonstrating the
viability of active cholinergic enteric neurons. However, in no case did the enhanced
rate of contractions in tissue from EGS cases approach the maximum found with
normal tissue, suggesting a reduced release of endogenous acetylcholine by tissues
taken from acute or chronic cases of EGS.
The prolonged latency with AGS tissue provides further evidence of a functional
deficit resulting from the nerve damage seen histologically in AGS. Fewer surviving
cholinergic neurons would be expected to take longer to release enough acetylcholine
to affect motility.
It appeared that the two regions of the gut were affected by EGS to different
degrees, with the ileum experiencing the greatest damage. Histological results have
also shown the greatest neuronal damage in the ileum (Scholes et al., 1993).
Functional identification of the damaged neurons has yet to be made.
The increase in tone produced by physostigmine was significantly greater in tissue
taken from CGS cases than in that from normal or AGS cases. This was a relative
change because the CGS duodenum was observed to be flaccid at collection and
absolute values for the tone are not known.
The enhanced rate of contraction and increased tone of equine intestinal tissue
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produced in vitro by physostigmine establishes a pharmacological basis for the
observed therapeutic usefulness of prokinetic drugs that may activate or supplement
the enteric cholinergic system in certain cases of grass sickness (Milne et al., 1994).
Bethanecol
Measurement of the peak tone produced by equimolar concentrations of bethanecol
demonstrated differences in the sensitivity of tissue taken from normal animals and
those with EGS. As shown in Figure 3, to reach 50% of its maximum response,
normal tissue requires 17 times as much bethanecol as tissue from an animal with
AGS. A number of mechanisms may be involved in this altered sensitivity to a
muscarinic agonist. There might be denervation hypersensitivity analogous to that
found in skeletal muscle (Janig, 1989) in which, following denervation, extrajunctional
muscarinic receptors of the fetal type are expressed on the muscle membrane, thus
increasing the sensitivity of the muscle (Ganong, 1991). Secondly, it is known that
pharmacologically active substances are released into gut tissue in EGS; these may
sensitize the muscle, and make it more excitable. Hyperactivity and subsequent
inactivation of neurons containing both VIP and substance P during EGS has been
proposed (Bishop et al., 1984; Hodson and Wright, 1987) and these mechanisms may
play a role in the changes in the excitability of muscle to cholinergic agents, as
reported here.
These results indicate that the loss of enteric neurons in EGS (Scholes et al., 1993)
leads to a reduction in the release of acetylcholine by cholinergic neurons that
accordingly reduces intestinal motility, the greatest detrimental effect occurring in
AGS and the ileum being affected to a greater extent than the duodenum. In addition,
sensitivity of the muscarinic receptors is altered, being enhanced in AGS but reduced
in CGS.
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